Search criteria | ||||
A real-world, retrospective, observational study examining treatment patterns and clinical outcomes in patients with FLT3m + AML in Japan | ||||
Toru Kiguchi 1, Masaya Sakurai 2, Yusuke Tanaka 2, Kazuyuki Kuramoto 2, Yuki Kado 3, Sono Sawada 3, Takeshi Mitomi 2 (rwesheorj 3) | ||||
1) Dokkyo Medical University Saitama Medical Center, Saitama, Japan 2) Astellas Pharma Inc., Tokyo, Japan 3) IQVIA Solutions Japan K.K., Tokyo, Japan | ||||
Current Medical Research and Opinion |
||||
, Abstract, Online article | ||||
, Japan | ||||
Abstract: https://www.tandfonline.com/doi/full/10.1080/03007995.2023.2271390 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2023 | English | , Database Study, Retrospective cohort analysis | |
The emerging role of real-world data in advanced breast cancer therapy: Recommendations for collaborative decision-making | ||||
Paul Cottu 1, Scott David Ramsey 2, Oriol Solà-Morales 3, Patricia A Spears 4, Lockwood Taylor 5 | ||||
1Department of Medical Oncology, Institut Curie, 26 Rue D'Ulm, 75005, Paris, France. Electronic address: paul.cottu@curie.fr. 2Hutchinson Institute for Cancer Outcomes Research, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, M2-B232, Seattle, WA, 98155, USA. Electronic address: sramsey@fredhutch.org. 3Health Innovation Technology Transfer Foundation, Aragó 60, E-08015, Barcelona, Spain. Electronic address: osola@fhitt.org. 48605 Carolingian Court, Raleigh, NC, 27615, USA. Electronic address: paspears88@gmail.com. 5Epidemiology, Real World Solutions at IQVIA, 4820 Emperor Boulevard, Durham, NC, 27703, USA. Electronic address: lockwood.taylor@iqvia.com. | ||||
Breast. 2021 Dec 22;61:118-122. doi: 10.1016/j.breast.2021.12.015. |
||||
, Article | ||||
, France, Italy, USA | ||||
Abstract: https://pubmed.ncbi.nlm.nih.gov/34959093/ | ||||
Condition | Year | Language | Analysis type | |
, Comparative Effectiveness & Health Technology Assessment, Drug safety, Oncology, Regulatory | 2022 | English | , Review | |
POSB392 Understanding the Secondary Care Characteristics and Pathways of Multiple Myeloma Patients Who Reach Second-Line Therapy Using the Hospital Episode Statistics (HES) Database | ||||
E Mary Babu S Fermahan S Chavda M Chetty S Navani A Matthew R Hudson | ||||
Sanofi, Reading, RDG, UK IQVIA, London, UK | ||||
Mary Babu, E et al. Value in Health, Volume 25, Issue 1, S257 |
||||
, Abstract, Article | ||||
, England | ||||
Abstract: https://www.valueinhealthjournal.com/article/S1098-3015(21)03050-3/fulltext#%20 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2022 | English | , Burden of illness, clinical setting: Secondary care, Database Study, Population Based Study, Retrospective database analysis | |
Assessing the correlation between second progression-free survival (PFS2) and overall survival (OS) in advanced prostate cancer patients using medical data vision (MDV) claims database in Japan | ||||
Masaki Shiota 1, Raf De Moor 2, Yosuke Koroki 2, Dae Young Yu 3, David Bin-Chia Wu 4 (rwesheorj A) | ||||
1) Department of Urology, Graduate School of Medical Sciences, Kyushu University Hospital, Fukuoka, Japan 2) Integrated Market Access, Janssen Pharmaceutical KK, Tokyo, Japan 3) Janssen Pharmaceutical Companies of Johnson and Johnson, Asia Pacific Regional Office, Singapore, Singapore 4) Janssen Pharmaceutical Companies of Johnson and Johnson, Asia Pacific Regional Office, Singapore, Singapore;e Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore;f School of Pharmacy, Monash University Malaysia, Bandar Sunway, Malaysia | ||||
Current Medical Research and Opinion |
||||
, Article | ||||
, Japan | ||||
Abstract: https://www.tandfonline.com/doi/full/10.1080/03007995.2022.2096353 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2022 | English | , Database Study | |
Validation of safety outcomes in routinely collected data: lessons learned from a multinational post-approval safety study | ||||
Arena PJ, Huang K, Löfling L, Bahmanyar S, Mo J, Schachterle SE, Nunes AP, Smits E, Juuti R, Hoti F, Korhonen P, Adelborg K, Sundbøll J, Rasmussen TR, Løkke A, Ehrenstein V. | ||||
"Pfizer Inc., New York, New York, United States of America. Department of Epidemiology, UCLA Fielding School of Public Health, Los Angeles, California, United States of America. EPID Research (an IQVIA company), Espoo, Finland." | ||||
Pharmacoepidemiol Drug Saf. 2022 Dec 10. doi: 10.1002/pds.5582 |
||||
, Article | ||||
, Denmark, Finland, Netherlands , Sweden, USA | ||||
Abstract: https://onlinelibrary.wiley.com/doi/10.1002/pds.5582 | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology, Drug safety, Oncology | 2022 | English | , Clinical setting: hospital, Clinical setting: Primary care, clinical setting: Secondary care, Retrospective database analysis | |
Patients' preferences for attributes of molecular targeting therapies for advanced non-small cell lung cancer with EGFR mutations in Japan - a discrete-choice experiment | ||||
Kazuhiko Nakagawa 1, Yoshinori Tanizawa 2, Zhihong Cai 2, Tomoko Matsui 2, Sotaro Enatsu 2 (rwesheorj A) | ||||
1) Kindai University, Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka, Japan 2) Eli Lilly Japan K.K., Japan Drug Development and Medical Affairs, Kobe, Japan | ||||
Japanese Journal of Cancer and Chemotherapy |
||||
, Article | ||||
, Japan | ||||
Abstract: https://www.pieronline.jp/content/article/0385-0684/49120/1329 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2022 | Japanese | , Patient questionnaire | |
Budget impact analysis of next-generation sequencing versus sequential single-gene testing in Japanese patients with advanced non-small-cell lung cancer | ||||
Hiroyuki Matsuda 1, Toru Ogawa 2*, Yasunari Sadatsuki 3, Toshiaki Tsujino 3, Shingo Wada 1, Seok-Won Kim 1, Yutaka Hatanaka 4 (rwesheorj 1) | ||||
1) Real World Evidence Solutions & HEOR, IQVIA Solutions Japan K.K., Tokyo, Japan 2) Market Access Oncology, Bayer Yakuhin, Ltd, Osaka, Japan 3) Medical Affairs & Pharmacovigilance, Bayer Yakuhin, Ltd, Osaka, Japan 4) Research Division of Genome Companion Diagnostics, Hokkaido University Hospital, Hokkaido, Japan | ||||
Respiratory Investigation |
||||
, Article | ||||
, Japan | ||||
Abstract: https://www.sciencedirect.com/science/article/pii/S2212534522001435?via%3Dihub | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2022 | English | , Budget impact, Database Study | |
Characteristics, treatment patterns, and healthcare costs of advanced/metastatic biliary tract cancer patients in Japan | ||||
CC Chen 1, X Wang 1, Seok-Won Kim 2*, Shingo Wada 2, J Garside 3, ES Reese 4 (rwesheorj 2) | ||||
1) IQVIA, Plymouth Meeting, PA, USA 2) IQVIA, Tokyo, Japan 3) GlaxoSmithKline, London, UK 4) EMD Serono Research & Development Institute, Inc, Billerica, MA, USA, an affiliate of Merck KGaA | ||||
Japanese Society of Medical Oncology Annual Meeting |
||||
, Conference, Oral presentation | ||||
, Japan | ||||
Abstract: https://www.c-linkage.co.jp/jsmo2022/en/index.html | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2022 | English | , Database Study | |
Prognosis of lung cancer patients treated with immune checkpoint inhibitors with or without antimicrobial history | ||||
Ryohei Kobayashi 1, Kenji Kanagawa 1, Sanesue Yasukawa 1, Takuma Kondo 1, Shingo Wada 2 (rwesheorj 2) | ||||
1) IQVIA Services Japan K.K. 2) IQVIA Solutions Japan K.K. | ||||
The 27th Annual Meeting of the Japanese Society for Pharmacoepidemiology |
||||
, Conference, Oral presentation | ||||
, Japan | ||||
Abstract: https://www.jspe.jp/meeting/soukai/272022.html | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2022 | Japanese | , Database Study, Retrospective cohort analysis | |
High‑Expenditure Disease in the EU‑28: Does Drug Spend Correspond to Clinical and Economic Burden in Oncology, Autoimmune Disease and Diabetes? | ||||
Wolfgang Greiner, Keyur Patel, Christina-Jane Crossman-Barnes, Troels Vingtoft Rye-Andersen, Christian Hvid, Tom Vandebrouck | ||||
Department for Health Economics, Bielefeld University, Bielefeld, Germany; IQVIA Ltd, HEOR, London, UK; Novo Nordisk Region Europe Pharmaceuticals A/S, Copenhagen, Denmark; Novo Nordisk Region Europe Pharmaceuticals A/S, Brussels, Belgium | ||||
PharmacoEconomics-Open. 2021 Jan; doi.org/10.1007/s41669-020-00253-4 |
||||
, Article | ||||
, Europe | ||||
Abstract: https://link.springer.com/epdf/10.1007/s41669-020-00253-4?sharing_token=k4IP2sUMn4HrAsHs0WBqlPe4RwlQNchNByi7wbcMAY4Tirkz8MqaNXdxznG7LjXgeeOE1lL_TUFtfOXdhNB_IQ05wAS6SyWtTgC3QV4GkZ1V3rKbHAI_lwyKV2fZ5OfrjVrTPTsYaJr4E7ZctQaMI_Yhmg_dNtoFcG1705dWSU4%3D | ||||
Condition | Year | Language | Analysis type | |
, Diabetes, Health economics, Oncology | 2021 | English | , Burden of illness, Clinical setting: Primary care, clinical setting: Secondary care, Epidemiological study, Literature Review, Quality of life, Retrospective database analysis, Review | |
Analisi di impatto sul budget sanitario italiano di gilteritinib per il trattamento della leucemia mieloide acuta FLT3+ recidivante o refrattaria | ||||
Fiorentino F, La Malfa P, Di Rienzo P | ||||
Fiorentino F: IQVIA Solutions Italy Srl, RWS | ||||
GIHTAD (2021) 14:4 |
||||
, Article | ||||
, Italy | ||||
Abstract: https://springerhealthcare.it/GIHTAD/2021/07/05/analisi-di-impatto-sul-budget-sanitario-italiano-di-gilteritinib-%E2%80%A8per-il-trattamento-della-leucemia-mieloide-acuta-flt3-recidivante-%E2%80%A8o-refrattaria/ | ||||
Condition | Year | Language | Analysis type | |
, Health economics, Oncology | 2021 | Italian | , Budget impact, clinical setting: Secondary care | |
Real-World Profiling of Non-Small Cell Lung Cancer Patients in Japan | ||||
Elaine Chang Takahashi 1, Shiho Wakase 2, Masayuki Ito 1, Todd D Taylor 3 (rwesheorj 3) | ||||
1) Novartis Pharma K.K., Minato-ku, Japan 2) Novartis Pharma K.K., Tokyo, Japan 3) IQVIA Solutions Japan K.K., Minato-ku, Tokyo, Japan | ||||
ISPOR Europe 2021 |
||||
, Conference, Poster, Presentation | ||||
, Japan | ||||
Abstract: https://www.ispor.org/heor-resources/presentations-database/presentation/euro2021-3407/111943 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2021 | English | , Database Study, Real World Evidence | |
Descriptive study on burden and communication of fatigue among castration-resistant prostate cancer patients in Japan | ||||
Taro Iguchi 1, Yusuke Nakamura 2, Takeshi Akiyama 3, Krishant Chand 3, Eric Yu 3 (rwesheorj 3) | ||||
1) Department of Urology, Kanazawa Medical University 2) Market and Regional Access, Bayer Yakuhin, Ltd 3) Real World Evidence Solutions, IQVIA Solutions Japan K.K. | ||||
Current Medical Research and Opinion |
||||
, Article | ||||
, Japan | ||||
Abstract: https://www.tandfonline.com/doi/full/10.1080/03007995.2021.2006534 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2021 | English | , Burden of illness, Observational study, Patient questionnaire, Population Based Study, Real World Evidence, Survey research | |
Modernizing Oncology Approvals | ||||
Christina Mack | ||||
CAEG | ||||
PharmaVoice. 2021 Mar |
||||
, Article | ||||
, USA | ||||
Abstract: https://www.pharmavoice.com/news/2021-03-modernizing-oncology-approvals/612107/ | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2021 | English | , clinical setting: Secondary care | |
Trifluridine/tipiracil hydrochloride in the treatment of polytreated metastatic colorectal carcinoma: a cost-effectiveness analysis in the private payer perspective in Brazil | ||||
Fernando Meton de Alencar Camara Vieira (1); Ana Paula Ornellas de Souza Victorino (1); Kelly Borges Araújo (1); Bianca Oesterreicher (2); Pedro Vitor Pereira Lima (2); Luciana Calvo Mardegan (3); Sandro Albuquerque (3); Juliana Simões Festa de Vasconcellos (3) | ||||
1: Instituto COI de Educação e Pesquisa, Rio de Janeiro, RJ, Brasil; 2: IQVIA Solutions, Real World Insights, São Paulo, SP, Brasil; 3: Laboratórios Servier, Rio de Janeiro, RJ, Brasil. | ||||
, Article | ||||
, Brazil | ||||
Abstract: https://jbes.com.br/wp-content/uploads/2022/01/DOI_10_21115_JBES_v13_n3_p242-52.pdf | ||||
Condition | Year | Language | Analysis type | |
, Health economics, Oncology | 2021 | Portuguese | , Cost effectiveness | |
Modernizing Regulatory Evidence with Trials and Real-World Studies | ||||
Nancy A. Dreyer PhD, MPH, FISPE, Marni Hall PhD, MPH & Jennifer B. Christian PharmD, MPH, PhD, FISPE | ||||
IQVIA Real World Solutions, 201 Broadway, 5th Floor, Cambridge, MA, 02139, USA Nancy A. Dreyer PhD, MPH, FISPE IQVIA Real-World Solutions, Rockville, MD, USA Marni Hall PhD, MPH IQVIA Real World Solutions, Research Triangle Park, NC, USA Jennifer B. Christian PharmD, MPH, PhD, FISPE | ||||
Ther Innov Regul Sci (2020). https://doi.org/10.1007/s43441-020-00131-5 |
||||
, Article | ||||
, USA | ||||
Abstract: https://link.springer.com/article/10.1007%2Fs43441-020-00131-5 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2020 | English | , Retrospective database analysis | |
The Burden Of Hpv In Head And Neck Cancers - Design Of The Broaden Study | ||||
Gómez Ulloa D1, Morais E2, Fenoll R1, Kothari S3, Giuliano A4, Mirghani H5, Mehanna H6, Waterboer T7, Roberts C3, Varga S3, Tu Y3, Pérez G3, Saah A3, Alemany L8 | ||||
1 IQVIA, Barcelona, Spain 2 MSD, CORE, Lyon, France 3 Merck & Co. Inc., Center for Observational and Real-world Evidence, Kenilworth, NJ, US 4 Moffitt Cancer Center and Research Institute, Center for Immunization and Infection Research in Cancer, Tampa, FL, US 5 HEGP, ORL, Paris, France 6 InHANSE, Head and Neck Surgery, Birmingham, UK 7 German Cancer Research Center (DKFZ), Infections and Cancer Epidemiology, Heidelberg, Germany 8 Catalan Institute of Oncology - IDIBELL, On behalf of Unit of Cancer and Infection in the Cancer Epidemiology Research Programme, Hospitalet Del Llobregat, Spain | ||||
IPVC, Barcelona, Spain, 23-27 March 2020 |
||||
, Oral presentation | ||||
, China, France, Germany, Italy, Japan, Portugal, Spain | ||||
Condition | Year | Language | Analysis type | |
, Infectious disease, Oncology | 2020 | English | , Burden of illness, Observational study, Retrospective Field Study | |
Real-world clinical outcomes for third-line standard of care regimens in deficient mismatch repair (dMMR) or microsatellite instability high (MSI-H) metastatic colorectal cancer (mCRC) in France | ||||
Cohen R1, Thierry A1, Roset M2, Amonkar M3, Patel R3, Lara N2, Kothari S3, Tougeron D4 | ||||
1 Sorbonne Université, medical oncology department, AP-HP, hôpital Saint-Antoine, F-75012 Paris, France 2 IQVIA, Barcelona, Spain 3 Merck & Co, Inc., Kenilworth, NJ, US 4 Gastroenterology Department, Poitiers University Hospital and University of Poitiers, Poitiers, France | ||||
ESMO GI, Barcelona, Spain 1-4 July 2020 |
||||
, Poster | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2020 | English | , Observational study, Population Based Study, Retrospective Field Study | |
Real-world treatment patterns, healthcare resource use and clinical outcomes of patients receiving second line therapy for advanced or metastatic gastric cancer | ||||
Gomez-Ulloa D1, Amonkar M2, Kothari S3, Cheung WY4, Chau I5, Zalcberg J6, Lara N1, Falcone A7 | ||||
1 IQVIA, Barcelona, Spain 2 Merck & Co., Inc., North Wales, PA, US 3 Merck & Co., Inc., Kenilworth, NJ, US 4 British Columbia Cancer Agency, Vancouver, BC, Canada 5 Royal Marsden Hospital, London, UK 6 Alfred Health, Melbourne, Australia 7 University of Pisa, Pisa, Italy | ||||
BMC Gastroenterology BMC Gastroenterology volume 20, Article number: 133 (2020) |
||||
, Article | ||||
, Australia, Canada, Italy, UK | ||||
Abstract: https://doi.org/10.1186/s12876-020-01232-z | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2020 | English | , Retrospective cohort analysis | |
Nivolumab-treated non-small cell lung cancer patients in the United Kingdom | ||||
Carroll R1, Tanna N1, Ghosh S2, Sanchez E3, Stawiarska Z4, Gemmen E5 | ||||
1 Bristol-Myers Squibb, Uxbridge, UK 2 IQVIA, Gurugram, India 3 IQVIA, Barcelona, Spain 4 IQVIA, Warsaw, Poland 5 IQVIA, Rockville, MD, US | ||||
BMC Gastroenterology |
||||
, Article | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2020 | English | , Observational study, Population Based Study, Retrospective Field Study | |
Annualized Hospitalization Rate With Natalizumab vs Fingolimod in Second-Line Treatment for RRMS in the Public Healthcare System in Brazil: A Claim Database Approach | ||||
Guilherme Silva Julian 1, Ricardo Papaléo Rosim 2, Estela Cristina Carneseca 3, Jéssica Rigolon 2 | ||||
1 IQVIA Brasil, São Paulo-SP, Brazil. 2 Biogen Brasil, São Paulo-SP, Brazil. 3 Proestat Consultoria Estatística, Ribeirão Preto-SP, Brazil. | ||||
PMID: 32119696 PMCID: PMC7051079 DOI: 10.1371/journal.pone.0229768 |
||||
, Article | ||||
, Brazil | ||||
Abstract: https://pubmed.ncbi.nlm.nih.gov/32119696/ | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2020 | English | , Retrospective database analysis | |
Descriptive study on perceptions and communication of fatigue among castration resistant prostate cancer (CRPC) patients in Japan | ||||
Taro Iguchi 1, Y Nakamura 2, Takeshi Akiyama 3, Krishant Chand 3, Eric Yu 3 (rwesheorj 3) | ||||
1) Osaka City University Graduate School of Medicine Urology and Pathology 2) Bayer Yakuhin Co., Ltd. Market Access Headquarters 3) IQVIA Solutions Japan Co., Ltd. Real World Evidence Solutions | ||||
Japanese Urological Association 2020 Annual Meeting |
||||
, Abstract, Conference, Presentation | ||||
, Japan | ||||
Abstract: http://www.congre.co.jp/jua2020/program/files/program_1223.pdf | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2020 | English | , Patient questionnaire, Survey research | |
Patient preferences, treatment satisfaction, and quality of life in newly diagnosed and relapsed/refractory multiple myeloma patients receiving injectable-containing or fully oral therapies: the EASEMENT study | ||||
Neil Rabin1, Rami Kotb2, Athanasios Zomas3, Alonso Fernandez-Nistal3, Rocco D’Ambrosio3, Nawal Bent-Ennakhil3, Montserrat Roset4, Ombretta Annibali5 | ||||
1 University College London Hospitals, London, and North Middlesex University Hospital, UK; 2 CancerCare Manitoba, Winnipeg, Manitoba, Canada; 3 Takeda Pharmaceuticals International AG, Zurich, Switzerland; 4 IQVIA, Barcelona, Spain; 5 Università Campus Bio-Medico di Roma, Rome, Italy | ||||
COMy (the 6th World Congress on Controversies in Multiple Myeloma), Virtual congress, 3-4 October 2020 |
||||
, Poster | ||||
, Canada, Italy, UK | ||||
Condition | Year | Language | Analysis type | |
, Hematology, Oncology | 2020 | English | , Population Based Study | |
A RETROSPECTIVE COHORT STUDY OF THE NATIONAL HEALTHCARE RESOURCE UTILISATION (HCRU) AND COSTS OF TREATING MULTIPLE MYELOMA (MM) IN FRANCE USING THE SYSTÈME NATIONAL DES DONNÉES DE SANTÉ (SNDS) DATABASE | ||||
A. Bessou X. Colin J. De Nascimento W. Sopwith S.A. Ferrante B. Gorsh B. Gutierrez L. Sansbury J. Willson S. Sapra F. Wang | ||||
1 IQVIA, Paris, France 2 GlaxoSmithKline, Rueil Malmaison, 92, France, 3 IQVIA,La Defense Cedex, 75, France, 4 IQVIA, London, UK, 5 Value Evidence and Outcomes, GlaxoSmithKline, Upper Providence, PA, USA, 6 Value Evidence and Outcomes, GlaxoSmithKline, Research Triangle Park, NC, USA, 7 Value Evidence and Outcomes, GlaxoSmithKline, London, UK | ||||
DOI:https://doi.org/10.1016/j.jval.2020.08.250 |
||||
, Abstract | ||||
, France | ||||
Abstract: https://www.valueinhealthjournal.com/article/S1098-3015(20)32506-7/fulltext | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2020 | English | , Observational study, Population Based Study | |
Adoption of immuno-oncology in NSCLC, a real-world study in EU5. | ||||
Alejandra Martinez De Pinillos,Isabel Ricote Lobera,Cristina Martinez,Caroline Anger,Filippo Guglielmetti,Roberto Jorge Bitton | ||||
IQVIA, London, United Kingdom; IQVIA, Madrid, Spain; IQVIA, Milan, Italy; IQVIA, Buenos Aires, Argentina | ||||
Journal of Clinical Oncology201937:15_suppl,e20631-e20631 |
||||
, Abstract | ||||
, France, Germany, Italy, Spain, UK | ||||
Abstract: https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.e20631 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2019 | English | , Retrospective database analysis | |
Validating an algorithm for multiple myeloma based on administrative data using a SEER tumor registry and medical record review. | ||||
Brandenburg NA1, Phillips S2, Wells KE3, Woodcroft KJ3, Amend KL4, Enger C4, Oliveria SA2 | ||||
1 - Global Drug Safety and Risk Management, Celgene Corporation, Summit, New Jersey, USA. 2 - IQVIA, New York, New York, USA. 3 - Department of Public Health Sciences, Henry Ford Health System, Detroit, Michigan, USA. 4 - Department of Epidemiology, Optum, Ann Arbor, Michigan, USA | ||||
Front Oncol. 2016;6:224. Published 2016 Oct 27. doi:10.3389/fonc.2016.00224 |
||||
, Article | ||||
, USA | ||||
Abstract: https://onlinelibrary.wiley.com/doi/epdf/10.1002/pds.4711 | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology, Oncology | 2019 | English | , Epidemiological study, Observational study, Retrospective cohort analysis, Retrospective database analysis | |
A REVIEW OF SWEDISH HEALTH TECHNOLOGY ASSESSMENTS BASED ON INDIRECT COMPARISONS OF HOSPITAL DRUGS IN ONCOLOGY | ||||
Rongrong Zhang, Heller Vincent, Maximilian Schlueter, Ashley Pitcher | ||||
IQVIA | ||||
ISPOR Europe, Copenhagen, Denmark, 2-6 November 2019 |
||||
, Abstract | ||||
, Sweden | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2019 | English | , Clinical setting: Home care, Review | |
Predicting Outcomes in Patients With Diffuse Large B-Cell Lymphoma Treated With Standard of Care | ||||
Galaznik A, Reich C, Klebanov G, Khoma Y, Allakhverdiiev E, Hather G, Shou Y | ||||
Cancer Inform. 2019 Mar 15;18:1176935119835538. doi: 10.1177/1176935119835538. eCollection 2019 |
||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/30906191 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2019 | English | , Methodology | |
Real-world evidence on patients with relapse/refractory FLT3 mutation-positive acute myeloid leukemia in Italy | ||||
La Malfa P1, Arenga A1, De Santo E1, Urbinati D1 | ||||
1 IQVIA, Milan, Italy | ||||
ISPOR 22nd Annual European Congress, 2-6 November 2019, Copenhagen, Denmark |
||||
, Poster | ||||
, Italy | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2019 | English | , Real World Data, Real World Evidence | |
Change in treatment paradigm of ALK+ Non-Small Cell Lung Cancer (NSCLC) in the Italian real practice | ||||
Tucci C1, Urbinati D1, De Santo E1, Fico M2, Fioravanti L2, Demma F2 | ||||
1 IQVIA, Milan, Italy 2 Takeda, Rome, Italy | ||||
ISPOR 22nd Annual European Congress, 2-6 November 2019, Copenhagen, Denmark |
||||
, Poster | ||||
, Italy | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2019 | English | , Public Health, Real World Data, Real World Evidence | |
Brentuximab Vedotin for consolidation therapy after ASCT in CD30+ Hodgkin's limphoma: a sustainable pharmaceutical expenditure for the Italian National Health Service | ||||
Peduto I1, Heiman F1, Morelli P2, Fioravanti L2, Demma F2 | ||||
1 IQVIA, Milan, Italy 2 Takeda, Rome, Italy | ||||
ISPOR 22nd Annual European Congress, 2-6 November 2019, Copenhagen, Denmark |
||||
, Poster | ||||
, Italy | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2019 | English | , Cost analysis, Economic evaluation | |
The Close Link between Anxiety and Cluster Symptoms in Lung Cancer Patients during First-Line Chemotherapy | ||||
Carnio S1, Galetta D2, Pilotto S3, Scotti V4, Cortionovis DL5, Antonuzzo A6, Pisconti S7, Rossi A8, Martelli O9, Cecere FL10, Lunghi A11, Del Conte A12, Montrone M2, Topulli J4, Canova S5, Rapetti SG1, Gianetta M1, Pacchiana MV1, Capelletto E1, Pegoraro V13, Cataldo N13, Bria E3 and Novello S1 | ||||
1 Thoracic Oncology Unit, San Luigi Hospital, University of Turin, Orbassano, Italy 2 Clinical Cancer Center Giovanni Paolo II, Bari, Italy 3 U.O.C. Oncology, Department of Medicine, University of Verona, Italy 4 Department of Oncology Radiation Therapy Unit, Careggi University Hospital, Florence, Italy 5 Medical Oncology Unit, San Gerardo Hospital, Monza, Italy 6 Division of Medical Oncology Department of Oncology, S. Chiara University Hospital, Pisa, Italy 7 Department of Onco-Ematology Medical Oncology, SG Moscati Hospital, Taranto, Italy 8 Division of Medical Oncology, IRCCS Casa Sollievo della Sofferenza Hospital, San Giovanni Rotondo (FG) 9 Medical Oncology Unit, San Giovanni Addolorata Hospital, Roma, Italy 10 Medical Oncology 1, Regina Elena National Cancer Institute, Roma, Italy 11 Department of Oncology, Medical Oncology Unit, Careggi University Hospital, Florence, Italy 12 IRCCS - Oncological Reference Center (CRO) - U.O. Oncology, Pordenone-S. Vito, Italy 13 IQVIA, Milan, Italy | ||||
J Cancer Sci Ther 2018, 10:9 |
||||
, Article | ||||
, Italy | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2019 | English | , Survey research | |
Use of subcutaneous and intravenous trastuzumab: real-world experience from three hospitals in Sweden. | ||||
Valachis A, Sundqvist M, Carlsson L, Li B, Chiesa F, Uhde M, Sanglier T | ||||
Department of Oncology, Faculty of Medicine & Health, ?rebro University, SE 70182 ?rebro, Sweden (Valachis) AND Real World & Analytic Solutions (RWAS), IQVIA, Stockholm, Sweden (Milica Uhde) | ||||
Future Oncol. 2019 Aug;15(23):2733-2741. doi: 10.2217/fon-2019-0160. Epub 2019 Jul 15. |
||||
, Article | ||||
, Nordic, Sweden | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/31306041 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2019 | English | , Clinical setting: hospital, Epidemiological study, Retrospective cohort analysis | |
An Exploratory Analysis of Real-World Endpoints for Assessing Outcomes Among Immunotherapy-Treated Patients with Advanced Non-Small Cell Lung Cancer. | ||||
Stewart M, Norden AD, Dreyer N, Henk HJ, Abernethy AP, Chrischilles E, Kushi L, Mansfield AS, Khozin S, Sharon E, Arunajadai S, Carnahan R, Christian JB, Miksad RA, Sakoda LC, Torres AZ, Valice E, Allen J. | ||||
JCO Clinical Care Informatics 2019. 3:1-15. |
||||
, Article | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2019 | English | ||
Observational evidence from patients diagnosed with chronic lymphocytic leukaemia (CLL) in Finland between 2005-2015 show improved survival over time. | ||||
Lindström V, Hakkarainen KM, Mehtälä J, Klement R, Leval A, Järvinen TM | ||||
VL: Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center and University of Helsinki, Helsinki, Finland. JM, KMH: StatFinn & EPID Research. AL, TMJ: Janssen-Cilag. | ||||
Eur J Haematol. 2019 Sep;103(3):190-199. doi: 10.1111/ejh.13273. |
||||
, Article | ||||
, Finland, Nordic | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/31210368 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2019 | English | , Clinical setting: hospital, Epidemiological study, Observational study, Retrospective cohort analysis | |
A Survey Among Health Care Professionals to Assess Their Knowledge and Understanding on Darzalex® (Daratumumab) Educational Materials Regarding the Risk of Interference for Blood Typing in 12 European Countries | ||||
Mathieu Rosé, Intissar Bourahla, Alessandro Ghiddi, Assem Al-Akabawi, Edmond Chan, Massoud Toussi | ||||
IQVIA, Courbevoie, France; Janssen EMEA, Medical Affairs, Italy; Janssen EMEA, Medical Affairs, UK | ||||
Presented at ISPE’s 35th International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE 2019), August 24–28, 2019 at the Pennsylvania Convention Center, Philadelphia, PA, USA. |
||||
, Poster | ||||
, Austria, Czech, Denmark, Finland, France, Germany, Hungary, Norway, Slovakia, Spain, Sweden, Switzerland | ||||
Abstract: https://www.coodoc.com/pages/p1822-Daratumumab-ICPE-2019 | ||||
Condition | Year | Language | Analysis type | |
, Hematology, Oncology | 2019 | English | , Public Health, Survey research | |
Real-world data confirming the efficacy and safety of decitabine in acute myeloid leukaemia - results from a retrospective Belgian registry study. | ||||
Meers S1, Bailly B2, Vande Broek I3, Malfait B4, Van Hoorenbeeck S4, Geers J4, Braakman J5, Van Kouwenhove M6, Doyle M7, Diels J8, Caekelbergh K9, Chevalier P9, Dierickx D10. | ||||
1 Department Oncology, AZ Klina , Brasschaat , Belgium. 2 Department Haematology, Groupe Jolimont , Haine Saint-Paul , Belgium. 3 Department Oncology, AZ Nikolaas , Haematology, Sint Niklaas , Belgium. 4 Department Market Access, Janssen-Cilag NV , Beerse , Belgium. 5 Department Market Access, Janssen-Cilag BV , Breda , The Netherlands. 6 Department Medical, Janssen-Cilag BV , Breda , The Netherlands. 7 Department Medical, Janssen Ireland , Dublin 24 , Ireland. 8 Department Statistics and Modelling, Janssen Pharmaceutica NV , Beerse , Belgium. 9 Department Real-World Solutions, IQVIA , Zaventem , Belgium. 10 Department Haematology, UZ Leuven , Leuven , BelgiumDepartment Haematology. | ||||
, Abstract | ||||
, Belgium | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/31551014 | ||||
Condition | Year | Language | Analysis type | |
, Infectious disease, Oncology | 2019 | English | , Retrospective database analysis | |
Real-world treatment patterns and clinical outcomes in patients receiving second-line (2L) treatment for advanced or metastatic gastric cancer (GC) | ||||
Amonkar M1, Gomez-Ulloa D2, Smita Kothari1, Cheung WY3, Chau I4, Zalcberg JR5, Lara N2, Falcone A6 | ||||
1 Merck & Co., Inc., Kenilworth, NJ, USA 2 IQVIA, Barcelona, Spain 3 British Columbia Cancer Agency, Vancouver, BC, Canada 4 Royal Marsden Hospital, London, UK 5 Alfred Health, Melbourne, Australia 6 University of Pisa, Pisa, Italy | ||||
BMC Gastroenterology volume 20, Article number: 133 (2020) |
||||
, Poster | ||||
, Australia, Canada, Italy, UK | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2019 | English | , Retrospective cohort analysis | |
Cost-offsets in relapsed/refractory multiple myeloma and resource consumption derived from Italian real practice | ||||
Ripellino C, Pegoraro V, Heiman F | ||||
Ripellino C: HEOR Consultant Freelance, Milan, Italy. Pegoraro V: Medical Writer & HEOR Consultat, IQVIA, RWS, Milan, Italy. Heiman F: HEOR Engagement Manager, IQVIA, RWS, Milan, Italy | ||||
CLINICO ECONOMICS ITALIAN ARTICLES ON OUTCOMES RESEARCH / VOL 14 / YEAR 2019 / PAG. 55-64 |
||||
, Article | ||||
, Italy | ||||
Abstract: http://www.clinicoeconomics.eu/articles/flipbook/14_2019_55-64/ | ||||
Condition | Year | Language | Analysis type | |
, Health economics, Oncology | 2019 | Italian | , Cost analysis | |
Use of Breast Cancer Screening and Its Association with Later Use of Preventive Services among Medicare Beneficiaries | ||||
Stella Kang; Miao Jiang; Richard Duszak, Jr.; Samantha Heller; Danny Hughes; Linda Moy | ||||
Stella Kang (Department of Radiology, NYU School of Medicine); Miao Jiang (IQVIA); | ||||
Radiology |
||||
, Article | ||||
, USA | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/29869958 | ||||
Condition | Year | Language | Analysis type | |
, Health policy, Oncology | 2018 | English | , Observational study, Population Based Study, Public Health, Retrospective cohort analysis | |
A HEALTH STATE UTILITY MODEL ESTIMATING THE IMPACT OF IVOSIDENIB ON QUALITY OF LIFE IN PATIENTS WITH RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA | ||||
Wehler EA, Storm M, Kowal S, Campbell C, Boscoe A | ||||
IQVIA | ||||
European Hematology Association |
||||
, Poster | ||||
, USA | ||||
Abstract: https://learningcenter.ehaweb.org/eha/2018/stockholm/215730/michael.storm.a.health.state.utility.model.estimating.the.impact.of.ivosidenib.html?f=ce_id=1346*ot_id=19069*media=3*speaker=664497 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | , Utility analysis | |
Real-World Study of Comorbidities and Complications in Relapsed/Refractory Acute Myeloid Leukemia Patients Identified Using a Claims-based Algorithm | ||||
Shahed Iqbal, Aimee Near, Neil Dhopeshwarkar, Huan Huang, Maribel Salas, Kathy Lang | ||||
Huan Huang and Aimee Near are IQVIA authors | ||||
ICPE (International Conference on Pharmacoepidemiology and Therapeutic Risk Management) |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | , Population Based Study, Retrospective database analysis | |
Real-world Treatment Patterns for Patients with Head and Neck Squamous Cell Carcinoma (HNSCC) Treated with Immuno-oncology Therapy | ||||
Huan Huang, Rahul Shenolikar, Brian Seal, Jenny Tse, Chakkarin Burudpakdee | ||||
Huan Huang, Jenny Tse and Chakkarin Burudpakdee are IQVIA authors | ||||
ISPOR |
||||
, Poster | ||||
, USA | ||||
Abstract: https://www.valueinhealthjournal.com/article/S1098-3015(18)30588-6/fulltext | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | , Population Based Study, Retrospective database analysis | |
Contemporary real-world evidences on ALK+ NSCLC patients in Italy | ||||
Tucci C1, Trimarchi C1, Urbinati D1, Demma F2, Fico M2, Fioravanti L2 | ||||
1 IQVIA, RWI, Milan, Italy 2 Takeda, Italy | ||||
ISPOR 21th Annual European Congress, 10-14 November 2018, Barcelona, Spain |
||||
, Poster | ||||
, Italy | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | , Database Study, Real World Data, Real World Evidence | |
Emerging trends in the management of NSCLC PD-L1+ patients in Italy | ||||
Trimarchi C1, Arenga A1, De Santo E1, Urbinati D1 | ||||
1 IQVIA, RWI, Milan, Italy | ||||
ISPOR 21st Annual European Congress, 10-14 November 2018, Barcelona, Spain |
||||
, Poster | ||||
, Italy | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | , Database Study, Real World Data, Real World Evidence | |
Cost-offsets associated with the new triplets available for the treatment of relapsed/refractory multiple myeloma and resource consumption derived from Italian real practice | ||||
Ripellino C1, Peduto I2, Heiman F2, Fioravanti L3, Rea M3, Demma F3 | ||||
1 HEOR Consultant Freelance, Milan, Italy 2 IQVIA, RWI, Milan, Italy 3 Takeda Italia S.p.a., Rome, Italy | ||||
ISPOR 21st Annual European Congress, 10-14 November 2018, Barcelona, Spain |
||||
, Poster | ||||
, Italy | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | , Cost analysis, Economic evaluation | |
Patterns of care and of biomolecular characterization of Right, Transverse, and Left Colorectal Cancer from real-life evidence in Asia Pacific and European countries | ||||
Ettore M1, Mpima S2, Guglielmetti F1, Nasuti P2 | ||||
1IQVIA , Milan, Italy 2IQVIA , London, UK | ||||
ESMO 2018 |
||||
, Poster | ||||
, China, France, Germany, Italy, Japan, South Korea, Spain, UK | ||||
Abstract: ESMO 2018 Congress | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | ||
Patterns of Therapy in Regional Lymph Node Positive Prostate Cancer in Europe and Asia: An International Analysis | ||||
Prentice M1, Mpima S2, Martinez de Pinillos A2, Nasuti P2, Davda R, Payne H 1 | ||||
1 University College Hospital, London, UK 2 IQVIA , London, UK | ||||
ESMO 2018 |
||||
, Poster | ||||
, China, France, Germany, Italy, Japan, South Korea, Spain, UK | ||||
Abstract: ESMO 2018 Congress | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | ||
Initial Management of localised prostate cancer in the Elderly: An International Data Review | ||||
Prentice M1, Mpima S2, Martinez de Pinillos A2, Nasuti P2, Davda R1, Payne H1 | ||||
1 University College Hospital, London, UK 2 IQVIA , London, UK | ||||
SIOG 2018 |
||||
, Poster | ||||
, China, France, Germany, Italy, Japan, South Korea, Spain, UK | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | ||
COMPARING THE ROLE OF DIFFERENT SPECIALITIES IN THE MANAGEMENT OF PROSTATE CANCER IN FRANCE AND ITALY: INSIGHTS FROM A REAL-WORLD STUDY | ||||
Mpima S , Nasuti P , Casey V | ||||
IQVIA London , UK | ||||
ISPOR Europe 2018 |
||||
, Poster | ||||
, France, Italy | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | , Clinical setting: Primary care | |
Profiling and treatment patterns in NSCLC patients with CNS (brain) metastases in Europe and Asia | ||||
Mari E1, Mpima S2, Guglielmetti F1, Nasuti P2, Manuguid F2, Heitner Enschede S3 | ||||
1IQVIA , Milan, Italy 2IQVIA , London, UK 3IQVIA Inc, USA | ||||
JCO ( ASCO 2018) |
||||
, Abstract | ||||
, Asia Pacific, China, Europe, France, Germany, Italy, Japan, South Korea, Spain, UK | ||||
Abstract: http://ascopubs.org/doi/abs/10.1200/JCO.2018.36.15_suppl.e21085 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | ||
EVALUATING NSCLC TREATMENT OPTIONS USING REAL WORLD DATA: FINDINGS FROM AN ONCOLOGY SURVEY ACROSS EIGHT COUNTRIES | ||||
Takeno S1, Tanaka S1, Saijo N1 Nasuti P2 | ||||
1IQVIA Solutions Japan K.K., Tokyo, Japan, 2IQVIA , London, UK | ||||
ISPOR 2018 APAC |
||||
, Poster | ||||
, Asia Pacific, Europe | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | ||
Drug treatment in melanoma: a real-world analysis across Europe and Japan | ||||
Martinez de Pinillos, Anger C, Nasuti P | ||||
IQVIA London UK | ||||
ESMO 2018 |
||||
, Poster | ||||
, France, Germany, Italy, Spain, UK | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | ||
Treatment algorithm for multiple myeloma: real-world insights across five European countries | ||||
Dr Rocci1, Bulger P1, Martinez de Pinillos A2 , Anger C2 , Nasuti P2, Manuguid F2 | ||||
1Manchester University NHS Foundation Trust, Manchester Royal Infirmary, 2 IQVIA London UK | ||||
ESMO 2018 |
||||
, Poster | ||||
, France, Germany, Italy, Spain, UK | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | ||
Verification of guideline conform mCRC treatment with EGFR inhibitors with real-world evidence data from EU5 countries | ||||
Hoyer L, Schmidt N | ||||
IQVIA Frankfurt Germany | ||||
ESMO 2018 |
||||
, Poster | ||||
, France, Germany, Italy, Spain, UK | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | ||
Clinical Characteristics of 3,030 Glioblastoma Multiforme (GBM) Patients in High, Upper Middle and Lower Middle Economic Regions Based on Real-World Data (RWD) | ||||
Mitrofan L1 , M.R. Krukas-Hampel M.R2 , L.A. Mendoza L.A3 | ||||
IQVIA, Paris, FR; IQVIA New York, US; IQVIA, Prague, CZ | ||||
ESMO 2018 |
||||
, Poster | ||||
, Australia, Brazil, Canada, France, Germany, Italy, Mexico, Spain, Taiwan, UK | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | ||
Clinical characteristics of Glioblastoma Multiforme (GBM) Patients Who Reached 400 Days Post Diagnostic from a Retrospective Real-World Data | ||||
Mitrofan L.M.1,Krukas-Hampel M.R.2, Mendoza L.A.3 | ||||
1 IQVIA, Paris, FR; 2IQVIA New York, US; 3IQVIA, Prague, CZ | ||||
ESMO 2018 |
||||
, Poster | ||||
, Australia, Brazil, Canada, France, Germany, Italy, Mexico, Spain, Taiwan, UK | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | ||
PATTERNS OF CARE OF ADVANCED SOFT TISSUE SARCOMAS (STS) NON-GIST IN FOUR EUROPEAN COUNTRIES (EU4) | ||||
Mari E1,Martinez de Pinillos A2, Nasuti P2,Guglielmetti F1, Anger C2 | ||||
1IQVIA Milan Italy , 2IQVIA London UK | ||||
CTOS 2018 Rome |
||||
, Poster | ||||
, France, Germany, Italy, Spain | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | ||
DESCRIPTIVE ANALYSIS OF THE USE OF TYROSINE KINASE INHIBITORS IN CHRONIC MYELOID LEUKAEMIA IN EUROPE, A REAL-WORLD PERSPECTIVE | ||||
Martinez de Pinillos A1, Nasuti P1, Anger C1, Ricorte I2 | ||||
1 IQVIA London UK , 2IQVIA Madrid Spain | ||||
ISPOR Europe 2018 |
||||
, Poster | ||||
, France, Germany, Italy, Spain, UK | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | ||
Real life patterns of care and progression free survival in metastatic renal cell carcinoma patients: retrospective analysis of cross-sectional data | ||||
Maroun R1,2, Mitrofan L3, Benjamin L1 Nachbaur G1, Maunoury F4 Le Jeunne P3 Durand-Zaleski I2,5 | ||||
1GlaxoSmithKline, Health Economics and Outcomes Research,France 2INSERM, ECEVE, UMR 1123, Paris, France 3IQVIA, La Défense, France 4Statesia, Le Mans, France 5URC-ECO, APHP, Paris, France | ||||
BMC Cancer. 2018; 18: 214. |
||||
, Article | ||||
, France | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5822611/ | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | ||
Assessing and modeling organizational impact of tilmanocept in performing sentinel lymph node biopsy in France | ||||
Clément Le Dissez1, Pascal Paubel2, Frédéric Courbon3, Rémy Herve4, Mark Rance5, Marie-Aude Courteille6 | ||||
1IQVIA Opération France, Paris, La Défense ; 2Inserm UMR S 1145, Institut Droit et Santé, faculté de pharmacie de Paris, Université Paris Descartes, Sorbonne Paris Cité, 4 avenue de l’observatoire, 75006 Paris, France ; 3 Department of Medical Imaging, Institut Universitaire du Cancer Toulouse-Oncopole, Toulouse, France ; 4 Department of Pharmacy, Institute of Cancerology Gustave Roussy, University of Paris-Sud, Villejuif, France ; 5Norgine, Corporate ; 6Norgine, France | ||||
, Poster | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Clinical practice, Health economics, Oncology | 2018 | English | , Budget impact, Literature Review, Public Health | |
Neue Krebstherapeutika: Personalisierte Medizin eröffnet neuartige Therapieoptionen | ||||
Hoyer L , Schmidt L | ||||
IQVIA Frankfurt Germany | ||||
Pharmamind |
||||
, Article | ||||
, Europe | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | German | ||
CHALLENGES AND OPPORTUNITIES IN CLINICAL NUTRITION IN ONCOLOGY: AVAILABLE EVIDENCE, REAL WORLD PRACTICES, AND THE WAY FORWARD | ||||
Goldwasser F, Piaggio T, Lucas J, Zalcman G, Tilleul P, Schiefke I, Marschal O, Pedrazzoli P, Caccialanza R | ||||
Medical Oncology, Cochin Hospital, AP-HP, IQVIA Basel | ||||
ISPOR Europe 2018 |
||||
, Abstract, Poster | ||||
, France, Germany, Italy | ||||
Condition | Year | Language | Analysis type | |
, Nutritional Disorders, Oncology | 2018 | English | , Clinical setting: Home care, Epidemiological study | |
The Impact of Label Extensions on the Reimbursed Price of Pharmaceutical Products Assessed According to §35A SGB V in Germany Oncological and Metabolic Diseases | ||||
Schmalhofer C, Eheberg D, Tremmel M, Bocuk D, Roxlau T, Antoni B, Bonduelle D | ||||
IQVIA Commercial GmbH & Co. OHG, Munich, Germany | ||||
, Abstract | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Health economics, Health policy, Metabolic Disorders , Oncology, Pricing and reimbursement | 2018 | English | , Cost analysis, Pricing & Reimbursement | |
Potential Delay in the Diagnosis of Vulvar Cancer and Associated Risk Factors in Women Treated in German Gynecological Practices | ||||
Muigai J, Jacob L, Klostev K, Kalder M | ||||
ONCOTARGET. 2018 JAN 3;9(9):8725-8730 |
||||
, Article | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Oncology, Womens Health | 2018 | English | ||
Impact of Tobacco Smoking on the Risk of Developing 25 Different Cancers in the UK: A Retrospective Study of 422,010 Patients Followed for up to 30 Years | ||||
Jacob L, Freyn M, Kalder M, Dinas K, Kostev k | ||||
ONCOTARGET. 2018 APR 3;9(25):17420-17429 |
||||
, Article | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | , Retrospective cohort analysis | |
Association of Laryngeal Cancer with Vocal Cord Leukoplakia and related Risk Factors in 1,184 Patients Diagnosed in Otorhinolaryngology Practices in Germany | ||||
Kostev K, Jacob L, Kalder M, Sesterhenn AM, MDD, Seidel DU | ||||
MOL CLIN ONCOLOGY 2018; 8: 689-693, 2018 |
||||
, Article | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | ||
The Impact of Non-Persistence in the Direct and Indirect Costs in Patients Treated with Subcutaneous Tumor Necrosis Factor-Alpha Inhibitors in Germany | ||||
Ziegelbauer K, Kostev K, Hübinger M, Dombrowski S, Friedrichs M, Friedel H, Kachroo S | ||||
RHEUMATOLOGY (OXFORD). 2018 APR 12 |
||||
, Article | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | ||
Diagnoses of Suspected Cancer in Otolaryngology Practices in Germany | ||||
Kostev K, Lasrich M, Schüller L, Diogo I, Sesterhenn A, Jacob L | ||||
MOL CLIN ONCOLOGY |
||||
, Article | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | ||
Association Between Sleep Disorders and the Presence of Breast Cancer Metastases in Gynecological Practices in Germany: A Case-Control Study of 11,412 Women | ||||
Jacob L, Schloten PC, Kostev K, Kalder M | ||||
BREAST CANCER RES TREAT. 2018 MAY 29. |
||||
, Article | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Mental health, Oncology | 2018 | English | ||
Feasibility Assessment for Conducting a Multi-Country Post-Marketing Safety Oncology Study Using Secondary Data Sources in Europe | ||||
Wells KE, Jiang R, Tyczynski JE, Secrest M, Oliveria SA | ||||
Wells KE: IQVIA; Jiang R: Abbvie; Tyczynski JE: Abbvie; Secrest M: IQVIA; Oliveria SA: IQVIA | ||||
34th International Conference on Pharmacoepidemiology & Therapeutic Risk Management |
||||
, Abstract | ||||
, Denmark, Finland, Germany, Norway, Sweden, UK | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology, Oncology, Patient Registries & Real-World Study Methods | 2018 | English | , Database Study, Epidemiological study, Retrospective cohort analysis, Retrospective database analysis, Review | |
Measuring Colorectal Cancer Screening Rates in a US Administrative Claims Database | ||||
Carrington CM, Johnson KE, Fedwa S, Wiatrek S, Lombardo J, Pirolli M, Oliveria SA | ||||
Carrington CM: IQVIA; Johnson KE: IMPAQ International; Fedwa S: American Cancer Society, Atlanta GA; Wiatrek S: American Cancer Society, Austin TX; Lombardo J: American Cancer Society Philadelphia PA; Pirolli M: American Cancer Society Philadelphia PA; Oliveria SA: IQVIA | ||||
34th International Conference on Pharmacoepidemiology & Therapeutic Risk Management |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology, Oncology | 2018 | English | , Database Study, Epidemiological study, Retrospective database analysis | |
Identification of Incident Pancreatic Cancer in Administrative Health Data: A Validation Study by the Canadian Network for Observational Drug Effect Studies | ||||
Wu JW, Axzoulay L, Huang A, Paterson M, Wu F, Secrest MH, Filion K | ||||
Wu JW: Analysis Group; Secrest MH: IQVIA | ||||
34th International Conference on Pharmacoepidemiology & Therapeutic Risk Management |
||||
, Abstract | ||||
, Canada | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology, Diabetes, Oncology | 2018 | English | , Database Study, Retrospective cohort analysis, Retrospective database analysis | |
#2811 Initial treatment in patients (pts) diagnosed with non-small cell lung cancer (NSCLC) in Denmark from 2005-2015: The SCAN-LEAF study | ||||
Jens Benn Sørensen, Simon Ekman, Pia Horvat, Deborah Layton, Joseph Kim, Mats Rosenlund, Ariadna Juarez‐Garcia, Melinda Daumont, Hazel C. Jacobs, Laure Lacoin, Odd Terje Brustugun, Maria Planck | ||||
Department of Oncology, Rigshospitalet, Copenhagen, Denmark; Department of Oncology, Karolinska University Hospital-Solna, Stockholm, Sweden; Real-World Evidence Solutions, IQVIA, London, UK; Data Science, IQVIA, London, UK; Worldwide Health Economics & Outcomes Research, Bristol-Myers Squibb, Uxbridge, UK; Worldwide Health Economics & Outcomes Research, Bristol-Myers Squibb, Braine-L?Alleud, Belgium; Department of Oncology, Radiumhospitalet, Oslo, Norway; Division of Oncology and Pathology, Skane University Hospital-Lund, Lund, Sweden | ||||
, Poster | ||||
, England, Nordic, UK | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | , Retrospective cohort analysis | |
Feasibility Analysis and Data Visualization to Identify a Complex Group of Cancer in the Simulacrum | ||||
ALI ABBASI1,2, Shubham Tayal3, Deborah Layton1 and Toby Gosden1 | ||||
1IQVIA, LONDON, United Kingdom2University Medical Centre Groningen, Groningen, Netherlands3IQVIA, Gurgaon, India | ||||
, Poster | ||||
, England | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | , Epidemiological study | |
Clinical Characteristics and Overall Survival of Patients Diagnosed With Non-Small Cell Lung Cancer (2006-2017) in Routine Clinical Practice: A Retrospective Analysis of a UK Hospital Database | ||||
Michael Snee, Sue Cheeseman, Matthew Thompson, Paul Godden, Will Sopwith, Carlos Chaib, Ariadna Juarez-Garcia, Laure Lacoin, John R Penrod, Geoff Hall | ||||
The Leeds Teaching Hospitals NHS Trust, Leeds, UK; IQVIA, London, UK; Bristol-Myers Squibb, Princeton, NJ, USA | ||||
, Abstract | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | , Retrospective database analysis | |
Treatment patterns in patients with stage IIIB-IV NSCLC in clinical practice: Retrospective analysis of a UK trust database | ||||
Michael Snee, Sue Cheeseman, Matthew Thompson, Laure Lacoin, Will Sopwith, Paul Godden, Carlos Chaib, Melinda Daumont, John R. Penrod, John O’Donnell & Geoff Hall | ||||
The Leeds Teaching Hospitals NHS Trust, Leeds/United Kingdom; IQVIA, London/United Kingdom; Bristol-Myers Squibb, Braine L’Alleud/Belgium; Bristol-Myers Squibb, Madrid/Spain; Bristol-Myers Squibb, Princeton, New Jersey/United States of America | ||||
, Poster | ||||
, England | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | , Retrospective database analysis | |
Epidemiologic and economic burden of HPV diseases in Spain: implication of additional 5 types from the 9-valent vaccine. | ||||
López N1, Torné A2, Franco A3, San-Martin M1, Viayna E4, Barrull C4, Perulero N4. | ||||
1Medical Affairs, MSD, Madrid, Spain.22Gynecologic Oncology Unit, Institut Clinic of Gynecology, Obstetrics and Neonatology (ICGON), Hospital Clínic-Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Faculty of Medicine, University of Barcelona, Barcelona, Spain.33Diagnostic Unit of Urology, Clinic Institute of Nephrology and Urology (ICNU) Hospital Clínic Barcelona, University of Barcelona, Barcelona, Spain.4Health Economics and Outcomes Research, Real World Insights, IQVIA, Barcelona, Spain. | ||||
Infect Agent Cancer. 2018 May 2;13:15. |
||||
, Article | ||||
, Spain | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/29743937 | ||||
Condition | Year | Language | Analysis type | |
, Health economics, Immunology and Vaccination, Infectious disease, Oncology | 2018 | English | , Burden of illness, clinical setting: Secondary care, Literature Review, Review, Survey research | |
Real World Data y Real World Evidence como fuentes de evidencia en oncología. Estado actual y perspectivas de futuro | ||||
Daniel Callejo y Anna de Prado | ||||
IQVIA Spain | ||||
New Medical Economics nº 79;22-24 |
||||
, Article | ||||
, Spain | ||||
Abstract: https://issuu.com/raizpublicidad/docs/nme_num79/22 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | Spanish | , Clinical setting: hospital, Review | |
A real-world data study regarding hospital resources use and costs associated with melanoma cancer in Spain | ||||
Carmen Barrull, Ángel Baltasar, Daniel Callejo, Vanessa Gómez, Neus Canal, Miriam Solozabal | ||||
HEOR-RWI, IQVIA Spain | ||||
ISPOR Europe 2018. 10-14 November 2018 | Barcelona, Spain |
||||
, Poster | ||||
, Spain | ||||
Abstract: https://www.iqvia.com/-/media/iqvia/pdfs/isporbarcelona2018posters/november-14/a-realworld-data-study-regarding-hospital-resources-use-and-costs-associated-with-melanoma-cancer-in.pdf?la=en&hash=8C1394471FDDA3956BBF8788628C6443F1E3D5B6 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | , Clinical setting: hospital, Cost analysis, Retrospective database analysis | |
A real-world data study regarding hospital resources use and costs associated with colorectal cancer in Spain | ||||
Laura Planellas, Míriam Solozabal, Carmen Barrull, Anna de Prado, Neus Canal, Vanessa Gómez | ||||
HEOR-RWI, IQVIA Spain | ||||
ISPOR Europe 2018. 10-14 November 2018 | Barcelona, Spain |
||||
, Poster | ||||
, Spain | ||||
Abstract: https://www.iqvia.com/-/media/iqvia/pdfs/isporbarcelona2018posters/november-14/a-realworld-data-study-regarding-hospital-resources-use-and-costs-associated-with-colorectal-cancer.pdf?la=en&hash=FE374C80DDC224B135913C13D65857DAE36D0007 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | , Clinical setting: hospital, Cost analysis, Retrospective database analysis | |
Hospital resources use and costs associated with 6 prevalent cancer in Spain, a Real World Data study | ||||
Daniel Callejo , Laura Planellas, Míriam Solozabal, Carmen Barrull, Neus Canal, Anna de Prado | ||||
HEOR-RWI, IQVIA Spain | ||||
ISPOR Europe, Barcelona, Spain, 10-14 November 2018 |
||||
, Poster | ||||
, Spain | ||||
Abstract: https://www.iqvia.com/-/media/iqvia/pdfs/isporbarcelona2018posters/november-14/hospital-resources-use-and-costs-associated-with-6-prevalent-cancers-in-spain-a-real-world-data-stud.pdf?la=en&hash=C28017910D9722573D7A318AB3782530D5F50054 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | , Clinical setting: hospital, Cost analysis, Retrospective database analysis | |
A real-world data study regarding hospital resources use and costs associated with breast cancer in Spain | ||||
Daniel Callejo , Vanessa Gómez, Míriam Solozabal, Laura Planellas, Ágata Carreño, Ángel Baltasar | ||||
HEOR-RWI, IQVIA Spain | ||||
ISPOR Europe, Barcelona, Spain, 10-14 November 2018 |
||||
, Poster | ||||
, Spain | ||||
Abstract: https://www.iqvia.com/-/media/iqvia/pdfs/isporbarcelona2018posters/november-14/a-realworld-data-study-regarding-hospital-resources-use-and-costs-associated-with-breast-cancer-in-s.pdf?la=en&hash=8547AD20386AF0B3E1DA95EDA710A7EEF6E40C68 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | , Clinical setting: hospital, Cost analysis, Retrospective database analysis | |
A real-world data study regarding hospital resources use and costs associated with bladder cancer in Spain | ||||
Anna de Prado, Ángel Baltasar, Vanessa Gómez, Carme Barrull, Àgata Carreño, Laura Planellas | ||||
HEOR-RWI, IQVIA Spain | ||||
ISPOR Europe 2018. 10-14 November 2018 | Barcelona, Spain |
||||
, Poster | ||||
, Spain | ||||
Abstract: https://www.iqvia.com/-/media/iqvia/pdfs/isporbarcelona2018posters/november-14/a-realworld-data-study-regarding-hospital-resources-use-and-costs-associated-with-bladder-cancer-in.pdf?la=en&hash=9A2EA74E7E8AEC14E41A2D6DACD80911C716853F | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | , Clinical setting: hospital, Cost analysis, Retrospective database analysis | |
A real-world data study regarding hospital resources use and costs associated with lung cancer in Spain | ||||
Anna de Prado, Daniel Callejo, Vanessa Gómez, Angel Baltasar, Neus Canal, Carme Barrull | ||||
HEOR-RWI, IQVIA Spain | ||||
ISPOR Europe 2018. 10-14 November 2018 | Barcelona, Spain |
||||
, Poster | ||||
, Spain | ||||
Abstract: https://www.iqvia.com/-/media/iqvia/pdfs/isporbarcelona2018posters/november-14/a-realworld-data-study-regarding-hospital-resources-use-and-costs-associated-with-lung-cancer-in-spa.pdf?la=en&hash=8F884E874C670E07BCA72315DC3B6E042F558F23 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | , Clinical setting: hospital, Cost analysis, Retrospective database analysis | |
A real-world data study regarding hospital resources use and costs associated with prostate cancer in Spain | ||||
Míriam Solozabal, Anna de Prado, Laura Planellas, Ángel Baltasar, Àgata Carreño, Daniel Callejo | ||||
HEOR-RWI, IQVIA Spain | ||||
ISPOR Europe 2018. 10-14 November 2018 | Barcelona, Spain |
||||
, Poster | ||||
, Spain | ||||
Abstract: https://www.iqvia.com/-/media/iqvia/pdfs/isporbarcelona2018posters/november-14/a-realworld-data-study-regarding-hospital-resources-use-and-costs-associated-with-prostate-cancer-in.pdf?la=en&hash=1DA52D1BC0EDBFCE32B1DB5C46308CE4E06D318F | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | , Clinical setting: hospital, Cost analysis, Retrospective database analysis | |
A comparison of patient-reported outcomes (PRO) study between Japan and the United States in oncology research: a systematic literature review | ||||
Krishant Chand 1, Junko Morii 1, T Sato 1 (rwesheorj 1) | ||||
1) IQVIA Solutions Japan K.K., Tokyo, Japan | ||||
ISPOR Asia Pacific 2018 Conference |
||||
, Abstract | ||||
, Japan | ||||
Abstract: https://www.ispor.org/heor-resources/presentations-database/presentation/ispor-asia-pacific-2018/a-comparison-of-patient-reported-outcomes-pro-study-between-japan-and-the-united-states-in-oncology-research-a-systematic-literature-review | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | , Literature Review | |
Predictors of Overall Survival for Multiple Myeloma Patients Depending on Transplant Status According to a Retrospective, Non-Interventional Study in Norway | ||||
Fredrik H. Schjesvold, MD PhD, Anderson Jenna, Jaak Sõnajalg, Amy Leval, PhD, Anna Lysén, MSc, Saeeda Rana, Päivi Castren-Kortekangas, Fredrik Borgsten | ||||
Fredrik H. Schjesvold - Oslo University; Jenna Anderson - EPID Research (now part of IQVIA); Jaak Sõnajalg - EPID Research (now part of IQVIA). | ||||
Blood (2018) 132 (Supplement 1): 5759. |
||||
, Abstract | ||||
, Norway | ||||
Abstract: https://ashpublications.org/blood/article/132/Supplement%201/5759/263137/Predictors-of-Overall-Survival-for-Multiple | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | , Observational study, Population Based Study | |
Evaluating the cost-effectiveness results of diagnostic strategies for hepatocellular carcinoma in Japan | ||||
M Uchida-Nakakoji 1, Akihiro Nishie 2, Graeme Ball 3, Eliza Kruger 4, Bruce Crawford 3, Hiroshi Honda 2 | ||||
1) Bayer Yakuhin Ltd., Tokyo, Japan 2) Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan 3) QuintilesIMS, Tokyo, Japan 4) QuintilesIMS, San Francisco, CA, USA | ||||
ISPOR 2017 Conference |
||||
, Abstract | ||||
, Japan | ||||
Abstract: https://www.ispor.org/heor-resources/presentations-database/presentation/ispor-22nd-annual-international-meeting/evaluating-the-cost-effectiveness-results-of-diagnostic-strategies-for-hepatocellular-carcinoma-in-japan | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2017 | English | , Cost effectiveness | |
A Budget Impact Model of Third-Line or Later Trifluridine/Tipiracil Treatment of Metastatic Colorectal Cancer. | ||||
Ferrufino C, Wiseman F, Wert TD, Barghout V | ||||
QuintilesIMS Health, Falls Church, VA; Taiho Oncology, Priceton, NJ; Taiho Oncology, Inc, Princeton, NJ; VEB Healthcare, Morristown, NJ | ||||
ASCO |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2017 | English | , Budget impact | |
Economic burden of toxicities associated with treating metastatic melanoma in eight countries | ||||
Wehler EA, Zhao Z, Bilir S Pinar, Munakata J, Barber B | ||||
Eur J Health Econ. 2017; 18: 49-58 |
||||
, Manuscript in preparation | ||||
, USA | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/26721505 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2017 | English | , Cost analysis | |
Patient database analysis of fulvestrant 500 mg in the treatment of metastatic breast cancer: A European perspective | ||||
Marchetti P1, Maass N2, Gligorov J3, Berger K4, MacDougall F5, Montonen J6, Lewis J6. | ||||
Department of Clinical and Molecular Medicine, Sapienza University of Rome and IDI-IRCCS, Rome, Italy. Electronic address: paolo.marchetti@ospedalesantandrea.it. 2 Department of Gynecology and Obstetrics, University Medical Center Schleswig-Holstein, Kiel, Germany. 3 Department of Medical Oncology, INSERM U938, APHP Tenon, IUC-UPMC, Sorbonne University, Paris, France. 4 Real World Evidence Solutions and HEOR, IMS Health, Munich, Germany. 5 Real World Evidence Solutions and HEOR, IMS Health, London, United Kingdom. 6 AstraZeneca, London, United Kingdom. | ||||
Breast. 2017 Apr;32:247-255. |
||||
, Article | ||||
, France, Germany, Italy, Spain | ||||
Abstract: http://www.sciencedirect.com/science/article/pii/S0960977616302648 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2017 | English | , clinical setting: Secondary care, Retrospective database analysis | |
THE ECONOMIC IMPACT OF DELAYING BRAIN METASTASES IN ALK-POSITIVE NON-SMALL CELL LUNG CANCER IN THE COMMERCIALLY INSURED US POPULATION | ||||
Wong W1, Burudpakdee C2, Seetasith A2, Corvino F3, Yeh D1, Gubens M4 | ||||
1Genentech, Inc., South San Francisco, CA, USA, 2QuintilesIMS, Fairfax, VA, USA, 3Genesis Research, Hoboken, NJ, USA, 4University of California, San Francisco, San Francisco, CA, USA | ||||
ISPOR 22nd Annual International Meeting, Boston, 2017 |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2017 | English | , Budget impact, Retrospective database analysis | |
Real-World Treatment Patterns, Time to Next Treatment, and Economic Outcomes in Relapsed or Refractory Multiple Myeloma Patients Treated with Pomalidomide or Carfilzomib. | ||||
Chen CC1, Parikh K2, Abouzaid S2, Purnomo L2, McGuiness C1B, Hussein M2, Wade RL1 | ||||
1QuintilesIMS, Plymouth Meeting, Pennsylvania. 2Celgene, Summit, New Jersey | ||||
J Manag Care Spec Pharm. 2017 Feb;23(2):236-246 |
||||
, Article | ||||
, USA | ||||
Abstract: http://www.jmcp.org/doi/pdf/10.18553/jmcp.2017.23.2.236 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2017 | English | , Budget impact, Retrospective database analysis | |
Cost-effectiveness of EOB-MRI for hepatocellular carcinoma in Japan | ||||
Akihiro Nishie 1, Satoshi Goshima 2, Hiroki Haradome 3, Etsuro Hatano 4, Yasuharu Imai 5, Masatoshi Kudo 6, Masanori Matsuda 7, Utaroh Motosugi 7, Satoshi Saitoh 8, Kengo Yoshimitsu 9, Bruce Crawford 10, Eliza Kruger 10, Graeme Ball 10, Hiroshi Honda 11 | ||||
1) Kyushu University, Fukuoka, Japan 2) Gifu University Hospital, Gifu, Japan 3) Nihon University Hospital, Tokyo, Japan 4) Hyogo University Hospital, Hyogo, Japan 5) Ikeda Municipal Hospital, Osaka, Japan 6) Kindai University Hospital, Osaka, Japan 7) Yamanashi University, Yamanashi, Japan 8) Toranomon Hospital, Tokyo, Japan 9) Fukuoka University Hospital, Fukuoka, Japan 10) Quintiles IMS, Tokyo, Japan 11) Kyushu University, Fukuoka, Japan" | ||||
Clinical Therapeutics |
||||
, Article | ||||
, Japan | ||||
Abstract: https://www.sciencedirect.com/science/article/pii/S0149291817301807?via%3Dihub | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2017 | English | , Cost analysis | |
Do characteristics of patients influencing the choice of pain treatment by GPs differ in osteoarthritis and cancer? – An Italian real world data study | ||||
Heiman F1, Pegoraro V1, Moretti R1 | ||||
1 QuintilesIMS, Milan, Italy | ||||
ISPOR 20th Annual European Congress, 4-8 November 2017, Glasgow, Scotland |
||||
, Poster | ||||
, Italy | ||||
Condition | Year | Language | Analysis type | |
, Musculoskeletal disease, Oncology, Pain | 2017 | English | , Database Study, Epidemiological study, Real World Data, Real World Evidence, Retrospective database analysis | |
The close link between anxiety and cluster symptoms in lung cancer patients during first-line chemotherapy: further data from a dedicated WALCE (Women Against Lung Cancer in Europe) survey | ||||
Carnio S1, Galetta D2, Scotti V3, Cortinovis DL4, Antonuzzo A5, Pisconti S6, Rossi A7, Martelli O8, Cecere FL9, Lunghi A9, Del Conte A10, Montagna ES2, Topulli J3, Pelizzoni D4, Rapetti SG1, Gianetta M1, Pacchiana MV1, Pegoraro V11, Cataldo N11, Bria E12, Novello S1 | ||||
1 Thoracic Oncology Unit at San Luigi Hospital (Orbassano), University of Turin, Italy 2 Clinical Cancer Center “Giovanni Paolo II” Bari, Italy 3 Department of Oncology Radiation Therapy Unit, Careggi University Hospital, Florence Italy 4 Medical Oncology Unit, San Gerardo Hospital, Monza, Italy 5 Division of Medical Oncology Department of Oncology, S. Chiara University Hospital, Pisa, Italy 6 Department of OncoEmatology Medical Oncology, SG Moscati Hospital, Taranto, Italy 7 Division of Medical Oncology SG Moscati Hospital, Avellino, Italy 8 Medical Oncology Unit, San Giovanni Addolorata Hospital, Roma, Italy 9 Department of Oncology, Medical Oncology Unit, Careggi University Hospital, Florence, Italy 10 Department of Medical Oncology , Azienda per l’Assistenza Sanitaria No.5, Friuli Occidentale, Presidio Ospedaliero di Pordenone, Pordenone, Italy 11 QuintilesIMS, Milan, Italy 12 Medical Oncology , Department of Medicine, Verona, Italy | ||||
XIX AIOM National Congress, Rome, Italy |
||||
, Poster | ||||
, Italy | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2017 | English | , Survey research | |
Prevalence of bisphosphonate therapy in women with breast cancer treated with aromatase inhibitors in Germany | ||||
Jacob L, Kostev K, Hadji P | ||||
Int J Clin Pharmacol Ther. 2017 May;55(5):394-39 |
||||
, Article | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2017 | English | , Epidemiological study | |
Impact of prior breast cancer on mode of delivery and pregnancy-associated disorders -A retrospective analysis of subsequent pregnancy outcomes- | ||||
Jacob L, Kalder M, Arabin B, Kostev K | ||||
J Cancer Res Clin Oncol. 2017 Feb 20. doi: 10.1007/s00432-017-2352-3. [Epub ahead of print] |
||||
, Article | ||||
Condition | Year | Language | Analysis type | |
, Oncology, Surgery, Womens Health | 2017 | English | , Retrospective cohort analysis | |
Association of Dipeptidyl Peptidase 4 Inhibitors with Risk of Metastases in Patients with Type 2 Diabetes and Breast, Prostate or Digestive System Cancer | ||||
Rathmann W, Kostev K | ||||
J Diabetes Complications. 2017 Jan 26. pii: S1056-8727(16)31034-0. doi: 10.1016/j.jdiacomp.2017.01.012. [Epub ahead of print] |
||||
, Article | ||||
Condition | Year | Language | Analysis type | |
, Diabetes, Oncology | 2017 | English | ||
Real-world treatment patterns and outcomes for mNSCLC patients receiving second- and third-line therapy in Germany | ||||
Yu N1, Rivera I2, Hipp J3, Zou M4, Pillai N4, Hammerschmidt S5 | ||||
1 Roche Products Ltd, Welwyn, UK 2 F. Hoffmann-La Roche, Basel, Switzerland 3 Roche Pharma AG, Grenzach-Wyhlen, Germany 4 QuintilesIMS, Basel, Switzerland 5 Klinikum Chemnitz gGmbH, Chemnitz, Germany | ||||
, Poster | ||||
, Germany | ||||
Abstract: https://academic.oup.com/annonc/article/28/suppl_2/mdx091.052/3799717/132PReal-world-treatment-patterns-and-outcomes-for | ||||
Condition | Year | Language | Analysis type | |
, Clinical practice, Health status & patient reported outcomes, Oncology | 2017 | English | , clinical setting: Secondary care, Patient questionnaire, Quality of life | |
Epidemiologic and economic burden of HPV-related diseases in Spain: Potential benefit of adding 5 additional types in the nonavalent vaccine. | ||||
López N1, Torné A2, Franco A3, San-Martin M1, Viayna E4, Barrull C4, Perulero N4 | ||||
1 Medical Affairs, Sanofi Pasteur MSD, Madrid, Spain 2 Gynecologic Oncology Unit, Institut Clinic of Gynecology, Obstetrics and Neonatology (ICGON), Hospital Clínic-Institut d′Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Faculty of Medicine, University of Barcelona, Barcelona, Spain 3 Diagnostic Unit of Urology, Clinic Institute of Nephrology and Urology (ICNU) Hospital Clínic Barcelona, University of Barcelona, Barcelona, Spain 4 Health Economics and Outcomes Research, IMS Health, Barcelona, Spain | ||||
HPV2017 31st International papillomavirus conference, 2017, February 28 – March 4, Cape Town, South Africa |
||||
, Poster | ||||
, Spain | ||||
Abstract: http://hpv2017.org/Documents/HPV%202017%20Final%20Program%20SPIRAL.pdf | ||||
Condition | Year | Language | Analysis type | |
, Dermatology, Health economics, Immunology and Vaccination, Oncology | 2017 | English | , Burden of illness, Clinical setting: hospital, Clinical setting: Primary care, clinical setting: Secondary care, Epidemiological study, Literature Review, Survey research | |
Impacto económico de las enfermedades asociadas al VPH en España: beneficio potencial de la vacuna nonavalente frente a la tetravalente [Economic impact of HPV-associated diseases in Spain: potential benefit of nonvalorent versus tetravalent vaccine]. | ||||
López N1, Torné A2, Franco A3, San-Martin M1, Viayna E4, Barrull C4 | ||||
1 Medical Affairs, MSD, Madrid, Spain 2 Gynecologic Oncology Unit, Institut Clinic of Gynecology, Obstetrics and Neonatology (ICGON), Hospital Clínic-Institut d′Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Faculty of Medicine, University of Barcelona, Barcelona, Spain 3 Diagnostic Unit of Urology, Clinic Institute of Nephrology and Urology (ICNU) Hospital Clínic Barcelona, University of Barcelona, Barcelona, Spain 4 Health Economics and Outcomes Research, IMS Health, Barcelona, Spain | ||||
XXXVII Jornadas de Economía de la Salud, 2017, 6 - 8 de septiembre, Barcelona, España |
||||
, Poster | ||||
, Spain | ||||
Abstract: http://www.aes.es/jornadas/en/ | ||||
Condition | Year | Language | Analysis type | |
, Dermatology, Health economics, Immunology and Vaccination, Oncology | 2017 | Spanish | , Burden of illness, Clinical setting: hospital, Clinical setting: Primary care, clinical setting: Secondary care, Literature Review, Survey research | |
Estimación de la carga epidemiológica de patologías asociadas a 9 genotipos del virus del papiloma humano en España: revisión de la literatura [Estimating the epidemiological burden of pathologies associated with 9 human papillomavirus genotypes in Spain: Literature review]. | ||||
Lopez N1, Viayna E2, Perulero N2, San-Martin M1 | ||||
1 Sanofi Pasteur-MSD 2 Quintiles IMS | ||||
Vacunas. 2017;18(2):36-42 |
||||
, Article | ||||
, Spain | ||||
Abstract: http://www.elsevier.es/es-revista-vacunas-72-avance-resumen-estimacion-carga-epidemiologica-patologias-asociadas-S1576988716300644?referer=buscador | ||||
Condition | Year | Language | Analysis type | |
, Dermatology, Health economics, Immunology and Vaccination, Oncology | 2017 | Spanish | , Burden of illness, Clinical setting: hospital, Clinical setting: Primary care, clinical setting: Secondary care, Literature Review | |
Carga epidemiológica y económica de las patologías asociadas al virus del papiloma humano en españa: revisión de la literatura [Epidemiological and economic burden of pathologies associated with human papillomavirus in Spain: literature review]. | ||||
Lopez N1, Viayna E2, Perulero N2, San-Martin M1 | ||||
1 Sanofi Pasteur-MSD 2 Quintiles IMS | ||||
XXXVII Jornadas de Economía de la Salud, 2017, 6 - 8 de septiembre, Barcelona, España |
||||
, Poster | ||||
, Spain | ||||
Abstract: http://www.aes.es/jornadas/en/ | ||||
Condition | Year | Language | Analysis type | |
, Dermatology, Health economics, Immunology and Vaccination, Oncology | 2017 | Spanish | , Burden of illness, Clinical setting: hospital, Clinical setting: Primary care, clinical setting: Secondary care, Literature Review | |
Clonal selection of TP53MUT and/or Del (p17) in CLL: evaluation of 3,373 CLL patients, A Real World Data story | ||||
Mpima S1, Moehler T2, Kanter S3, Mitrofan L4 | ||||
1 QuintilesIMS Health, Paris, France 2 QuintilesIMS Health, London, UK 3 QuintilesIMS Health, Frankfurt, Germany 4 QuintilesIMS Health, Durham, USA | ||||
ASCO 2017, Journal of Clinical Oncology, 2017, 35(Suppl no. 15):e19004-e19004 |
||||
, Abstract | ||||
, France, Germany, Italy, Spain, UK | ||||
Abstract: http://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.e19004 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2017 | English | , Retrospective database analysis | |
Treatment paradigm shift in NSCLC: patient data analysis from 2005 to 2016. | ||||
Mitrofan L1, Sahni MK2, Dhingra D2, Mistry H3, Anger C3 | ||||
1 Quintiles IMS, Paris, France 2 Quintiles IMS, Gurgaon, India 3 Quintiles IMS, London, United Kingdom | ||||
ESMO 2017 Annual meeting, 2017, 8-12 September, Madrid, Spain |
||||
, Poster | ||||
, France, Germany, Italy, Spain, UK | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2017 | English | , Retrospective database analysis | |
Changing treatment patterns in metastatic colorectal cancer in EU5 countries from 2014 to 2016. | ||||
Hoyer L, Schmidt N | ||||
QuintilesIMS Global Oncology, Central, East & South Europe | ||||
ESMO 2017 Annual meeting, 2017, 8-12 September, Madrid, Spain |
||||
, Poster | ||||
, France, Germany, Italy, Spain, UK | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2017 | English | , Retrospective database analysis | |
Measuring Breast Cancer Screening Rates in a US Administrative Claims Database | ||||
Karin E. Johnson, Stacey Fedewa, Dawn Wiatrek, Jennifer Lomardo, Melissa Pirolli, Susan A. Oliveria | ||||
QuintilesIMS | ||||
33rd International Conference on Pharmacoepidemioligy, Montreal, Canada; August 2017 |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology, Patient Registries & Real-World Study Methods | 2017 | English | , Retrospective cohort analysis, Retrospective database analysis | |
Characteristics and treatment patterns among US patients with hairy cell leukemia: a retrospective claims analysis. | ||||
Divino V., Karve S., Gaughan A., DeKoven M., Gao G., Knopf KB., Lanasa MC. | ||||
AstraZeneca, MedImmune. IMS authors: Divino V, DeKoven M | ||||
J Comp Eff Res. |
||||
, Article | ||||
, USA | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/28485619 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2017 | English | , Retrospective database analysis | |
FINANCIAL IMPACT OF INTRODUCING SC TRASTUZUMAB (HERCEPTIN) VERSUS CURRENTLY USED IV TRASTUZUMAB (HERCEPTIN) ON THE BUDGETS OF DIFFERENT HOSPITALS ACROSS KINGDOM OF SAUDI ARABIA (KSA) | ||||
AL-Tweigeri T1, Al-Shihri A2, Abdelhafeez N2, Ali A3, Zekri J4, Al Mansour M5, Al-gahmi A6, Ansari J7, Elbahaei A8, F Husseiny8, Awad N9, Safwat M9, Goyal R10 | ||||
1King Faisal Specialist Hospital, Riyadh, Kingdom of Saudi Arabia (KSA), 2King Fahad National Guard Hospital, Riyadh, Saudi Arabia and 9QuintilesIMS, Dubai; 10QuintilesIMS, India | ||||
ISPOR 20th European conference, 4-8 November, 2017 |
||||
, Abstract | ||||
, Saudi Arabia | ||||
Abstract: https://ispor.confex.com/ispor/euro20/research/papers/index.cgi?username=78109&password=956822 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2017 | English | , Budget impact, Clinical setting: hospital, Survey research | |
Patterns of use of systemic therapies among patients with metastatic melanoma: a retrospective claims database analysis in the United States | ||||
Qiufei Ma1, Yaozhu Juliette Chen, Dionne M Hines2, Julie Munakata2, Nicolas Batty1, Beth Louise Barber1, Zhongyun Zhao1 | ||||
1Amgen, 2QuintilesIMS | ||||
J Dermatolog Treat. 2017 Sep;28(6):549-553 Journal of Dermatological Treatment |
||||
, Article | ||||
, USA | ||||
Abstract: http://www.tandfonline.com/doi/full/10.1080/09546634.2016.1277176 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2017 | English | , Retrospective database analysis | |
Healthcare Resource Utilization and Costs of Skeletal-Related Events in Patients with Multiple Myeloma | ||||
Debajyoti Bhowmik1, Dionne M. Hines2, Michele Intorcia1, Catherine B. McGuiness2, Rolin L. Wade2 | ||||
1Amgen, 2QuintilesIMS | ||||
ISPOR |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2017 | English | , Retrospective database analysis | |
A Retrospective Real-World Study of Incident Comorbidities and Complications Among Acute Myeloid Leukemia Patients and A Retrospective Real-World Study of Incident Comorbidities and Complications Among Acute Myeloid Leukemia Patients and Non-Cancer Comparison Patients in the US | ||||
Aimee Near, Shahed Iqbal, Huan Huang, Neil Dhopeshwarkar, Kathy Lang, Nicola Wallis | ||||
QuintilesIMS | ||||
American Society of Hematology 2017 |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2017 | English | , Burden of illness, Retrospective database analysis | |
Real-World Adherence and Its Determinants in Patients With Multiple Myeloma Treated With Pomalidomide and Carfilzomib | ||||
Chi-Chang Chen, PhD, MsPharm; KejalParikh, B. Pharm, MS; RolinL. Wade, RPh, MS; Catherine B. McGuiness, MA, MSc; Ali | ||||
QuintilesIMS, Plymouth Meeting, PA Celgene Corporation | ||||
Annual Conference of the Hematology/Oncology Pharmacy Association (HOPA); March 29-April 1, 2017; Anaheim, CA |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2017 | English | , Retrospective cohort analysis | |
The economic impact of delaying brain metastases in ALK-positive non-small cell lung cancer in the commercially insured US population | ||||
William Wong, Chakkarin Burudpakdee, Arpamas Seetasith, Frank A Corvino, Wei-Shi Yeh, Matthew Gubens | ||||
Genentech, Inc.; Medical and Scientific Services, Real-World Evidence Solutions, IQVIA | ||||
International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 22nd Annual International Meeting |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2017 | English | , Cost of illness, Retrospective cohort analysis | |
Chemotherapy-induced nausea and vomiting (CINV) in patients with advanced lung cancer during the first-line treatment: assessment by physicians, nurses, and patients from an Italian multicenter survey | ||||
Carnio S1, Galetta D2, Scotti V3, Cortinovis DL4, Antonuzzo A5, Pisconti S6, Rossi A7, Martelli O8, Cecere FL9, Lunghi A9, Del Conte A10, Montagna ES2, Topulli J3, Pelizzoni D4, Rapetti SG11, Gianetta M11, Pacchiana MV11, Pegoraro V12, Cataldo N12, Bria E13, Novello S11. | ||||
1 Thoracic Oncology Unit, San Luigi Hospital, University of Turin, Regione Gonzole 10, Orbassano, Turin, Italy 2 Clinical Cancer Center "Giovanni Paolo II", Bari, Italy 3 Department of Oncology Radiation Therapy Unit, Careggi University Hospital, Florence, Italy 4 Medical Oncology Unit, San Gerardo Hospital, Monza, Italy 5 Division of Medical Oncology Department of Oncology, S. Chiara University Hospital, Pisa, Italy 6 Department of OncoEmatology Medical Oncology, SG Moscati Hospital, Taranto, Italy 7 Division of Medical Oncology, SG Moscati Hospital, Avellino, Italy 8 Medical Oncology Unit, San Giovanni Addolorata Hospital, Rome, Italy 9 Department of Oncology, Medical Oncology Unit, Careggi University Hospital, Florence, Italy 10 Department of Medical Oncology, Azienda per l'Assistenza Sanitaria No.5, Friuli Occidentale, Presidio Ospedaliero di Pordenone, Pordenone, Italy 11 Thoracic Oncology Unit, San Luigi Hospital, University of Turin, Regione Gonzole 10, Orbassano, Turin, Italy 12 IQVIA, RWI, Milan, Italy 13 Medical Oncology, Department of Medicine, Verona, Italy | ||||
Support Care Cancer. 2018 Jun;26(6):1841-1849 |
||||
, Article | ||||
, Italy | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/?term=Chemotherapy-induced+nausea+and+vomiting+(CINV)+in+patients+with+advanced+lung+cancer+during+the+first-line+treatment%3A+assessment+by+physicians%2C+nurses%2C+and+patients+from+an+Italian+multicenter+survey | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2017 | English | , Survey research | |
Evaluating Renal Cell Carcinoma treatment options using real world data: findings from an oncology survey across seven countries | ||||
S. Mpima, S. Menon, P. Nasuti, H. Mistry | ||||
IQVIA London UK | ||||
ESMO - ImmunoOncology |
||||
, Poster | ||||
, Asia Pacific, Europe | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2017 | English | ||
Real World analysis for immune related side effects in 3000 patients | ||||
Mitrofan L 1, Moehler T 2, Ruiz M 3 | ||||
1IQVIA Paris , France 2IQVIA , Frankfurt, Germany, 3IQVIA, Madrid, Spain | ||||
ESMO - ImmunoOncology |
||||
, Poster | ||||
, Europe, France, Germany, Spain, UK | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2017 | English | ||
I-O Optimise: Developing a Unique Multinational Real-World Evidence-Based Research Platform in Oncology | ||||
Isabelle Durand-Zaleski, Melinda Manley-Daumont, Paul Baas, Carlos Chaib, David Chao, Christos Chouaid, Simon Ekman, Timothy d’Estrubé, Frank Griesinger, Ariadna Juarez-Garcia, Masha Khovratovich, Deborah Layton, Aoife McNamara, John C O’Donnell, John R Penrod, Marta Pereira, Henrik Toft Sørensen | ||||
URC Eco IdF, Unité de Recherche Clinique en Économie de la Santé d’Ile de France, AP-HP Paris, Paris, France; Bristol-Myers Squibb, Rueil-Malmaison, France; Department of Thoracic Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Bristol-Myers Squibb, Madrid, Spain; Department of Oncology, Royal Free Hospital, London, UK; Pneumology Unit, Centre Hospitalier Intercommunal de Créteil, Créteil, France; Department of Oncology, Karolinska University Hospital, Stockholm, Sweden; QuintilesIMS, London, UK; Department of Haematology and Oncology, University Division Internal Medicine-Oncology, Pius-Hospital Oldenburg, Oldenburg, Germany; Bristol-Myers Squibb, Mexico City, Mexico; Irish Cancer Society, Dublin, Ireland; Bristol-Myers Squibb, Princeton, NJ, USA; Bristol-Myers Squibb, Uxbridge, UK; Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark | ||||
, Abstract | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2017 | English | , Retrospective database analysis | |
I-O Optimise: Developing a Unique Multinational Real-World Evidence-Based Research Platform in Oncology | ||||
Isabelle Durand-Zaleski, Melinda Manley-Daumont, Paul Baas, Carlos Chaib, David Chao, Christos Chouaid, Simon Ekman, Timothy d’Estrubé, Frank Griesinger, Ariadna Juarez-Garcia, Masha Khovratovich, Deborah Layton, Aoife McNamara, John C O’Donnell, John R Penrod, Marta Pereira, Henrik Toft Sørensen | ||||
URC Eco IdF, Unité de Recherche Clinique en Économie de la Santé d’Ile de France, AP-HP Paris, Paris, France; Bristol-Myers Squibb, Rueil-Malmaison, France; Department of Thoracic Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Bristol-Myers Squibb, Madrid, Spain; Department of Oncology, Royal Free Hospital, London, UK; Pneumology Unit, Centre Hospitalier Intercommunal de Créteil, Créteil, France; Department of Oncology, Karolinska University Hospital, Stockholm, Sweden; QuintilesIMS, London, UK; Department of Haematology and Oncology, University Division Internal Medicine-Oncology, Pius-Hospital Oldenburg, Oldenburg, Germany; Bristol-Myers Squibb, Mexico City, Mexico; Irish Cancer Society, Dublin, Ireland; Bristol-Myers Squibb, Princeton, NJ, USA; Bristol-Myers Squibb, Uxbridge, UK; Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark | ||||
, Abstract | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2017 | English | , Retrospective database analysis | |
Pioglitazone Use and Risk of Bladder Cancer: A Systematic Literature Review and Meta-Analysis of Observational Studies | ||||
Hoti F, Mehtälä J, Khanfir H, Christopher S, Bennett D, Ye Y, Korhonen P | ||||
EPID Research, Espoo, Finland | ||||
Pharmacoepidemiology and Drug Safety (2017);26 (S2): 3-636 |
||||
, Abstract | ||||
, Finland | ||||
Abstract: https://onlinelibrary.wiley.com/doi/epdf/10.1002/pds.4275 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2017 | English | , Literature Review, Meta analysis | |
Impact of locally advanced or metastatic prostate cancer on the quality of life | ||||
López-Calderero I, López-Fando L, Ríos-González E, Maisonobe P, Hernández-Yuste E, Sarmiento-Jordán M | ||||
López-Calderero I: Hospital Can Misses, Ibiza, España Sarmiento M: QuintilesIMS, Barcelona, España | ||||
Actas Urológicas Españolas 2017;41(6):368-75 |
||||
, Article | ||||
, Spain | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/28256271 | ||||
Condition | Year | Language | Analysis type | |
, Oncology, Urology | 2017 | English | , Quality of life | |
Patterns of use of systemic therapies among patients with metastatic melanoma: a retrospective claims database analysis in the United States. | ||||
Ma Q1, Chen YJ2, Hines DM2, Munakata J3, Batty N4, Barber BL1, Zhao Z1. | ||||
1 a Department of Global Health Economics , Amgen Inc , Thousand Oaks , CA , USA. 2 b Health Economics & Outcomes Research, IMS Health , Fairfax , VA , USA. 3 c Real World Evidence Solutions, IMS Health , San Francisco , CA , USA. 4 d Department of Medical Affairs , Amgen Inc , Thousand Oaks , CA , USA. | ||||
J Dermatolog Treat. 2017 Sep;28(6):549-553 |
||||
, Article | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2017 | English | , Retrospective database analysis | |
UTILIZATION OF RADIUM-223 DICHLORIDE (RA-223) IN PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER IN CANADA: A REAL-WORLD RETROSPECTIVE STUDY | ||||
Lapierre M, Fraelic A | ||||
IMS Health, Kirkland, QC, Canada, IMS Health, Canada, Kanata, QC, Canada | ||||
ISPOR 21st, May 21-25 - 2016 Washington DC USA Value in Health, 2016, 19(3): A162 |
||||
, Poster | ||||
, Canada | ||||
Abstract: http://www.valueinhealthjournal.com/article/S1098-3015(16)01560-6/abstract | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2016 | English | , Retrospective database analysis | |
REAL-WORLD COMPARISON OF METASTATIC MELANOMA TREATMENTS BETWEEN ACADEMIC AND COMMUNITY HOSPITALS IN CANADA: A RETROSPECTIVE STUDY | ||||
Lapierre M | ||||
IMS Health, Kirkland, QC, Canada | ||||
ISPOR 21st, May 21-25 - 2016 Washingtown DC USA |
||||
, Poster | ||||
, Canada | ||||
Abstract: http://www.imsbrogancapabilities.com/pdf/rwe/metastatic-melanoma-ispor-poster-2016.pdf | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2016 | English | , Retrospective database analysis | |
TREATMENT PATTERNS OF METASTATIC MELANOMA IN FIVE EUROPEAN COUNTRIES | ||||
Burudpakdee C1, Zhao Z2, Seetasith A1, Ma Q2, Campos Tapias I3, Barber BL2 | ||||
1 MS Health, Fairfax, VA, USA, 2 Amgen Inc, Thousand Oaks, CA, USA, 3 Amgen SA, Barcelona, Spain | ||||
ISPOR 21st, May 2016 Washington, USA |
||||
, Poster | ||||
, France, Germany, Italy, Spain, UK | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2016 | English | , Retrospective database analysis | |
Stage-specific survival and recurrence in patients with cutaneous malignant melanoma in Europe - a systematic review of the literature. | ||||
Svedman FC1, Pillas D2, Taylor A2, Kaur M2, Linder R3, Hansson J1. | ||||
1Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital Solna, Stockholm, Sweden. 2Centre for Observational Research, Amgen Ltd, Uxbridge, UK. 3IMS Health Sweden, Stockholm, Sweden. | ||||
Clinical Epidemiology |
||||
, Article | ||||
, Australia, Austria, Belgium, Bulgaria, Croatia, Czech, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Israel, Italy, Netherlands, Norway, Poland, Portugal, Russian Federation, Serbia and Montenegro, Slovakia, Slovenia, Spain, Sweden, Switzerland, Turkey, UK | ||||
Abstract: http://www-ncbi-nlm-nih-gov.proxy.kib.ki.se/pmc/articles/PMC4887072/ | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2016 | English | , Literature Review | |
Population-based study of giant cell tumor of bone in Sweden (1983-2011). | ||||
Amelio JM1, Rockberg J2, Hernandez RK3, Sobocki P4, Stryker S5, Bach BA3, Engellau J6, Liede A5 | ||||
1Amgen Ltd. Uxbridge, UK. Electronic address: justyna.amelio@amgen.com. 2Pygargus/IMS Health, Stockholm, Sweden. 3Amgen Inc. Thousand Oaks, CA, USA. 4Pygargus/IMS Health, Stockholm, Sweden; Karolinska Institutet, Stockholm, Sweden. 5Amgen Inc. South San Francisco, CA, USA. 6Lund University, Lund, Sweden. | ||||
Cancer Epidemiol |
||||
, Article | ||||
, Nordic, Sweden | ||||
Abstract: http://www.cancerepidemiology.net/article/S1877-7821(16)30039-X/abstract | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2016 | English | , Real World Evidence | |
Italian electronic health records mapping: is clinical data collection getting in line with the real world evidence era? | ||||
Avitabile A, Caputo A, Gilardelli G, Golotta C, La Grasta L, Heiman F1, Porrello N. | ||||
1 IMS Health Information Solutions Italy Srl, Milan, Italy. | ||||
ISPOR 19th Annual European Congress, 2016, 29 October-2 November, Vienna, Austria. |
||||
, Poster | ||||
, Italy | ||||
Condition | Year | Language | Analysis type | |
, Health policy, Neurological disorders, Oncology | 2016 | English | , Clinical setting: hospital, Real World Data, Real World Evidence | |
Hospitalization cost and length of stay associated with HPV-related diseases. | ||||
Tsakeu E1, Petit C2, Chevalier P1 | ||||
1 QuintilesIMS, Zaventem, Belgium 2 Sanofi-Pasteur MSD, Diegem, Belgium | ||||
19th ISPOR Annual European Congress, 2016, October 29- November 2, Vienna, Austria |
||||
, Abstract | ||||
, Belgium | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2016 | English | , Cost analysis | |
Description of first-line treatments in patients with non-resectable colorectal cancers in Belgium. | ||||
Chevalier P, van Gils C, Lamotte M | ||||
QuintilesIMS, Zaventem, Belgium | ||||
19th ISPOR Annual European Congress, 2016, October 29- November 2, Vienna, Austria |
||||
, Abstract | ||||
, Belgium | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2016 | English | ||
In-hospital mortality and complications following surgical resection of glioblastoma. | ||||
Chevalier P, van Gils C, Lamotte M | ||||
QuintilesIMS, Zaventem, Belgium | ||||
19th ISPOR Annual European Congress, 2016, October 29- November 2, Vienna, Austria |
||||
, Abstract | ||||
, Belgium | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2016 | English | ||
Costs of HPV-related cancers in The Netherlands. | ||||
Ahmed Salem1, Shahbaz Pervaiz1, Vidya Breeveld-dwarkasing2, Dhont Patrick3, Slierendregt Bas2, Chantal van Gils1 | ||||
1 QuintilesIMS, Zaventem, Belgium 2 Sanofi-Pasteur MSD, Hoofddorp, The Netherlands 3 Sanofi-Pasteur MSD, Diegem, Belgium | ||||
19th ISPOR Annual European Congress, 2016, October 29- November 2, Vienna, Austria |
||||
, Abstract | ||||
, Netherlands | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2016 | English | , Real World Data | |
COSTS EVOLUTION OF CANCER THERAPIES IN EUROPE FROM 2004 TO 2014 | ||||
Tetafort A, Aubert JM, Perrot D, Brigot G, Kolahi C, Ansolabehere X | ||||
IMS Health France | ||||
19th ISPOR Congress 2016 |
||||
, Abstract, Poster | ||||
, France, Germany, Italy, UK | ||||
Abstract: https://www.ispor.org/research_pdfs/54/pdffiles/PCN82.pdf | ||||
Condition | Year | Language | Analysis type | |
, Oncology, Pricing and reimbursement | 2016 | English | , Clinical setting: hospital, Cost analysis, Pricing & Reimbursement, Retrospective database analysis | |
USE OF REAL WORLD DATA IN IDENTIFYING RELEVANT COMPARATORS IN MEDICO ECONOMIC MODELS AT EU5 LEVEL: A CASE STUDY ON MULTIPLE MYELOMA | ||||
Jubert H, Kolahi C, Karusisi N, Mitrofan L | ||||
IMS Health France | ||||
19th ISPOR congress 2016 |
||||
, Abstract, Poster | ||||
, France, Germany, Italy, Spain, UK | ||||
Abstract: https://www.ispor.org/research_pdfs/54/pdffiles/PCN150.pdf | ||||
Condition | Year | Language | Analysis type | |
, Health economics, Oncology | 2016 | English | , Clinical setting: hospital, Population Based Study, Real World Data, Retrospective database analysis | |
Epidemiology of cutaneous melanoma in Sweden-Stage-specific survival and rate of recurrence. | ||||
Rockberg J1, Amelio JM2, Taylor A2, Jörgensen L1, Ragnhammar P3, Hansson J4. | ||||
1Pygargus AB/IMS Health Sweden AB, Pyramidvägen 7, Solna, Sweden 169 56. 2Amgen Inc, Uxbridge Business Park, Uxbridge, UK UB8 1DH. 3Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital, Solna, Sweden 171 76. 4Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital, Solna, Sweden 171 76. johan.hansson@ki.se. | ||||
Int J Cancer |
||||
, Article | ||||
, Nordic, Sweden | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/27563839 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2016 | English | , Epidemiological study, Real World Evidence | |
Overall survival and intermediate outcomes among Scandinavian non-small cell lung cancer patients: the SCAN-LEAF study | ||||
Simon Ekman (MD, PhD)1, Jens Benn Sørensen (MD, DMSc, MPA)2, Julia Rockberg (MSc, PhD)3, Martin Sandelin (MD, PhD)4, Melinda Manley Daumont (PhD)5, Patrik Sobocki (PhD)3, Peter Klint (PhD)6, Han-Yao Huang (PhD)7, Jenny Svärd (MSc, PhD)3, Oana Cristina Chirita (MPharm, MSc)8, Leif Jörgensen (MSc)3, Maria Planck (MD, PhD)9 | ||||
1. Karolinska University Hospital, Stockholm, Sweden 2. Rigshospitalet, Copenhagen, Denmark 3. Pygargus/IMS Health, Solna, Sweden 4. Uppsala University, Uppsala, Sweden 5. Bristol-Myers Squibb, Paris, France 6. Bristol-Myers Squibb, Solna, Sweden 7. Bristol-Myers Squibb, Pennington, NJ, USA 8. Bristol-Myers Squibb, Uxbridge, UK 9. Lund University, Lund, Sweden | ||||
IASLC 17th World Conference on Lung Cancer, Vienna 2016 |
||||
, Abstract | ||||
, Sweden | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2016 | English | , Epidemiological study, Real World Evidence | |
Patient database analysis of fulvestrant 500 mg in the treatment of metastatic breast cancer: A European perspective | ||||
Marchetti P1, Maass N2, Gligorov J3, Berger K4, MacDougall F5, Montonen J6, Lewis J7. | ||||
1Department of Clinical and Molecular Medicine, Sapienza University of Rome and IDI-IRCCS, Rome, Italy. Electronic address: paolo.marchetti@ospedalesantandrea.it. 2Department of Gynecology and Obstetrics, University Medical Center Schleswig-Holstein, Kiel, Germany. Electronic address: Nicolai.Maass@uksh.de. 3Department of Medical Oncology, INSERM U938, APHP Tenon, IUC-UPMC, Sorbonne University, Paris, France. Electronic address: joseph.gligorov@aphp.fr. 4Real World Evidence Solutions and HEOR, IMS Health, Munich, Germany. Electronic address: KBerger@de.imshealth.com. 5Real World Evidence Solutions and HEOR, IMS Health, London, United Kingdom. Electronic address: FMacDougall@uk.imshealth.com. 6AstraZeneca, London, United Kingdom. Electronic address: jukka.montonen@astrazeneca.com. 7AstraZeneca, London, United Kingdom. Electronic address: Jan.Lewis@astrazeneca.com. | ||||
Breast. 2016 Dec 20. pii: S0960-9776(16)30264-8. |
||||
, Article | ||||
, France, Germany, Italy, Spain | ||||
Abstract: https://linkinghub.elsevier.com/retrieve/pii/S0960-9776(16)30264-8 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2016 | English | , Retrospective database analysis | |
Real world data: use of novel treatments and biomarkers in malignant melanoma in European countries | ||||
von Bredow D1, Kolb N1, Schmidt N2, Eheberg D1 | ||||
1 QuintilesIMS, Munich, Germany 2 QuintilesIMS, Frankfurt, Germany | ||||
, Poster | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2016 | English | , Real World Data | |
Second-line drug regimens in metastatic melanoma patients based on BRAF mutation status: A Canadian real-world retrospective study | ||||
Bremner S1, Lapierre M2, Fraelic A1, Stewart D1 | ||||
1 IMS Health, Kanata, ON, Canada 2 IMS Health, Kirkland, QC, Canada | ||||
2016 ASCO Annual Meeting |
||||
, Abstract | ||||
, Canada | ||||
Abstract: http://meetinglibrary.asco.org/content/168312-176 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2016 | English | , Retrospective database analysis | |
The Protective Effect of Low-Dose Aspirin against Colorectal Cancer Is Unlikely Explained by Selection Bias: Results from Three Different Study Designs in Clinical Practice | ||||
Cea Soriano L, Soriano-Gabarró M, García Rodríguez LA | ||||
Spanish Centre for Pharmacoepidemiological Research (CEIFE); Epidemiology, Bayer Pharma AG | ||||
, Article | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2016 | English | , Retrospective database analysis | |
Validity and completeness of colorectal cancer diagnoses in a primary care database in the United Kingdom | ||||
Cea Soriano L, Soriano-Gabarró M, García Rodríguez LA | ||||
Spanish Centre for Pharmacoepidemiologic Research (CEIFE); Global Epidemiology, Bayer Pharma AG | ||||
, Article | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2016 | English | , Retrospective database analysis | |
The Risk of Cancer in Patients With Psoriasis: A Population-Based Cohort Study in the Health Improvement Network | ||||
Chiesa Fuxench ZC, Shin DB, Ogdie Beatty A, Gelfand JM | ||||
Departments of Dermatology, University of Pennsylvania; Epidemiology and Biostatistics, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania Perelman School of Medicine | ||||
, Article | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Dermatology, Miscellaneous, Oncology | 2016 | English | , Retrospective database analysis | |
Disentangling the Association between Statins, Cholesterol, and Colorectal Cancer: A Nested Case-Control Study. | ||||
Mamtani R, Lewis JD, Scott FI, Ahmad T, Goldberg DS, Datta J, Yang YX, Boursi B | ||||
Division of Hematology/Oncology, University of Pennsylvania; Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania; Division of Gastroenterology, University of Pennsylvania; Section of Cardiovascular Medicine, Yale School of Medicine; Department of Surgery, University of Pennsylvania; Tel-Aviv University | ||||
, Article | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2016 | English | , Retrospective database analysis | |
Living With an Older Person Dying From Cancer, Lung Disease, or Dementia: Health Outcomes From a General Practice Cohort Study | ||||
Sampson EL, Lodwick R, Rait G, Candy B, Low J, King M, Petersen I | ||||
Marie Curie Palliative Care Research Department, Division of Psychiatry University College London; Research Department of Primary Care and Population Health, University College London | ||||
, Article | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Miscellaneous, Neurological disorders, Oncology, Respiratory disease | 2016 | English | , Retrospective database analysis | |
Chemotherapy-induced nausea and vomiting (CINV) in Italian lung cancer patients: assessment by physician, nurse and patient | ||||
Carnio S1, Galetta D2, Scotti V3, Cortinovis DL4, Antonuzzo A5, Pisconti S6, Rossi A7, Martelli O8, Lunghi A9, Pilotto S10, Del Conte A11, Pegoraro V12, Montagna ES2, Topulli J3, Pelizzoni D4, Rapetti SG1, Gianetta M1, Pacchiana MV1, Novello S1 | ||||
1 Thoracic Oncology Unit at San Luigi Hospital (Orbassano), University of Turin, Italy 2 Clinical Cancer Center “Giovanni Paolo II” Bari, Italy 3 Department of Oncology Radiation Therapy Unit, Careggi University Hospital, Florence, Italy 4 Medical Oncology Unit, San Gerardo Hospital, Monza, Italy 5 5Division of Medical Oncology Department of Oncology, S. Chiara University Hospital, Pisa, Italy 6 Department of OncoEmatology Medical Oncology, SG Moscati Hospital, Taranto, Italy 7 Division of Medical Oncology SG Moscati Hospital, Avellino, Italy 8 Medical Oncology Unit, San Giovanni Addolorata Hospital, Roma, Italy 9 Department of Oncology, Medical Oncology Unit, Careggi University Hospital, Florence, Italy 10 Medical Oncology , Department of Medicine, Verona, Italy 11 Department of Medical Oncology , Azienda per l’Assistenza Sanitaria No.5, Friuli Occidentale, Presidio Ospedaliero di Pordenone, Pordenone, Italy, QuintilesIMS, Milan, Italy 13 | ||||
, Poster | ||||
, Italy | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2016 | English | , Survey research | |
Impact of Metformin on Metastases in Patients with Breast Cancer and Type 2 Diabetes | ||||
Jacob L, Kostev K, Rathmann W, Kalder M | ||||
J Diabetes Complications. 2016 Aug;30(6):1056-9 |
||||
, Article | ||||
Condition | Year | Language | Analysis type | |
, Diabetes, Oncology | 2016 | English | ||
Age-related differences in persistence in women with breast cancer treated with tamoxifen or aromatase inhibitors in Germany | ||||
Jacob L, Hadji P, Kostev K | ||||
J Geriatr Oncol. 2016 Apr 16. pii: S1879-4068(16)30019-4 |
||||
, Article | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Oncology, Womens Health | 2016 | English | ||
Age-related differences in persistence with bisphosphonates in women with metastatic breast cancer. | ||||
Jacob L, Hadji P, Kostev K | ||||
J Bone Oncol. 2016 Mar 2;5(2):63-6 |
||||
, Article | ||||
Condition | Year | Language | Analysis type | |
, Oncology, Womens Health | 2016 | English | ||
Novel therapy options for advanced & metastatic melanoma patients in EU5 countries result in a changing treatment pattern especially in BRAF mutant patients. | ||||
Bernhardt M, Schmidt N, Mambrini T | ||||
IMS Health Global Oncology, Central, East & South Europe | ||||
ESMO 2016 Annual Meeting, 2016, 07 Oct - 11 Oct, Copenhagen, Denmark |
||||
, Poster | ||||
, France, Germany, Italy, Spain, UK | ||||
Abstract: http://poster-submission.com/esmo2016/visitors/eposter/32626 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2016 | English | , Retrospective database analysis | |
Changing treatment patterns in advanced & metastatic melanoma towards targeted therapies in EU5 countries from 2011 to 2015. | ||||
Bernhardt M, Schmidt N, Mambrini T | ||||
IMS Health Global Oncology, Central, East & South Europe | ||||
ESMO 2016 Annual Meeting, 2016, 07 Oct - 11 Oct, Copenhagen, Denmark |
||||
, Poster | ||||
, France, Germany, Italy, Spain, UK | ||||
Abstract: http://poster-submission.com/esmo2016/visitors/eposter/32287 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2016 | English | , Retrospective database analysis | |
Brain metastasis in NSCLC in the era of precision Medicine. | ||||
Mpima S, Anger C, Mitrofan L | ||||
1 IMS Health, London, United Kingdom 2 IMS Health, La Defense, France | ||||
ESMO 2016 Annual Meeting, 2016, 07 Oct - 11 Oct, Copenhagen, Denmark |
||||
, Poster | ||||
, France, Germany, Italy, Spain, UK | ||||
Abstract: http://oncologypro.esmo.org/Meeting-Resources/ESMO-2016/Brain-metastases-in-NSCLC-patients-in-the-era-of-precision-medicine | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2016 | English | , Observational study | |
17P Deletion and TP53 Gene Mutation (17P/TP53) testing behaviour and treatment patterns for Chronic Lymphocytic Leukaemia (CLL) patients in France, Germany, Italy, Spain and U.K. (EU5). | ||||
Bermudez F, Karanais Y, Mistry H, Anger C | ||||
IMS Health, London, United Kingdom | ||||
ESMO 2016 Annual Meeting, 2016, 07 Oct - 11 Oct, Copenhagen, Denmark |
||||
, Poster | ||||
, France, Germany, Italy, Spain, UK | ||||
Abstract: http://poster-submission.com/esmo2016/visitors/eposter/32724 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2016 | English | , Retrospective database analysis | |
Real Life Progression Free Survival and treatment Patterns for Patients with Metastatic Renal Cell Carcinoma treated with Targeted Therapies in France: Analysis of IMS RWD Oncology Cross-sectional Survey Data. | ||||
Maroun R, Mitrofan L, Benjamin L, Nachbaur G, Maunoury F, Le Jeunne P, Durand Zaleski I | ||||
GlaxosmithKline, Health Economics and Outcome Research, Marly le Roi France, Eceve, Paris, France, Quintiles IMS, France Le Mans, France, URC Eco, Paris, France | ||||
ESMO 2016 Annual Meeting, 2016, 07 Oct - 11 Oct, Copenhagen, Denmark |
||||
, Poster | ||||
, France, Germany, Italy, Spain, UK | ||||
Abstract: https://www.ispor.org/research_pdfs/54/pdffiles/PCN47.pdf | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2016 | English | , Longitudinal study | |
Understand the Role of dermatologists and Oncologists in the treatment of Melanoma in France and the UK. | ||||
Mpima S, Casey V, Nasuti P | ||||
QuintilesIMS, London, United Kingdom | ||||
IPSOR 2016 Annual Meeting |
||||
, Poster | ||||
, France, Germany, Italy, Spain, UK | ||||
Abstract: http://www.valueinhealthjournal.com/article/S1098-3015(16)32943-6/pdf | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2016 | English | , Observational study | |
Use of Real World Data in identifying relevant comparators in medico economic models at EU5 level: A case study on Multiple Myeloma. | ||||
Jubert H, Karusisi N, Kolahi C, Mitrofan L | ||||
QuintilesIMS, La Defense, France | ||||
IPSOR 2016 Annual Meeting |
||||
, Poster | ||||
, France, Germany, Italy, Spain, UK | ||||
Abstract: https://www.ispor.org/research_pdfs/54/pdffiles/PCN150.pdf | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2016 | English | ||
Increasing economic burden of tyrosine kinase inhibitor treatment failure by line of therapy in chronic myeloid leukemia. | ||||
McGarry LJ., Chen YJ., Divino V., Pokras S., Taylor CR., Munakata J., Nieset CC., Huang H., Jabbour E., Malone DC. | ||||
ARIAD. IMS authors: Divino V, Munakata J | ||||
Curr Med Res Opin. Curr Med Res Opin. 2016;32(2):289-99 |
||||
, Article | ||||
, USA | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/26566171 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2016 | English | , Burden of illness | |
GENERIC DRUG VOLUME AND COST SAVINGS IN ONCOLOGY: A 2005-2014 MIDAS ANALYSIS | ||||
Divino V., Coyle K., Kleinrock M., Wade RL., DeKoven M., Kaura S. | ||||
Celgene. IMS authors: Divino V, Coyle K, Kleinrock M, Wade RL, DeKoven M | ||||
ISPOR 19th Annual European Congress |
||||
, Poster | ||||
, USA | ||||
Abstract: https://www.ispor.org/ScientificPresentationsDatabase/Presentation/68602?pdfid=47233 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2016 | English | , Retrospective database analysis | |
New and emerging novel therapy combinations for relapsed and refractory multiple myeloma (RRMM) | ||||
Victoria Divino, Kejal Parikh, Mitch DeKoven, Katharine Coyle, Safiya Abouzaid | ||||
Celgene, IMS authors: Divino V, DeKoven M, Katharine Coyle | ||||
2016 AMCP Managed Care & Specialty Pharmacy Annual Meeting |
||||
, Poster | ||||
, USA | ||||
Abstract: http://www.jmcp.org/doi/pdf/10.18553/jmcp.2016.22.4.S1 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2016 | English | , Literature Review | |
Mortality and Vascular Events among Elderly Patients with Chronic Myeloid Leukemia: A Retrospective Analysis of Linked SEER-Medicare Data | ||||
Lang K, McGarry L, Huang H, Dorer D, Kaufman E, Knopf K | ||||
Huan Huang is IQVIA author | ||||
Clin Lymphoma Myeloma Leuk |
||||
, Article | ||||
, USA | ||||
Abstract: https://www.sciencedirect.com/science/article/pii/S2152265016000525?via%3Dihub | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2016 | English | , Population Based Study, Retrospective database analysis | |
Guidelines for Breast Cancer Gene Mutation Testing in Healthy Individuals and Patients Diagnosed with Breast Cancer | ||||
Casso D, Telford C, Oliveria SA, Saggar JK, Tyczynski JE. | ||||
Casso D: IQVIA; Telford C: AstraZeneca; Oliveria SA: IQVIA; Tyczynski JE: AstraZeneca | ||||
6th International Symposium on Hereditary Breast and Ovarian Cancer, Montreal, Canada |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2016 | English | , Literature Review, Review | |
Reduced risk of breast cancer mortality in women using postmenopausal hormone therapy: a Finnish nationwide comparative study | ||||
Mikkola TS, Savolainen-Peltonen H, Tuomikoski P, Hoti F, Vattulainen P, Gissler M, Ylikorkala O | ||||
Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, 00029 Helsinki, Finland | ||||
Menopause (2016);23(11):1199-1203 |
||||
, Article | ||||
, Finland | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/27465718 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2016 | English | , Epidemiological study, Population Based Study, Retrospective database analysis | |
Reduced risk of breast cancer mortality in women using postmenopausal hormone therapy: a Finnish nationwide comparative study | ||||
Mikkola TS, Savolainen-Peltonen H, Tuomikoski P, Hoti F, Vattulainen P, Gissler M, Ylikorkala O. | ||||
Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland | ||||
Menopause (2016) 23(11): 1199-1203 |
||||
, Article | ||||
, Finland | ||||
Abstract: https://journals.lww.com/menopausejournal/Abstract/2016/11000/Reduced_risk_of_breast_cancer_mortality_in_women.8.aspx | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2016 | English | , Population Based Study, Prospective study | |
Real-World Axitinib Use in the United States: A Retrospective Study Using Linked Datasets. | ||||
MacLean E, Cisar L, Mehle K, Eremina D, Quigley JM | ||||
Outcomes and Evidence, Global Health and Value, New York, New York. US Medical Affairs, Oncology, Pfizer, New York, New York. Commercial Effectiveness Services, IMS Health, Plymouth Meeting, Pennsylvania. Statistical Methodology, IMS Health, Plymouth Meeting, Pennsylvania. Commercial Effectiveness Services, IMS Health, Plymouth Meeting, Pennsylvania. | ||||
J Manag Care Spec Pharm. 2016 Jun;22(6):723-732u |
||||
, Abstract | ||||
, USA | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/27231799 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2016 | English | , Retrospective database analysis | |
THERAPY OF DEPRESSION IN CANCER AND NON-CANCER PATIENTS IN GERMAN NEUROPSYCHIATRIC PRACTICES | ||||
Ziegelbauer K, Engelhard J, Kostev K | ||||
IMS Health, Frankfurt am Main, Germany | ||||
ISPOR 18th Annual European Congress Milan, Italy November, 2015 |
||||
, Poster | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Mental health, Oncology | 2015 | English | ||
Axitinib as Subsequent Therapy in Renal Cell Carcinoma: Real-World Treatment Patterns in the United States | ||||
MacLean E1, Mehle K2, Eremina D2, Quigley J2 | ||||
1 Pfizer, New York, US, 2 IMS Health, Plymouth Meeting, US | ||||
American Society of Clinical Oncology, 2014 JMCP; 2015; 21(4):S15 |
||||
, Abstract | ||||
, USA | ||||
Abstract: http://www.amcp.org/mwg-internal/ogf7f4h09szyk7/progress?id=WFRYx0FI68JadqynyZ9ANLnilO3lKxogo0_mDztGEXc,&dl | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2015 | English | , Retrospective database analysis | |
Cost-effectiveness of Radium-223 Dichloride (Radium-223) in Alsympca: A Cost-effectiveness analysis of Radium-223+Best standard of care (BSOC) compared with placebo+BSOC in treatment of Castration-Resistant Prostate Cancer (CRPC) and symptomatic bone metastases in Canada | ||||
Henricks P1, Cislo P2, Zhan L2, Beaudet A3, Grabbi E4, Lloyd A4, Fleshner N5, Chin W6 | ||||
1Bayer Inc, Toronto, ON, Canada, 2Bayer HealthCare, Whippany, NJ, USA, 3IMS Health, Basel, Switzerland, 4IMS Health, London, UK, 5Princess Margaret Hospital, University Health Network, Toronto, ON, Canada, 6ILEX Consulting, Toronto, ON, Canada | ||||
ISPOR 20th Annual International Meeting, Philadelphia, PA, USA, May 16-20 2015 |
||||
, Poster | ||||
, Canada | ||||
Abstract: https://www.ispor.org/research_pdfs/49/pdffiles/PCN74.pdf | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2015 | English | , Cost effectiveness | |
NSAIDs, statins, low-dose aspirin and PPIs, and the risk of oesophageal adenocarcinoma among patients with Barrett’s oesophagus: a populationbased case–control study | ||||
Masclee GM1, Coloma PM2, Spaander MC3, Kuipers EJ3, Sturkenboom MC4. | ||||
1Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, The Netherlands. 2Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands. 3Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, The Netherlands. 4Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands Department of Epidemiology, Erasmus University Medical Center, Rotterdam, The Netherlands | ||||
BMJ Open. 2015 Jan 29;5(1):e006640. |
||||
, Article | ||||
, Netherlands, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4316430/pdf/bmjopen-2014-006640.pdf | ||||
Condition | Year | Language | Analysis type | |
, Gastrointestinal disorders, Oncology | 2015 | English | , Epidemiological study, Retrospective database analysis | |
Real-world treatment with abiraterone acetate (Zytiga®) in metastatic castration-resistant prostate cancer (mCRPC) patients in the post-chemotherapy setting in Europe | ||||
L Dearden, P Musingarimi, N Shalet, T Maher, D Demuth, L Garcia-Alvarez, A Muthutantri, A Venerus, R Lasry, M Hankins | ||||
, Conference | ||||
, Europe | ||||
Condition | Year | Language | Analysis type | |
, Methodology, Oncology | 2015 | English | , Real World Data, Real World Evidence | |
Chemotherapy treatment patterns, costs, and outcomes of patients with gastric cancer in the United States: a retrospective analysis of electronic medical record (EMR) and administrative claims data. | ||||
Hess L, Michael D,Mytelka D, Beyrer J, Liepa1 A and Nicol S | ||||
Lilly Oncology | ||||
Gastric Cancer |
||||
, Article | ||||
, USA | ||||
Abstract: http://scholar.google.com/scholar_url?url=http://link.springer.com/article/10.1007/s10120-015-0486-z/fulltext.html&hl=en&sa=X&scisig=AAGBfm3--GVI9iCpWS5h2bj0yC44jPhJVQ&nossl=1&oi=scholaralrt | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2015 | English | , Retrospective database analysis | |
Axitinib as subsequent therapy in renal cell carcinoma: real world treatment patterns in the United States | ||||
MacLean E, Mehle K, Eremina D, Quigley J | ||||
Pfizer Global Health & Value, New York, NY | ||||
, Poster | ||||
, USA | ||||
Abstract: http://congress-download.pfizer.com/public/download.aspx?docID=my4%2fLzgcvl8%3d | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2015 | English | , Retrospective cohort analysis | |
Increased Treatment Cost Associated with Mantle Cell Lymphoma Disease Progression | ||||
Wade R1, Hu X2, Chen Y3, Mahmoud D4, Le Gouill S3 | ||||
IMS Health Global Market Access, Celgene, Summit, NJ, USA, Haematology Department, CHU Nantes and UMR892 INSERM, Nantes, France | ||||
EHA 2015, Congress of the European Hematology Association, June 2015 |
||||
, Abstract, Poster | ||||
, France, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2015 | English | , Cost analysis | |
Costs Associated with Routine Management of Febrile Neutropenia/Leukopenia in Three Tumour Types in German Hospitals - A Cost Study Update | ||||
Ihbe-Heffinger A1, Shlaen M5, Jacobs V3, Von Schilling C4, Paessens B1, Berger K6, Kiechle M3, Bernard R1, Peschel C2 | ||||
1 Hospital Pharmacy Unit, Klinikum rechts der Isar, Technische Universität München, Munich, Germany 2 Third Medical Dept., Klinikum rechts der Isar, Technische Universität München, Munich, Germany 3 Dept. of Gynecology, Klinikum rechts der Isar, Technische Universität München, Munich, Germany 4 Third Medical Dept., Klinikum Freising, Freising, Germany 5 IMS Health GmbH, Munich, Germany 6 Medizinische Klinik III, Hämatologie, Onkologie, Klinikum der Universität, Munich, Germany | ||||
MASCC/ISOO Annual Meeting on Supportive Care in Cancer, 2015, February 15th, Copenhagen, Denmark |
||||
, Abstract, Poster | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2015 | English | ||
Evaluation of Pharmaceutical Transaction Data for Potential Augmentation of SEER Treatment Data | ||||
Cronin, K., Barrett, M., Warren, J., Tran, Q., Annett, D., Pressman, E., Wu, X., Hsieh, M., Pirolli, M., Penberthy, L. | ||||
SEER |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2015 | English | , Retrospective database analysis | |
Prevalence of bone loss among nonmetastatic breast cancer patients treated with aromatase inhibitors in the United States | ||||
Pirolli M, Hernandez R, Reich A, Liede A | ||||
Amgen | ||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2015 | English | , Epidemiological study | |
Estimating the Budget Impact of Switching from Bortezomib Intravenous (IV) to Bortezomib Subcutaneous (SQ) in the Treatment of Relapsed/Refractory Multiple Myeloma (MM) in Mexico | ||||
Wehler EA1, Kowal S2, Hernandez-Garduno A3, Danese de los Santos L3, De Anda, Anaya P5, Munakata J6, Gonzalez-Michaca L7 | ||||
1IMS Health, Plymouth Meeting, PA, USA 2IMS Health, Seattle, WA, USA 3Janssen, Mexico City, Mexico 4IMS Health, Mexico City, Mexico 5IMS Health, Mexico, D.F., Mexico 6IMS Heath, San Francisco, CA, USA 7Janssen, Raritan, NJ, USA | ||||
Value Health, 2015, 18(7); A818 |
||||
, Poster | ||||
, Mexico, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2015 | English | , Cost analysis | |
An assessment of chemotherapy-induced nausea and vomiting direct costs in three EU countries. | ||||
Turini M1, Piovesana V1, Ruffo P1, Ripellino C2, Cataldo N2. | ||||
1 Helsinn S A., Lugano, Switzerland, 2 IMS Health Information Solutions Medical Research srl, Milan, Italy. | ||||
Drugs Context. 28;4:212285. |
||||
, Article | ||||
, France, Germany, Italy | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4544273/pdf/dic-4-212285.pdf | ||||
Condition | Year | Language | Analysis type | |
, Health economics, Oncology | 2015 | English | , Survey research | |
Parents’ expressed emotion and mood, rather than their physical disability are associated with adolescent adjustment: A longitudinal study of families with a parent with multiple sclerosis | ||||
A Bogosian 1, J Hadwin 2, M Hankins 3, R Moss-Morris 4 | ||||
1 Psychology Department, City University, UK 2 Psychology Department, Southampton University, UK 3 Real-World Evidence Solutions, IMS Health, UK 4 Institute of Psychiatry, Psychology and Neuroscience, King’s College London, | ||||
Clin Rehabil. 2015 Apr 14 |
||||
, Article | ||||
, England, Europe | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/25872520 | ||||
Condition | Year | Language | Analysis type | |
, Musculoskeletal disease, Neurological disorders, Oncology | 2015 | English | , Longitudinal study | |
Development and psychometric evaluation of a new patient-reported outcome measure for stroke self-management: The Southampton Stroke Self-Management Questionnaire (SSSMQ) | ||||
Boger EJ1, Hankins M2, Demain SH3, Latter SM4. | ||||
1Faculty of Health Sciences, University of Southampton, Southampton, SO17 1BJ, UK. 2Real-World Evidence Solutions, IMS Health, London, N1 9JY, UK. 3Faculty of Health Sciences, University of Southampton, Southampton, SO17 1BJ, UK.4Faculty of Health Sciences, University of Southampton | ||||
Health and Quality of Life Outcomes |
||||
, Article | ||||
, England | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease, Methodology, Oncology, Pain | 2015 | English | , Database Study, Quality of life | |
Real-world Assessment of Renal Involvement in Tuberous Sclerosis Complex (TSC) Patients in the United Kingdom (UK): A Retrospective Cohort Study in the Clinical Practice Research Datalink (CPRD) | ||||
Kingswood, Chris1, Nasuti, Paola2, Demuth, Dirk2, Patel, Keyur2, Myland, Melissa2, Erhard, Clement3, Gray, Elizabeth4, Pinnegar, Alun4, Magestro, Matthew5 | ||||
The Royal Sussex County Hospital, Brighton, England 2 IMS Health, London, UK 3 CE Analytics, Cambridge, UK 4 Novartis Pharmaceuticals UK Ltd, Frimley, UK 5 Novartis Pharmaceuticals Corporation, East Hanover NJ, USA | ||||
International TSC Research Conference (Windsor, 11th Sept 2015). |
||||
, Poster | ||||
, England | ||||
Condition | Year | Language | Analysis type | |
, Oncology, Pediatrics, Rare disease | 2015 | English | , Retrospective cohort analysis | |
Patterns of use of oral anticancer treatments in France: a Retrospective Analysis of Cancer Treatments given ORally from 2004 to 2012 (Re-ACTOR study) | ||||
Benjamin L1, Maroun R, Maurel F, Bardoulat I, Ricarte C | ||||
1GlaxoSmithKline, Health Economics and Outcomes Research , Marly-le-Roi , France;2 IMS Health, La defense, Paris | ||||
Curr Med Res Opin. 2015 Feb;31(2):323-32 |
||||
, Article | ||||
, France | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/26005879 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2015 | English | , Database Study | |
PREVALENCE OF DEPRESSION AND ANXIETY AND THEIR RISK FACTORS IN WOMEN WITH BREAST CANCER IN GERMAN PRIMARY CARE | ||||
Engelhard J1, Bleicher L2, Kostev K1 | ||||
1IMS Health, Frankfurt am Main, Germany, 2University Clinic of Marburg, Marburg, Germany | ||||
ISPOR 18th Annual European Congress Milan, Italy November, 2015 |
||||
, Poster | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Mental health, Oncology | 2015 | English | ||
A DESCRIPTION OF REAL-WORLD TREATMENT WITH ABIRATERONE ACETATE IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER PATIENTS IN THE POST-CHEMOTHERAPY SETTING IN FRANCE AND THE NETHERLANDS | ||||
Dearden L1, Musingarimi P2, Shalet N3, Demuth D4, Garcia Alvarez L4, Muthutantri A4, Venerus A4, Lasry R4, Hankins M4, Maher T3 | ||||
1Janssen EMEA HEMAR, High Wycombe, UK, 2Janssen-Cilag Ltd., High Wycombe, UK, 3Janssen, High Wycombe, UK, 4IMS Health, London, UK | ||||
ISPOR 18th Annual European Congress Milan, Italy November, 2015 |
||||
, Poster | ||||
, France, Netherlands | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2015 | English | ||
THE ANALYSIS OF INPATIENTS COST OF BREAST CANCER IN CHINA, 2011 | ||||
Song S, Wang Z, Zhang M | ||||
IMS consulting group, Shanghai, China | ||||
ISPOR 18th Annual European Congress Milan, Italy November, 2015 |
||||
, Poster | ||||
, China | ||||
Condition | Year | Language | Analysis type | |
, Mental health, Oncology | 2015 | English | ||
ESTIMATION OF DIRECT MEDICAL COSTS ASSOCIATED WITH TREATMENT OF METASTATIC MELANOMA IN SWITZERLAND | ||||
Christoffersen P1, Khan N1, Lucas J1, Christodoulopoulou A2, Del Ponte A2, Gutzwiller F2 | ||||
1IMS Health, Basel, Switzerland, 2Amgen Switzerland AG, Zug, Switzerland | ||||
ISPOR 18th Annual European Congress Milan, Italy November, 2015 |
||||
, Poster | ||||
, Switzerland | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2015 | English | ||
4+ YEARS OF AMNOG – CLINICAL DRIVERS FOR SUCCESSFUL DOSSIER SUBMISSIONS IN ONCOLOGY | ||||
Dehnen J, Goldhagen K, Petry D | ||||
IMS Consulting Group, Muenchen, Germany | ||||
ISPOR 18th Annual European Congress Milan, Italy November, 2015 |
||||
, Poster | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2015 | English | ||
UTILIZATION AND COST OF SUPPORTIVE CARE AMONG PATIENTS RECEIVING NAB-PACLITAXEL + GEMCITABINE VERSUS FOLFIRINOX FOR METATSTATIC PANCREATIC CANCER | ||||
Patel M1, Parisi M1, Hill JW2, De AP2, Wade RL2 | ||||
Celgene Corporation, Summit, NJ, USA, 2IMS Health, Plymouth Meeting, PA, USA | ||||
ISPOR 21th, May 2016 Washington, DC USA |
||||
, Poster | ||||
, USA | ||||
Abstract: http://www.ispor.org/ | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2015 | English | , Cost analysis | |
Incidence Trends in the Diagnosis of Giant Cell Tumor of Bone in Sweden Since 1958. | ||||
Rockberg J1, Bach BA2, Amelio J3, Hernandez RK4, Sobocki P1, Engellau J5, Bauer HC6, Liede A7. | ||||
1IMS Health (Pygargus), Sveavägen 155, SE-113 46, Stockholm, Sweden. 2Amgen Inc., One Amgen Center Drive, MS 38-2-B, Thousand Oaks, CA 91320-1799. 3Amgen Ltd, 1 Uxbridge Business Park, Sanderson Road, Uxbridge UB8 1DH, England. 4Amgen Inc., One Amgen Center Drive, MS 24-2-A, Thousand Oaks, CA 93120-1799. 5Lund University, SE-221 85 Lund, Sweden. 6Karolinska Universitetssjukhuset, Solna, A2:07,171 76 Stockholm, Sweden. 7Center for Observational Research, Amgen, Inc., 1120 Veterans Boulevard, ASF3, South San Francisco, CA 94080. E-mail address: aliede@amgen.com. | ||||
, Article | ||||
, Nordic, Sweden | ||||
Abstract: http://jbjs.org/content/97/21/1756.long | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2015 | English | , Real World Evidence | |
Recurrence/progression and surgery of malignant melanoma in a retrospective Swedish cohort | ||||
Hansson J.*, Rockberg J., Taylor A., Jörgensen L., Linder R., Ragnhammar P., Amelio J | ||||
European Association of Dermato Oncology (EADO) Congress |
||||
, Abstract | ||||
, Sweden | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2015 | English | , Real World Evidence | |
Comparative Effectiveness of Oxaliplatin Versus 5-flourouricil in Older Adults: An Instrumental Variable Analysis. | ||||
Mack CD1, Brookhart MA, Glynn RJ, Meyer AM, Carpenter WR, Sandler RS, Stürmer T. | ||||
Department of Epidemiology, UNC Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC | ||||
Epidemiology. 2015 Sep;26(5):690-9. |
||||
, Article | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Comparative Effectiveness & Health Technology Assessment, Oncology | 2015 | English | , Retrospective database analysis | |
Metastatic Melanoma Patient Characteristics as a Determining Factor for Braf Gene Mutation Testing and Treatment in Canada – a retrospective cohort study | ||||
Djokic S1, Lapierre M2 | ||||
1 IMS Health, Ottawa, ON, Canada 2 IMS Health, Kirkland, QC, Canada | ||||
ISPOR 20th Annual International Meeting |
||||
, Poster | ||||
, Canada | ||||
Abstract: https://www.ispor.org/ScientificPresentationsDatabase/Presentation/55700 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2015 | English | , Retrospective cohort analysis | |
Evolution of BRAF gene mutation testing and treatment options in BRAF mutation carriers in Canada | ||||
Djokic S | ||||
IMS Brogan, Kanata, ON, Canada | ||||
2015 ASCO Annual Meeting |
||||
, Abstract | ||||
, Canada | ||||
Abstract: http://meetinglibrary.asco.org/content/152450-156 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2015 | English | , Retrospective database analysis | |
Comparison of Public Reimbursement for Oncology versus Non-oncology Drugs in Canada | ||||
Bosnic N, Donepudi K, Goodfield J, Zhang Y | ||||
1 IMS Brogan, Kanata, ON, Canada 2 IMS Brogan, Mississauga, ON, Canada | ||||
2015 ASCO Annual Meeting |
||||
, Abstract | ||||
, Canada | ||||
Abstract: http://meetinglibrary.asco.org/content/153179-156 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2015 | English | , Retrospective database analysis | |
Comparison of patient characteristics and chromosomal abnormalities by first-line treatment in chronic lymphoid leukemia (CLL) patients in Canada | ||||
Marc Lapierre | ||||
IMS Brogan, Kirkland, QC, Canada | ||||
2015 ASCO Annual Meeting |
||||
, Abstract | ||||
, Canada | ||||
Abstract: http://meetinglibrary.asco.org/content/152361-156 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2015 | English | , Retrospective cohort analysis | |
New-onset type 2 diabetes, elevated HbA1c, anti-diabetic medications, and risk of pancreatic cancer | ||||
Lu Y, García Rodríguez LA, Malgerud L, González-Pérez A, Martín-Pérez M, Lagergren J, Bexelius TS | ||||
Department of Molecular Medicine and Surgery, Karolinska Institutet; 2Department of Epidemiology and Biostatistics, Imperial College London; 3Centro Espan˜ ol de Investigacio´ n Farmacoepidemiolo´ gica; 4Department of Clinical Sciences, Intervention and Technology (CLINTEC), Karolinska Institutet; 5Division of Cancer Studies, King´ s College London; 6Department of Medical Epidemiology and Biostatistics, Karolinska Institutet | ||||
, Article | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Diabetes, Miscellaneous, Oncology | 2015 | English | , Retrospective database analysis | |
What characteristics of primary care and patients are associated with early death in patients with lung cancer in the UK? | ||||
O'Dowd EL, McKeever TM, Baldwin DR, Anwar S, Powell HA, Gibson JE, Iyen-Omofoman B, Hubbard RB | ||||
Division of Public Health and Epidemiology, University of Nottingham; Department of Respiratory Medicine, Nottingham City Hospital | ||||
, Article | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2015 | English | , Retrospective database analysis | |
Metastatic Melanoma Patient Characteristics as a determining Factor for BRAF Gene Mutation Testing and treatment in Canada. | ||||
Djokic S, Lapierre M | ||||
IMS Health Canada | ||||
IPSOR 2015 Annual Meeting |
||||
, Poster | ||||
, Canada | ||||
Abstract: https://www.ispor.org/research_pdfs/49/pdffiles/PCN137.pdf | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2015 | English | , Retrospective database analysis | |
Comparison of patient characteristics and chromosomal abnormalities by first-line treatment in chronic lymphoid leukemia (CLL) patients in Canada. | ||||
Lapierre M | ||||
IMS Health Canada | ||||
ASCO 2015 Annual Meeting, 2015, May 29-June 2, Chicago, Illinois, USA |
||||
, Abstract | ||||
, Canada | ||||
Abstract: http://meetinglibrary.asco.org/record/112933/abstract | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2015 | English | , Retrospective database analysis | |
Evolution of BRAF gene mutation testing and treatment options in BRAF Mutation carriers in Canada. | ||||
Djokic S | ||||
IMS Health Canada | ||||
ASCO 2015 Annual Meeting, 2015, May 29-June 2, Chicago, Illinois, USA |
||||
, Abstract | ||||
, Canada | ||||
Abstract: http://meetinglibrary.asco.org/record/114023/abstract | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2015 | English | , Observational study, Retrospective cohort analysis | |
Dose variation in metastatic breast cancer: Are European Medicines Agency summary of product characteristics (SmPC) being followed? | ||||
Charnock J, Bruce A, Anger C | ||||
IMS Health, London, United Kingdom | ||||
ASCO 2015 Annual Meeting, 2015, May 29-June 2, Chicago, Illinois, USA |
||||
, Abstract | ||||
, France, Germany, Italy, Spain, UK | ||||
Abstract: http://ascopubs.org/doi/abs/10.1200/jco.2015.33.15_suppl.e11581 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2015 | English | ||
Evolution of RAS testing in colorectal cancer, in France, Germany, Italy, Spain and UK (EU5). | ||||
Bruce A, Anger C, Gajeperia C | ||||
IMS Health, London, United Kingdom | ||||
ASCO 2015 Annual Meeting, 2015, May 29-June 2, Chicago, Illinois, USA |
||||
, Abstract | ||||
, France, Germany, Italy, Spain, UK | ||||
Abstract: http://ascopubs.org/doi/abs/10.1200/jco.2015.33.15_suppl.e14679 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2015 | English | , Retrospective database analysis | |
Standards of care for first-line HER2+ metastatic breast cancer (mBC): Russia vs. EU5 (France, Germany, Italy, Spain, and UK). | ||||
Bruce A, Hurlock J | ||||
IMS Health, London, United Kingdom | ||||
ESMO 2015 Annual Meeting |
||||
, Poster | ||||
, France, Germany, Italy, Spain, UK | ||||
Abstract: http://www.poster-submission.com/ecc2015/visitors/eposter/29740 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2015 | English | , Retrospective database analysis | |
Stratification of high risk HER2-/HR+ patients following AI therapy. | ||||
Mitrofan L, Gajperia C, Charnock J, Anger C | ||||
IMS Health, London, United Kingdom | ||||
ESMO 2015 Annual Meeting |
||||
, Poster | ||||
, France, Germany, Italy, Spain, UK | ||||
Abstract: http://www.poster-submission.com/ecc2015/visitors/eposter/29751 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2015 | English | , Retrospective database analysis | |
Economic Burden of Tyrosine Kinase Inhibitor Treatment Failure in Chronic Myeloid Leukemia. | ||||
Knopf KB., Divino V., McGarry L., Chen YJ., Pokras S., Munakata J., Taylor C., Ng D., Nieset C., Huang H. | ||||
ARIAD. IMS authors: Divino V, Munakata J | ||||
Clin Lymphoma Myeloma Leuk |
||||
, Article | ||||
, USA | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/26411541 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2015 | English | , Burden of illness | |
Real-World Treatment Patterns and Outcomes Among Patients with Hairy Cell Leukemia | ||||
Karve S., Divino V., Gaughan A., DeKoven M., Gao G., Lanasa MC. | ||||
AstraZeneca, MedImmune. IMS authors: Divino V, DeKoven M | ||||
57th ASH Annual Meeting and Exposition |
||||
, Poster | ||||
, USA | ||||
Abstract: https://ash.confex.com/ash/2015/webprogramscheduler/Paper84903.html | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2015 | English | , Retrospective database analysis | |
Healthcare Utilization and Costs Among Patients with Hairy Cell Leukemia: Analysis of a Large US Administrative Claims Database | ||||
Divino V., Karve S., Gaughan A., DeKoven M., Gao G., Lanasa MC. | ||||
AstraZeneca, MedImmune. IMS authors: Divino V, DeKoven M | ||||
57th ASH Annual Meeting and Exposition |
||||
, Poster | ||||
, USA | ||||
Abstract: https://ash.confex.com/ash/2015/webprogramscheduler/Paper84933.html | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2015 | English | , Retrospective database analysis | |
Comparative Effectiveness Research (CER) of Treatments for Advanced Melanoma in Europe Using Existing Real-World Data Sources: A Feasibility Assessment | ||||
Daumont MM, Juuti R, Hoeller C, Zagorska A, Mertano E, Korhonen P | ||||
Worldwide Health Economics & Outcomes Research, Bristol-Myers Squibb, Rueil-Malmaison, France | ||||
Pigment Cell & Melanoma Research (2015) 28 (6), pp. 753-826 |
||||
, Abstract | ||||
, Europe | ||||
Abstract: https://onlinelibrary.wiley.com/doi/epdf/10.1111/pcmr.12419 | ||||
Condition | Year | Language | Analysis type | |
, Comparative Effectiveness & Health Technology Assessment, Oncology | 2015 | English | , Literature Review, Review | |
Physicians influence on breast cancer patient compliance. | ||||
Kostev K1, Waehlert L2, Jockwig A2, Jockwig B2, Hadji P3 | ||||
1 IMS Health, Frankfurt, Germany 2 Fresenius University of Applied Sciences, Idstein, Germany 3 Phillips-University of Marburg, Marburg, Germany | ||||
GMS Ger Med Sci., 2014, 12:Doc03 doi: 10.3205/000188, http://www.egms.de/static/en/journals/gms/2014-12/000188.shtml |
||||
, Article | ||||
, Germany | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3895867/ | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2014 | English | , Compliance | |
Gender differences in persistency to bisphosphonates in patients with metastatic breast and prostate cancer. | ||||
Hadji P1, Kyvernitakis J1, Albert U, Jockwig J2, Kostev K3 | ||||
1 Phillips-University of Marburg, Marburg, Germany 2 Fresenius University of Applied Sciences, Idstein, Germany 3 IMS Health, Frankfurt, Germany | ||||
Int J Clin Pharmacol Ther., 2014, Apr 2. [Epub ahead of print] |
||||
, Article | ||||
, Germany | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/?term=Gender+differences+in+persistency+to+bisphosphonates+in+patients+with+metastatic+breast+and+prostate+cancer | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2014 | English | , Retrospective database analysis | |
Increasing burden of tyrosine kinase inhibitor (TKI) treatment failure with later lines of therapy in chronic myeloid leukemia: a real world retrospective database analysis. | ||||
Chen Y1, Huang H2, Divino V1, Pokras S1, Hallinan S1, Munakata J1, Taylor C2, McGarry L2, Malone D3 | ||||
IMS Health, USA 2 Ariad Pharmaceuticals, Inc, Cambridge, USA 3 University of Arizona College of Pharmacy, Phoenix, USA | ||||
Academy of Managed Care Pharmacy 26th Annual Meeting & Expo, 2014, April, Tampa, USA |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2014 | English | , Retrospective database analysis | |
Building a real world non-small cell lung cancer cohort by linking a claims database to oncology electronic medical records. | ||||
Chen C1, Wade R2, Khan N1, Pokras S3, Semonelli C1, Zeng S1, Marcus M1 | ||||
1 IMS Health, Plymouth Meeting, USA 2 IMS Health, Parsippany, USA, 3 IMS Health, Alexandria, USA | ||||
International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 19th Annual International Meeting, 2014, May, Montreal, Canada |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2014 | English | , Retrospective database analysis | |
Evidence around criteria for selecting ovarian cancer patients for BRCA mutation testing - findings from the literature and guidelines review. | ||||
Garcia E1,Eccles E2,Balmana J3,Ehlken B4,Schroeder C4,Clune J5,Hirst C6,Potter D7,Tyczynski J | ||||
1 Maastricht UMC,Maastricht, Netherlands 2 University of Southampton, Southampton, United Kingdom 3 Familial Cancer Program,Barcelona,Spain 4IMS Health,Munich,Germany 5 AstraZeneca,Melbourne,United Kingdom 6 Hoggmann-La Roche Ltd,Basel,Switzerland 7 AstraZeneca,Gaitherburg,USA | ||||
, Abstract | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2014 | English | , Literature Review | |
Selecting ovarian cancer patients for BRCA mutation testing - Findings from guidelines and literature review | ||||
Eccles D1, Garcia E2, Balmana J3, Ehlken B4, Schroeder C4, Clune J5, Hirst C6, Potter D6, Tyczynski J6 | ||||
1 University of Southampton, Southampton, UK 2 Maastricht UMC, Maastricht, Netherlands 3 Familial Cancer Program, Barcelona, Spain 4 IMS Health, München, Germany 5 AstraZeneca, Melbourne, UK 6 AstraZeneca, Gaithersburg, USA | ||||
Conference of The British Society of Genetic Medicine (BSGM), Liverpool, UK, 22–24 September, 2014 (Poster) |
||||
, Abstract | ||||
, Germany, Netherlands, Spain, UK, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2014 | English | , Literature Review | |
Population-based study of giant cell tumour of the bone in Sweden | ||||
Amelio J1, Sandberg J2, Hernandez RK4, Sobocki P2,Stryker S4, Engellau J3, Bach BA4, Liede A4 | ||||
1Center For Oberservational Research, Amgen Ltd., UB8 1DH - Uxbridge/UK 2., IMS Health, 113 46 - Stockholm/SE 3Center For Oberservational Research, Amgen Inc., Thousand Oaks/US 4Department Of oncology, Lund University Hospital, 221 00 - Lund/SE | ||||
ESMO 2014 CTOS 19th Annual Meeting, October 15- 18, 2014 at the InterContinental Hotel in Berlin, Germany |
||||
, Poster | ||||
, Nordic, Sweden | ||||
Abstract: http://oncologypro.esmo.org/Meeting-Resources/ESMO-2014/Sarcoma/Population-based-study-of-giant-cell-tumour-of-the-bone-in-Sweden | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2014 | English | , Database Study | |
Afatinib in the treatment of EGFR mutation-positive NSCLC - A network meta-analysis. | ||||
Popat S1, Mok T2, Yang JC3, Wu YL4, Lungershausen J5, Stammberger U5, Griebsch I5, Fonseca T6, Paz-Ares L7 | ||||
1Royal Marsden Hospital, London, UK. 2State Key Laboratory of Southern China, Hong Kong Cancer Institute, The Chinese University of Hong Kong, Hong Kong. 3National Taiwan University, Taipei, Taiwan. 4Guangdong Lung Cancer Institute, Guangzhou, China. 5Boehringer Ingelheim GmbH, Ingelheim, Germany. 6IMS Health, London, UK. 7Instituto de Biomedicina de Sevilla - IBIS (University Hospital Virgen del Rocío, US, CSIC), Seville, Spain. | ||||
Lung Cancer. 2014 Aug;85(2):230-8 |
||||
, Article | ||||
, China, Germany, Hong Kong, Spain, Taiwan, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/24929780 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2014 | English | , Meta analysis | |
Association of diabetes and cancer diagnosis in primary care practices in France | ||||
Grandfils N, Ricarte C, Solomiac A | ||||
IMS Health, Paris La Défense, France | ||||
ISPOR 17th Annual European Congress, 8-12 November 2014, Amsterdam, The Netherlands |
||||
, Abstract, Poster | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Diabetes, Oncology | 2014 | English | , Retrospective database analysis | |
Clinical utility of the collect scale to assess comorbidities in patients with chronic lymphocytic leukemia | ||||
De La Serna J1, Carbonell F2, Giraldo P3, Lopez A4, González I5, García C5, Orofino J5, Roset M6, Perulero N6, Rios E | ||||
1Hospital Universitario 12 de Octubre, Madrid, Spain, 2Consorci Hospital General Universitari Valencia, Valencia, Spain, 3Hospital Universitario Miguel Servet, Zaragoza, Spain, 4Hospital Universitari Valle d'Hebron, Barcelona, Spain, 5Roche Pharma, Madrid, Spain, 6IMS Health, Barcelona, Spain, 7Hospital Virgen de Valme, Sevilla, Spain | ||||
ISPOR 17th Annual European Congress, 8-12 November 2014, Amsterdam, The Netherlands |
||||
, Poster | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2014 | English | , Utility analysis | |
A guideline-based estimate of healthcare resource use and cost of metastatic unresectable osteosarcoma | ||||
Cornelio N, Burudpakdee C | ||||
ISPOR 17th Annual European Congress, 8-12 November 2014, Amsterdam, The Netherlands |
||||
, Poster | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2014 | English | , Cost consequence | |
Cost-effectiveness of ipilimumab in previously untreated patients for advanced melanoma in Sweden | ||||
Barzey V1, Asukai Y1, Gueron B2, Holmberg C3, Kotapati S4 | ||||
1IMS Health, London, UK, 2Bristol-Myers Squibb, Rueil Malmasion, France, 3Bristol-Myers Squibb, Bromma, Sweden, 4Bristol-Myers Squibb Pharmaceuticals, Wallingford, CT, USA | ||||
ISPOR 17th Annual European Congress, 8-12 November 2014, Amsterdam, The Netherlands |
||||
, Poster | ||||
, Nordic, Sweden | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2014 | English | , Cost effectiveness | |
Treatment patterns and costs of neoadjuvant systemic therapies (NAT) for early breast cancer (EBC): A retrospective claims analysis | ||||
Chen YJ, Santos E, Schabert V, Antao VP, De AP, Portera CC, Wang Y, Kamath T | ||||
ISPOR 17th Annual European Congress, 8-12 November 2014, Amsterdam, The Netherlands |
||||
, Poster | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2014 | English | , Retrospective database analysis | |
Oncology products in the AMNOG process – learnings for a successful dossier submission | ||||
Dehnen J1, Goldhagen K2 | ||||
1 IMS Health, Cambridge, UK 2 IMS Health, Munich, Germany | ||||
ISPOR 17th Annual European Congress, 8-12 November 2014, Amsterdam, The Netherlands |
||||
, Poster | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2014 | English | , Willingness to pay | |
Current guidance for BRCA mutation testing in ovarian cancer patients | ||||
Ehlken B1, Driedger J2, Hofmann-Xu L1, Paulus G2, Berger K1, de Moor C3, Schroeder C1, Clune J4, Tyczynski J5 | ||||
1IMS Health Germany, Munich, Germany, 2IMS Health, Munich, Germany, 3IMS Health US, Alexandria, VA, USA, 4AstraZeneca, London, UK, 5AstraZeneca, Gaithersburg, MD, USA | ||||
ISPOR 17th Annual European Congress, 8-12 November 2014, Amsterdam, The Netherlands |
||||
, Poster | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2014 | English | , Database Study | |
Envisioning oncology coverage decision framework: how do current and future trends in Asia-Pacific affect the accessibility? | ||||
Leartsakulpanitch J1, Chiu C-F2, Bae SJ3, Tan SC4 | ||||
1 Johnson & Johnson, Bangkok, Thailand 2 China Medical University Hospital, Taipei, Taiwan 3 Ewha Womans University, Seoul, South Korea 4 IMS Asia Pacific, Singapore, Singapore | ||||
ISPOR 6th Asia-Pacific Conference, Beijing, China, 6-9 September, 2014 |
||||
, Symposium | ||||
, Asia Pacific | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2014 | English | , Methodology | |
Understanding treatment in metastatic castrate-resistant prostate cancer: Implications of variance between UK and Asia | ||||
King C | ||||
IMS Health Asia-Pac & China, Singapore | ||||
AccessPoint, 2014, May; 4(8): 36-39 |
||||
, Article | ||||
, Asia Pacific, UK | ||||
Abstract: http://issuu.com/ims_heor_publications/docs/ims_rwe_accesspoint_8_-_250514f_iss | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2014 | English | , Real World Evidence | |
Drug utilization in oncology: Current topics and challenges | ||||
Ehlken B1, Keja J1, Kallich J2 | ||||
1 IMS Health, Munich, Germany 2 Big Health Data, Los Angeles, California, USA | ||||
AccessPoint, 2014, May; 4(8): 51-55 |
||||
, Article | ||||
Abstract: http://issuu.com/ims_heor_publications/docs/ims_rwe_accesspoint_8_-_250514f_iss | ||||
Condition | Year | Language | Analysis type | |
, Clinical practice, Oncology | 2014 | English | , Real World Data | |
Evidence-based insights in oncology: The journey is only just beginning | ||||
Ghai C | ||||
RWE Solutions & HEOR, IMS Health, New York, USA | ||||
AccessPoint, 2014, May; 4(8): 14-20 |
||||
, Article | ||||
, USA | ||||
Abstract: http://issuu.com/ims_heor_publications/docs/ims_rwe_accesspoint_8_-_250514f_iss | ||||
Condition | Year | Language | Analysis type | |
, Health economics, Oncology | 2014 | English | , Real World Evidence | |
Innovation in cancer care: Implications for global healthcare systems | ||||
Johnson K | ||||
Global Oncology, IMS Health, Plymouth Meeting, USA | ||||
AccessPoint, 2014, May; 4(8): 8-13 |
||||
, Article | ||||
Condition | Year | Language | Analysis type | |
, Health policy, Oncology | 2014 | English | , Real World Evidence | |
Future access to innovative oncology drugs in the EU: Evolution and proactive application of real-world evidence | ||||
McDonell A1, Opel M1, Berger K2 | ||||
1 IMS Health, London, UK 2 IMS Health, Munich, Germany | ||||
AccessPoint, 2014, May; 4(8): 32-35 |
||||
, Article | ||||
, Europe | ||||
Abstract: http://issuu.com/ims_heor_publications/docs/ims_rwe_accesspoint_8_-_250514f_iss | ||||
Condition | Year | Language | Analysis type | |
, Health policy, Oncology | 2014 | English | , Real World Evidence | |
Transforming oncology outcomes research through data linkage in Sweden: A unique real-world lens on the entire patient journey | ||||
Sobocki P | ||||
IMS Health, Stockholm, Sweden | ||||
AccessPoint, 2014, May; 4(8): 21-25 |
||||
, Article | ||||
, Nordic, Sweden | ||||
Abstract: http://issuu.com/ims_heor_publications/docs/ims_rwe_accesspoint_8_-_250514f_iss | ||||
Condition | Year | Language | Analysis type | |
, Methodology, Oncology | 2014 | English | , Real World Evidence | |
Research question-driven data selection: A comparison of real-world insights in non-small cell lung cancer | ||||
Chen CC, Pokras S, Wade R | ||||
IMS Health, Parsippany, USA | ||||
AccessPoint, 2014, May; 4(8): 40-45 |
||||
, Article | ||||
Abstract: http://issuu.com/ims_heor_publications/docs/ims_rwe_accesspoint_8_-_250514f_iss | ||||
Condition | Year | Language | Analysis type | |
, Methodology, Oncology | 2014 | English | , Real World Evidence | |
Payment by use: Achieving a new value paradigm for oncology | ||||
Woolmore A, Simpson D | ||||
RWE Solutions, IMS Health, London, UK | ||||
AccessPoint, 2014, May; 4(8): 26-31 |
||||
, Article | ||||
Abstract: http://issuu.com/ims_heor_publications/docs/ims_rwe_accesspoint_8_-_250514f_iss | ||||
Condition | Year | Language | Analysis type | |
, Oncology, Pricing and reimbursement | 2014 | English | , Real World Evidence | |
High-value oncology targeted therapies: Opportunities and challenges in emerging Asia Pacific markets | ||||
Afable A, Caputo J | ||||
IMS Health, Asia-Pac, Singapore, Singapore | ||||
AccessPoint, 2014, May; 4(8): 46-50 |
||||
, Article | ||||
, Asia Pacific | ||||
Abstract: http://issuu.com/ims_heor_publications/docs/ims_rwe_accesspoint_8_-_250514f_iss | ||||
Condition | Year | Language | Analysis type | |
, Oncology, Pricing and reimbursement | 2014 | English | , Real World Evidence | |
A case–control study comparing the incidence of early symptoms in pancreatic and biliary tract cancer | ||||
Keane MG, Horsfall L, Rait G & Pereira SP | ||||
UCL Institute for Liver and Digestive Health | ||||
BMJ Open2014 Nov 19;4(11):e005720. |
||||
, Article | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4244441/ | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2014 | English | , Retrospective database analysis | |
A phase II trial of high-dose chemotherapy (HDCT) supported by hematopoietic stem-cell transplantation (HSCT) in germ-cell tumors (GCTs) patients failing cisplatin-based chemotherapy: the Multicentric TAXIF II study | ||||
Selle F1, Wittnebel S2, Biron P3, Gravis G4, Roubaud G5, Bui BN5, Delva R6, Bay JO7, Fléchon A3, Geoffrois L8, Caty A9, Soares DG10, de Revel T11, Fizazi K2, Gligorov J12, Micléa JM13, Dubot C10, Provent S10, Temby I10, Gaulet M14, Horn E15, Brindel I16, Lotz JP12 | ||||
1Department of Medical Oncology and Cellular Therapy, APREC (Alliance Pour la Recherche En Cancérologie), Hôpital Tenon (Hôpitaux Universitaires de l'Est-Parisien, AP-HP), Paris Sorbonne Universités, Université Pierre et Marie Curie (UPMC Univ Paris 06), Paris frederic.selle@tnn.aphp.fr. 2Department of Medicine, Institut Gustave Roussy, Villejuif. 3Department of Medical Oncology, Centre Léon Bérard, Lyon. 4Department of Medical Oncology, Institut Paoli Calmette, Marseille. 5Department of Medicine, Institut Bergonié, Bordeaux. 6Department of Chemotherapy, Centre Paul Papin, Angers. 7Department of Medicine, Centre Hospitalier Universitaire, Clermont-Ferrand. 8Department of Medicine, Centre Alexis Vautrin, Nancy. 9Department of Medicine, Centre Oscar Lambret, Lille. 10Department of Medical Oncology and Cellular Therapy, APREC (Alliance Pour la Recherche En Cancérologie), Hôpital Tenon (Hôpitaux Universitaires de l'Est-Parisien, AP-HP), Paris. 11Department of Hematology, Hôpital D'Instruction des Armées Percy, Clamart. 12Department of Medical Oncology and Cellular Therapy, APREC (Alliance Pour la Recherche En Cancérologie), Hôpital Tenon (Hôpitaux Universitaires de l'Est-Parisien, AP-HP), Paris Sorbonne Universités, Université Pierre et Marie Curie (UPMC Univ Paris 06), Paris. 13Cytapheresis and Cell Therapy Unit, Hôpital St Louis (AP-HP), Paris. 14Statistic, 3ES-Cegedim Strategic Data, Boulogne, France. 15Department of Internal Medicine, Brown University, Rhode Island Hospital, Providence, Rhode Island, USA. 16Department of Clinical Research, Hôpital St Louis (AP-HP), Paris, France | ||||
Ann Oncol. 2014 Sep;25(9):1775-82. |
||||
, Article | ||||
, France | ||||
Abstract: http://annonc.oxfordjournals.org/content/25/9/1775.full.pdf+html | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2014 | English | , Prospective study | |
Diagnosis of pernicious anemia and the risk of pancreatic cancer. | ||||
Shah P, Rhim AD, Haynes K, Hwang WT & Yang YX | ||||
Memorial Sloan Kettering Cancer Center Department of Medicine, Gastroenterology and Nutrition Service | ||||
Pancreas. 2014 Apr;43(3):422-6. doi: 10.1097/MPA.0000000000000054 |
||||
, Article | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4015141/ | ||||
Condition | Year | Language | Analysis type | |
, Hematology, Oncology | 2014 | English | , Retrospective database analysis | |
Digoxin use and the risk for colorectal cancer. | ||||
Boursi B, Haynes K, Mamtani R & Yang YX | ||||
University of Pennsylvania Division of Gastroenterology | ||||
Pharmacoepidemiol Drug Saf. 2014 Nov;23(11):1147-53. doi: 10.1002/pds.3717. Epub 2014 Sep 29 |
||||
, Article | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4525471/ | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2014 | English | , Retrospective database analysis | |
Five-year malignancy incidence in patients with chronic pruritus: a population-based cohort study aimed at limiting unnecessary screening practices | ||||
Fett N, Haynes K, Propert KJ & Margolis DJ | ||||
Philadelphia Department of Veterans Affairs Medical Center | ||||
J Am Acad Dermatol. 2014 Apr;70(4):651-8. doi: 10.1016/j.jaad.2013.11.045. Epub 2014 Jan 28 |
||||
, Article | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3959616/ | ||||
Condition | Year | Language | Analysis type | |
, Dermatology, Oncology | 2014 | English | , Retrospective database analysis | |
Real World Data in Oncology: Third- and Fourth-Line Treatments administered in Metastatic Colon-Rectal Cancer (mCRC) | ||||
Heiman F, Ripellino C ,Visentin E | ||||
CSD Medical Research, Milan, Italy | ||||
ISPOR 17th Annual European Congress Amsterdam, The Netherlands November, 2014 |
||||
, Poster | ||||
, Italy | ||||
Abstract: http://www.ispor.org/ScientificPresentationsDatabase/Presentation/51939 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2014 | English | , Real World Data | |
Sociodemographic Trends in the Incidence of Pancreatic and Biliary Tract Cancer in UK Primary Care. | ||||
Keane MG, Horsfall LJ Rait G2 & Pereira SP Keane MG1, Horsfall LJ2, Rait G2, Pereira SP1. | ||||
UCL Institute for Liver and Digestive Health 1Institute for Liver and Digestive Health, University College London, London, United Kingdom. 2Research Department of Primary Care and Population Health, University College London, London, United Kingdom. | ||||
30;9(9):e108498 PLoS One DOI: 10.1371/journal.pone.0108498 |
||||
, Article | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4182488/ | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2014 | English | , Retrospective database analysis | |
The incidence of Barrett's oesophagus and oesophageal adenocarcinoma in the United Kingdom and The Netherlands is levelling off. | ||||
Masclee GMC, Coloma PM, de Wilde M, Kuipers EJ & Sturkenboom M | ||||
Erasmus University Medical Center Department of Medical Informatics | ||||
Aliment Pharmacol Ther. 2014 Jun;39(11):1321-30. doi: 10.1111/apt.12759. Epub 2014 Apr 16 |
||||
, Article | ||||
, Netherlands, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/24738722 | ||||
Condition | Year | Language | Analysis type | |
, Gastrointestinal disorders, Oncology | 2014 | English | , Retrospective database analysis | |
Validation of a coding algorithm to identify bladder cancer and distinguish stage in an electronic medical records database. | ||||
Mamtani R, Haynes K, Boursi B, Scott F, Goldberg DS, Keefe SM, Vaughn DJ, Malkowicz SB & Lewis JD | ||||
University of Pennsylvania Abramson Cancer Center | ||||
Cancer Epidemiol Biomarkers Prev. 2015 Jan;24(1):303-7. doi: 10.1158/1055-9965.EPI-14-0677. Epub 2014 Nov 11 |
||||
, Article | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4294969/ | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology, Oncology | 2014 | English | , Retrospective database analysis | |
Identifying patients with undetected colorectal cancer: an independent validation of QCancer (Colorectal). | ||||
Collins GS & Altman DG | ||||
Centre for Statistics in Medicine, Wolfson College Annexe, University of Oxford, Linton Road, Oxford OX2 6UD, UK | ||||
Br J Cancer. 2012 Jul 10 Br J Cancer. 2012 Jul 10; 107(2): 260–265. |
||||
, Article | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3394989/ | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2014 | English | , Retrospective database analysis | |
HERPES ZOSTER-RELATED HEALTHCARE RESOURCE USE IN CANCER PATIENTS IN FIVE EUROPEAN COUNTRIES | ||||
Berhanu Gebremeskel, MD, MPH, MSCE(c.)1a, Lorena Lopez-Gonzalez, PhD2 ,Pallavi Patwardhan, PhD, BSPharm1b, Jiyoung Chin, PhD3,Marie-Sophie Schwalm, MS4, Camilo Acosta, MD, PhD1a, Jay Margolis, PharmD5 | ||||
1Merck & Co. Inc., (aWest Point, PA, bCokesbury, NJ) Whitehouse Station, NJ, USA;2Truven Health Analytics, Austen, TX, USA; 3Cegedim Strategic Data, Jersey City, NJ, USA; 4Cegedim Strategic Data, Paris, France; 5Truven Health Analytics, Bethesda, MD, USA | ||||
ISPOR 17th Annual European Congress 8-12 November 2014 Amsterdam RAI Amsterdam, The Netherlands |
||||
, Poster | ||||
, Europe | ||||
Abstract: http://www.ispor.org/event/ProgramList/2014Amsterdam?type=Poster&sess=V&acode=PIN | ||||
Condition | Year | Language | Analysis type | |
, Infectious disease, Oncology | 2014 | English | , Retrospective database analysis | |
Incidence of Bladder Cancer in Patients With Type 2 Diabetes Treated With Metformin or Sulfonylureas. | ||||
Mamtani R, Pfanzelter N, Haynes K, Finkelman BS, Wang X, Keefe SM, Haas NB, Vaughn DJ & Lewis JD | ||||
University of Pennsylvania Abramson Cancer Center | ||||
Diabetes Care. 2014 Jul;37(7):1910-7. doi: 10.2337/dc13-1489. Epub 2014 Feb 4 |
||||
, Article | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/24496803 | ||||
Condition | Year | Language | Analysis type | |
, Diabetes, Oncology | 2014 | English | , Retrospective database analysis | |
Demographic and Comorbidity Characteristics of Newly Diagnosed Multiple Myeloma Patients in the United States: A Real World Data Analysis | ||||
Chen Y, De A, Cong Z, Aggarwal S, Wade R | ||||
Onyx Pharmaceuticals, Inc | ||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2014 | English | , Real World Evidence | |
Characterization of HER2 Testing and Treatment Patterns among Gastric Cancer Patients in the United States using the Oncology Services Comprehensive Electronic Records (OSCER) Database | ||||
Lowe K1, Reich A2, Bobiak S2, Chau D1, Quigley J2, Kelsh M1 | ||||
1 Amgen, Inc. 2 IMS Health | ||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2014 | English | , Review | |
Endometrial cancer after endometrial ablation vs medical management of abnormal uterine bleeding | ||||
Dood RL, Gracia CR, Sammel MD, Haynes K, Senapati S, Strom BL | ||||
University of Pennsylvania Center for Clinical Epidemiology and Biostatistics | ||||
J Minim Invasive Gynecol. 2014 Sep-Oct;21(5):744-52. doi: 10.1016/j.jmig.2014.02.012. Epub 2014 Feb 28 |
||||
, Article | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4470903/ | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2014 | English | , Retrospective database analysis | |
Risk factors for the development of oesophageal adenocarcinoma in Barrett’s oesophagus: a UK primary care retrospective nested case–control study | ||||
Cooper S, Menon S, Nightingale P & Trudgill N | ||||
Sandwell and West Birmingham Hospitals NHS Trust Department of Gastroenterology | ||||
United European Gastroenterol J. 2014 Apr; 2(2): 91–98 |
||||
, Article | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4040819/ | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2014 | English | , Retrospective database analysis | |
Validation of Bone Metastases Coding in an Oncology Electronic Medical Records Database and a Commercial Claims Database | ||||
Hernandez, R1, Quach, D2, Wade, S3, Pirolli, M2, Reich, A2, Quigley, J2, Liede, A1 | ||||
1. Center for Observational Research, Amgen Inc., CA 2. IMS Health, Plymouth Meeting, PA 3. Wade Outcomes Research and Consulting, Salt Lake City, UT | ||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2014 | English | , Retrospective database analysis | |
Prevalence of Renal Impairment (RI) and Use of Nephrotoxic Agents Among Patients with Bone Metastases From Solid Tumors in the United States | ||||
Pirolli, M, Quach, D, Quigley, J | ||||
Cancer Medicine |
||||
, Manuscript in preparation | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2014 | English | , Retrospective database analysis | |
Patterns of use of oral anticancer treatments in France: a Retrospective Analysis of Cancer Treatments given ORally from 2004 to 2012 (Re-ACTOR study) | ||||
L. Benjamin 1, R. Maroun 1, F. Maurel 2, I. Bardoulat 2, C. Ricarte 2 | ||||
1. GlaxoSmithKline, Health Economics and Outcomes Research, Marly-le-Roi, France; 2. IMS Health, La Défense, France | ||||
Current Medical Research & Opinion 2014 |
||||
, Article | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2014 | English | , Market impact, Retrospective database analysis | |
Prevalence of women with early-stage breast cancer receiving active management using electronic health records from oncology clinics in the United States. | ||||
Hernandez RK1, Quach D, Wade SW, Pirolli M, Quigley J, Narod SA, Liede A. | ||||
1Center for Observational Research, Amgen Inc, IMS Health Plymouth, | ||||
Breast Cancer Res Treat. 2014 Aug;146(3):637-46 |
||||
, Article | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2014 | English | , Retrospective database analysis | |
Survival and clinical metastases among prostate cancer patients treated with androgen deprivation therapy in Sweden | ||||
Banefelt J1, Liede A2, Mesterton J3, Stålhammar J4, Hernandez RK5, Sobocki P6, Persson BE7. | ||||
1Quantify Research, Hantverkargatan 8, 112 21 Stockholm, Sweden. 2Amgen Inc., Center for Observational Research, South San Francisco, CA, United States. 3Quantify Research, Hantverkargatan 8, 112 21 Stockholm, Sweden; Institute of Environmental Medicine, Karolinska Institute, 171 77 Stockholm, Sweden. 4Department of Public Health and Caring Sciences, Uppsala University, 751 22 Uppsala, Sweden. 5Amgen Inc., Center for Observational Research, One Amgen Center Drive 24-2-A, Thousand Oaks, CA 91320, United States. 6IMS Health/Pygargus, Sveavägen 155, 113 46 Stockholm, Sweden; LIME/Medical Management Centre, Karolinska Institute, 171 77 Stockholm, Sweden. 7Uppsala University, 751 05 Uppsala, Sweden. Electronic address: Bo-Eric.Persson@ferring.com. | ||||
Cancer Epidemiol |
||||
, Article | ||||
, Nordic, Sweden | ||||
Abstract: http://www.cancerepidemiology.net/article/S1877-7821(14)00089-7/abstract | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2014 | English | , Real World Evidence | |
Population-based study of giant cell tumour of the bone in Sweden. | ||||
Amelio J.1, Sandberg J.2, Hernandez R.H.3, Sobocki P.4, Stryker S.5, Engellau J.6, Bach B.A.3, Liede A.5 | ||||
1Amgen Ltd. Uxbridge, UK 2Pygargus/IMS Health, Stockholm, Sweden 3Amgen Inc. Thousand Oaks, CA, USA 4Pygargus/IMS Health, Stockholm, Sweden; Karolinska Institutet, Stockholm, Sweden 5Amgen Inc. South San Francisco, CA, USA. 6Lund University, Lund, Sweden. | ||||
The Connective Tissue Oncology Society (CTOS) Annual Meeting 2014 October 15–18, Berlin Germany |
||||
, Oral presentation | ||||
, Sweden | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2014 | English | , Real World Evidence | |
Population-based study of giant cell tumour of the bone in Sweden | ||||
J. Amelio1, J. Sandberg2, R.K. Hernandez3, P. Sobocki2, S. Stryker3, J. Engellau4, B. Bach3, A. Liede3 | ||||
1Center For Oberservational Research, Amgen Ltd., UB8 1DH - Uxbridge/UK 2., IMS Health, 113 46 - Stockholm/SE 3Center For Oberservational Research, Amgen Inc., Thousand Oaks/US 4Department Of Oncology, Lund University Hospital, 221 00 - Lund/SE | ||||
European Society for Medical Oncology Meeting 2014, 29 Sept 2014, Madrid Spain |
||||
, Abstract | ||||
, Sweden | ||||
Abstract: http://oncologypro.esmo.org/Meeting-Resources/ESMO-2014/Sarcoma/Population-based-study-of-giant-cell-tumour-of-the-bone-in-Sweden | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2014 | English | , Real World Evidence | |
Trends in giant cell tumour of the bone and osteosarcoma incidence in the Sweden (1958-2011. | ||||
A. Liede1, J. Sandberg2, J. Amelio3, R.K. Hernandez4, P. Sobocki2, H.C..F. Bauer5, B. Bach6, J. Engellau7 | ||||
1Center For Observational Research, Amgen Inc., 94080 - South San Francisco/US 2., IMS Health, 113 46 - Stockholm/SE 3Center For Oberservational Research, Amgen Ltd., UB8 1DH - Uxbridge/UK 4Center For Observational Research, Amgen Inc., 91320 - Thousand Oaks/US 5Molecular Medicine And Surgery, Karolinska Institute, Stockholm/SE 6Clinical Development, Amgen Inc., Thousand Oaks/US 7Department Of Oncology, Lund University Hospital, 221 00 - Lund/SE | ||||
European Society for Medical Oncology (ESMO) Meeting 2014, Madrid Spain, 29 September |
||||
, Abstract | ||||
, Nordic, Sweden | ||||
Abstract: http://oncologypro.esmo.org/Meeting-Resources/ESMO-2014/Sarcoma/Trends-in-Giant-Cell-Tumour-of-the-Bone-and-Osteosarcoma-Incidence-in-the-Sweden-1958-2011 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2014 | English | , Real World Evidence | |
Impact of symptom burden on work-related abilities in patients with locally recurrent or metastatic breast cancer: Results from a substudy of the VIRGO observational cohort study | ||||
Cleeland CS, Mayer M, Dreyer NA, Yim YM, Yu E, SuZ, Mun Y, Sloan JA, Kaufman PA | ||||
Breast 2014; Sep 2. pii: S0960-9776(14)00140-4. doi: 10.1016/j.breast.2014.08.004 |
||||
, Article | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2014 | English | , RWLPR (Real-World Late Phase Research-quintiles | |
Description of GCSF usage in oncology in 5 European countries. | ||||
Anger C1, Schmidt N2, Ricarte C3 | ||||
1 IMS Health, London, United Kingdom 2 IMS Health, Frankfurt, Germany 3 IMS Health, La Defense, France | ||||
ASCO 2014 Annual Meeting, 2014, May 30 - June 03, Chicago, Illinois, USA |
||||
, Abstract | ||||
, France, Germany, Italy, Spain, UK | ||||
Abstract: http://meetinglibrary.asco.org/record/97923/abstract | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2014 | English | , Observational study | |
Association of diabetes and cancer diagnoses in primary care practices in Germany. | ||||
Schmidt N, Kostev K, Ziller V, Kowall B, Rathmann W | ||||
1 IMS Health GmBH & Co. OHG, Frankfurt/Main, 2 Department of Gynecology Endocrinology and Oncology, Phillips University of Marburg, Germany, 3 Institute of Biometrics and Epidemiology, German Diabetic Center, Duesseldorf, Germany | ||||
ASCO 2014 Annual Meeting, 2014, May 30 - June 03, Chicago, Illinois, USA |
||||
, Poster | ||||
, Germany | ||||
Abstract: http://meetinglibrary.asco.org/record/96337/abstract | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2014 | English | ||
Importance of durational hormone therapy in breast cancer patients in Germany: Retrospective database analysis. | ||||
Schmidt N, Haas G, Kostev K, Peyman H | ||||
1IMS Health GmBH & Co. OHG, Frankfurt/Main, 2Department of Gynecology Endocrinology and Oncology, Phillips University of Marburg, Germany, 3 Institute of Biometrics and Epidemiology, German Diabetic Center, Duesseldorf, Germany | ||||
ASCO 2014 Annual Meeting, 2014, May 30 - June 03, Chicago, Illinois, USA |
||||
, Poster | ||||
, Germany | ||||
Abstract: http://meetinglibrary.asco.org/record/96376/abstract | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2014 | English | , Retrospective database analysis | |
Evaluation of treatment patterns in acute nausea and vomiting in EU5 countries. | ||||
Schmidt N, Ricarte C, Haas G | ||||
1 IMS Health CES Oncology, Central Europe; 2 Client Service Oncology, IMS Health France | ||||
ESMO 2014 Annual Meeting, 2014, 26 Sep - 30 Sep, Madrid, Spain |
||||
, Poster | ||||
, France, Germany, Italy, Spain, UK | ||||
Abstract: http://oncologypro.esmo.org/Meeting-Resources/ESMO-2014/Evaluation-of-treatment-patterns-in-acute-nausea-and-vomiting-in-EU5-countries | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2014 | English | , Retrospective database analysis | |
Analysis of treatment patterns of patients with Advanced Gastrointestinal Stromal Tumors (GIST) in EU5. | ||||
Jehle K, Rabiller M, Grippon S, Haas G, Ngai C, Mohamed A, Chang J | ||||
1 IMS Health Global Oncology, Plymouth Meeting, PA, USA, and Frankfurt, Germany; 2 IMS Health CE Consulting, Frankfurt, Germany; 3 Bayer Healthcare Pharmaceuticals, Whippany NJ, USA | ||||
ESMO 2014 Annual Meeting, 2014, 26 Sep - 30 Sep, Madrid, Spain |
||||
, Poster | ||||
Abstract: https://academic.oup.com/annonc/article/25/suppl_4/iv499/2242114/1427PANALYSIS-OF-TREATMENT-PATTERNS-OF-PATIENTS | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2014 | English | , Retrospective database analysis | |
Comparing patterns of BRAF testing and treatment in Metastatic Melanoma (MeM) in France, Germany, Italy, Spain and UK with the US. | ||||
Charnock J, Bruce A, Murch L, Anger C | ||||
Client Service Oncology, IMS Health, UK | ||||
ESMO 2014 Annual Meeting, 2014, 26 Sep - 30 Sep, Madrid, Spain |
||||
, Poster | ||||
, France, Germany, Italy, Spain, UK | ||||
Abstract: poster-submission.com/cdrom/download_poster/37/27774/1110P | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2014 | English | , Retrospective database analysis | |
Patterns of patients stopping their anti-cancer drug due to its associated side effects in France, Germany, Italy, Spain and UK. | ||||
Khanna R, Anger C | ||||
Client Service Oncology, IMS Health, UK | ||||
ESMO 2014 Annual Meeting, 2014, 26 Sep - 30 Sep, Madrid, Spain |
||||
, Poster | ||||
, France, Germany, Italy, Spain, UK | ||||
Abstract: http://oncologypro.esmo.org/Meeting-Resources/ESMO-2014/Patterns-of-patients-stopping-their-anti-cancer-drug-due-to-its-associated-side-effects-in-France-Germany-Italy-Spain-and-UK-EU5 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2014 | English | , Retrospective database analysis | |
Association of diabetes and cancer diagnosis in primary care practices in France. | ||||
Grandfils N, Ricarte C, Solomiac A | ||||
1IMS Health, La Defense, France | ||||
ISPOR 2014 Annual Meeting |
||||
, Poster | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2014 | English | , Retrospective database analysis | |
Population-based study of Giant Cell Tumor of the bone in Sweden | ||||
Amelio J, Sandberg J, Hernandez R, Sobocki P, Stryker S, Engellau J, Bach B, Liede A | ||||
Center for Oberservational Research, Amgen Ltd., Uxbridge, UK|IMS Health, Stockholm Sweden | ||||
Annals of Oncology (2014) 25(suppl 4):iv509-iv510 |
||||
, Poster | ||||
, Nordic, Sweden | ||||
Abstract: https://academic.oup.com/annonc/article/25/suppl_4/iv509/2242151 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2014 | English | , Epidemiological study, Population Based Study, Retrospective database analysis | |
Herpes Zoster-Related Health Care Resource Utilization in Cancer Patients in 5 European Countries | ||||
Gebremeskel B.G.1, Lopez-Gonzalez L.2, Patwardhan P.3, Chin J.4, Schwalm M.S.4, Acosta C.J.3,Margolis J.M.5 | ||||
VALUE IN HEALTH 17 ; A684 |
||||
, Abstract | ||||
, Belgium, France, Germany, Italy, Spain | ||||
Condition | Year | Language | Analysis type | |
, Health economics, Immunology and Vaccination, Oncology | 2014 | English | , Cost of illness, Retrospective database analysis | |
Economic burden of tyrosine kinase inhibitor (TKI) treatment failure in patients with chronic myeloid leukemia (CML). | ||||
Yaozhu J Chen, Hui Huang, Victoria Divino, Shibani Pokras, Shawn Hallinan, Julie Munakata, Catherine Taylor, Lisa McGarry, Daniel Ng, Christopher Nieset, Kevin B. Knopf | ||||
ARIAD; IMS authors: Victoria Divino, Julie Munakata | ||||
2014 ASCO Annual Meeting |
||||
, Poster | ||||
, USA | ||||
Abstract: http://meetinglibrary.asco.org/record/92488/abstract | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2014 | English | , Retrospective database analysis | |
The economic burden associated with skeletal-related events in patients with bone metastases secondary to solid tumors in Belgium. | ||||
Body JJ1, Chevalier P2, Gunther O3, Hechmati G4, Lamotte M2 | ||||
1 CHU Brugmann, Université Libre de Bruxelles, Brussels, Belgium 2 IMS Health, Vilvoorde, Belgium 3 Centre for Observational Research, Amgen Ltd, Uxbridge, UK 4 Health Economics, Amgen (Europe) GmbH, Zug, Switzerland | ||||
J Med Econ., 2013, 16(4): 539-46 |
||||
, Article, Manuscript in preparation | ||||
, Belgium | ||||
Condition | Year | Language | Analysis type | |
, Musculoskeletal disease, Oncology | 2013 | English | , Burden of illness | |
Comparative Analysis of Radium-223 Dichloride in Symptomatic Metastatic Castration Resistant Prostate Cancer versus Best Supportive Care on Skeletal-Related Events Outcomes | ||||
Seal B1, Pawar V1, Valderrama A1, Grabbi E2, Lloyd A2, Beaudet A3 | ||||
1Bayer Healthcare Pharmaceuticals, Montville, NJ, USA, 2IMS Health, London, United Kingdom, 3IMS Health, Basel, Switzerland | ||||
ISPOR US 2013 |
||||
, Poster | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2013 | English | , Cost analysis, Quality of life | |
Cost of palliative radiation to the bone for patients with bone metastases secondary to breast or prostate cancer | ||||
Hess G1, Barlev A2, Chung K2, Hill JW1, Fonseca E1 | ||||
1 IMS Health, Plymouth Meeting, USA 2 Amgen Inc, Thousand Oaks, USA | ||||
Radiation Oncology. 2012, 7:168. Impact Factor: 2.3. Published October 12, 2012 |
||||
, Article | ||||
, USA | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3561237/ | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2013 | English | , Cost analysis | |
The impact of chemotherapy-induced side effects on medical care usage and cost in German hospital care — an observational analysis on non-small-cell lung cancer patients. | ||||
Ihbe-Heffinger A13, Paessens B1, Berger K24, Shlaen M2, Bernard R1, von Schilling C56, Peschel C5 | ||||
1 Hospital Pharmacy Department Klinikum rechts der Isar Technische Universität Munich, Germany 2 IMS Health, Munich, Germany 3 Department of Gynaecology Klinikum rechts der Isar Technische Universität München, Munich, Germany 4 Department of Transfusion Medicine and Haemostaseology, Klinikum der Universität München, Munich, Germany 5 Third Medical Department, Klinikum rechts der Isar, Technische Universität München, Munich, Germany 6 Department of Internal Medicine III Klinikum Freising, Freising, Germany | ||||
Support Care Cancer, 2013, 21: 1665–1675 |
||||
, Article | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2013 | English | , Cost consequence, Observational study | |
COST/BENEFIT ANALYSIS OF FIRST LINE CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) TREATMENTS IN MEXICO | ||||
Munakata J1, Leyva V1, Wehler E1, Bertwistle D1, Valencia A2, Hernández A2, Torre L2, Gonzalez-Michaca L2 | ||||
1IMS Health, 2Janssen de Mexico | ||||
ISPOR 4th Latin America Conference, 2013 |
||||
, Poster | ||||
, Mexico | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2013 | English | , Cost analysis, Cost benefit | |
Burden of actinic keratosis in germany-results of a literature research | ||||
Pfiffner C1, Macheleidt O2, Batscheider A1, Ehlken B1, Greiner RA1, Schroeder C1, Hutt HJ2 | ||||
1 IMS Health, Munich, Germany 2 LEO Pharma GmbH, Neu Isenburg, Germany | ||||
ISPOR 16th annual european congress, 2013, November 2-6, Dublin, Ireland |
||||
, Poster | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Dermatology, Oncology | 2013 | English | , Burden of illness | |
Oncology real-world data in Europe | ||||
Noibi S1, Bertwistle D1, Berger K2 | ||||
1IMS Health, London, UK, 2IMS Health, Munich, Germany | ||||
AccessPoint, May 2013; Vol 3(6); 24-29 |
||||
, Article | ||||
Abstract: http://issuu.com/ims_heor_publications/docs/rwe_accesspoint_6_-_080513f_epub | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2013 | English | , Real World Data | |
Identification and qualitative assessment of real world data sources: example of lymphoma and multiple myeloma in Europe | ||||
Noibi S1, Bertwistle D1, MacDougall F1, Berger K2, Mehta J3, Trask P3 | ||||
1IMS Health, London, UK, 2IMS Health, Munich, Germany, 3Sanofi, Cambridge, MA, USA | ||||
ISPOR 16th Annual European Congress, 2013. PRM48. |
||||
, Abstract, Poster | ||||
, Europe | ||||
Abstract: http://www.ispor.org/Events/Posters.aspx?eventId=42&sess=V | ||||
Condition | Year | Language | Analysis type | |
, Hematology, Oncology | 2013 | English | , Real World Data | |
Cost-effectiveness of bendamustine versus fludarabine for first-line treatment of chronic lymphocytic leukemia (cll) in Colombia | ||||
Bertwistle D1, Munakata J2, Wehler E3, Leyva V4, Ariza JG5, Zambrano C5, Gonzalez L6 | ||||
1IMS Health, London, United Kingdom, 2IMS Health, San Francisco, CA, USA, 3IMS Health, Alexandria, VA, USA, 4IMS Health, Mexico City, Mexico, 5Janssen Cilag, Bogotá, Colombia, 6Janssen, Raritan, NJ, USA | ||||
ISPOR 16th Annual European Congress, 2013. PCN119. |
||||
, Abstract, Poster | ||||
, Colombia | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2013 | English | , Cost effectiveness | |
The cost-effectiveness of bendamustine versus fludarabine for the first-line treatment of chronic lymphocytic leukemia (cll) in Mexico. | ||||
Bertwistle D1, Munakata J2, Wehler E3, Leyva V4, Valencia A5, Hernandez A5, de la Torre L5, Gonzalez L6 | ||||
1IMS Health, London, United Kingdom, 2IMS Health, San Francisco, CA, USA, 3IMS Health, Alexandria, VA, USA, 4IMS Health, Mexico City, Mexico, 5Janssen, Mexico City, Mexico, 6Janssen, Raritan, NJ, USA | ||||
ISPOR 16th Annual European Congress, 2013. PCN99. |
||||
, Abstract, Poster | ||||
, Mexico | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2013 | English | , Cost effectiveness | |
TREATMENTS FOR EGFR MUTATION POSITIVE NSCLC – A NETWORK META-ANALYSIS | ||||
Fonseca T1;Lungershausen J2;Wallenstein G3;Stammberger U3;Bertwistle D1, Griebsch I2 | ||||
1IMS Health, London, United Kingdom, 2Boehringer Ingelheim Pharma GmbH, Ingelheim am Rhein, Germany, 3Boehringer Ingelheim Pharma GmbH & Co.KG, Ingelheim, Germany | ||||
ISPOR 16th Annual European Congress, 2013. PCN24. |
||||
, Abstract | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2013 | English | , Meta analysis | |
Validating an indolent non-hodgkin's lymphoma (nhl) cost-effectiveness analysis model using two software tools: key implementation considerations and results | ||||
Wehler EA1;Bilir SP2;Bertwistle D3;Leyva V4, Munakata J2 | ||||
1IMS Health, Alexandria, VA, USA, 2IMS Health, San Francisco, CA, USA, 3IMS Health, London, United Kingdom, 4IMS Health, Mexico City, Mexico | ||||
ISPOR 16th Annual European Congress, 2013. PRM82 |
||||
, Abstract | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2013 | English | , Cost effectiveness | |
The cost-effectiveness of bendamustine-rituximab versus fludarabine-rituximab for patients with indolent non-hodgkin's lymphoma (inhl) who have progressed following treatment with rituximab or a rituximab-containing regimen in Mexico | ||||
Bertwistle D1, Munakata J2, Wehler E3, Leyva V4, Valencia A5, Hernandez A5, de la Torre L5, Gonzalez L6 | ||||
1IMS Health, London, United Kingdom, 2IMS Health, San Francisco, CA, USA, 3IMS Health, Alexandria, VA, USA, 4IMS Health, Mexico City, Mexico, 5Janssen, Mexico City, Mexico, 6Janssen, Raritan, NJ, USA | ||||
ISPOR 16th Annual European Congress, 2013. PCN110. |
||||
, Abstract, Poster | ||||
, Mexico | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2013 | English | , Cost effectiveness | |
The cost-effectiveness of bendamustine-rituximab versus fludarabine-rituximab for patients with indolent non-hodgkin's lymphoma (inhl) who have progressed following treatment with rituximab or a rituximab-containing regimen in Colombia | ||||
Bertwistle D1, Munakata J2, Wehler E3, Leyva V4, Ariza JG5, Zambrano C5, Gonzalez L6 | ||||
1IMS Health, London, United Kingdom, 2IMS Health, San Francisco, CA, USA, 3IMS Health, Alexandria, VA, USA, 4IMS Health, Mexico City, Mexico, 5Janssen Cilag, Bogotá, Colombia, 6Janssen, Raritan, NJ, USA | ||||
ISPOR 16th Annual European Congress, 2013. PCN94. |
||||
, Abstract, Poster | ||||
, Colombia | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2013 | English | , Cost effectiveness | |
Synchronization of administrations of chemotherapy and erythropoiesis-stimulating agents and frequency of associated healthcare visits | ||||
Hill J1, Shreay S2, McGarvey N3, Hess GP4, Corey-Lisle P2 | ||||
1 IMS Health, PA, USA 2 Amgen Inc., CA, USA 3 University of California, CA, USA 4 Leonard Davis Institute UPenn, PA, USA | ||||
, Article | ||||
, USA | ||||
Abstract: http://link.springer.com/article/10.1007/s00520-013-1830-7 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2013 | English | , Retrospective cohort analysis | |
Current situation of oral anticancer treatments use in france: the actor study (analysis of cancer treatments given orally) | ||||
Benjamin L1, Maurel F2, Bardoulat I2, Ricarte C2 | ||||
1. GlaxoSmithKline, Marly-leRoi, France; 2. IMS Health, La Défense, France | ||||
ISPOR 16th anual European congress - 2013 Value Health November 2013 Volume 16, Issue 7, Page A425 |
||||
, Abstract, Poster | ||||
, France | ||||
Abstract: www.ispor.org/Events/Posters.asp | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2013 | English | , Real World Data, Retrospective database analysis | |
Management costs of the first five years after diagnosis in breast cancer by stage in France made with the french National Cancer Institute | ||||
Atsou K1, Bardoulat I2, Colin X1, Lemasson H1, Ricarte C1, Maurel F1, Ajjouri R2, Lançon F2 | ||||
1.IMS Health, La Défense, France; 2. Institut national du Cancer, Boulogne-Billancourt, France | ||||
ISPOR 16th annual congress Value Health November 2013 Volume 16, Issue 7, Page A403 |
||||
, Abstract, Poster | ||||
, France | ||||
Abstract: www.ispor.org/Events/Posters.asp | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2013 | English | , Economic evaluation, Retrospective database analysis | |
Evolution of oral anticancer treatments use in France from 2004-2012 : RE-ACTOR study (retrospective analysis of cancer treatments given orally) | ||||
Benjamin L1, Maurel F2, Bardoulat I2, Ricarte C2 | ||||
1. GlaxoSmithKline, Marly-le-Roi, France; 2. IMS Health, La Défense, France | ||||
Ispor 16th annual European congress - Nov2013 Value Health November 2013 Volume 16, Issue 7, Page A425 |
||||
, Abstract, Poster | ||||
, France | ||||
Abstract: www.ispor.org/Events/Posters.asp | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2013 | English | , Retrospective database analysis | |
Persistence in patients with breast cancer treated with tamoxifen or aromatase inhibitors: a retrospective database analysis. | ||||
Hadji P1, Ziller V1, Kyvernitakis J1, Bauer M1, Haas G2, Schmidt N2, Kostev K2 | ||||
1 Philipps - University of Marburg, Marburg, Germany 2 IMS Health, Frankfurt, Germany | ||||
Breast Cancer Res Treat., 2013, Feb;138(1):185-91 |
||||
, Article | ||||
, Germany | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/23334803 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2013 | English | , Retrospective database analysis | |
Persistence with bisphosphonates in patients with metastatic breast cancer: A retrospective database analysis. | ||||
Hadji P1, Ziller V1, Kyvernitakis J1, Schmidt N2, Kostev K2 | ||||
1 Philipps - University of Marburg, Marburg, Germany 2 IMS Health, Frankfurt, Germany | ||||
J Cancer Res Clin Oncol., 2013, Jul;139(7):1149-55 |
||||
, Article | ||||
, Germany | ||||
Abstract: http://link.springer.com/article/10.1007%2Fs00432-013-1427-z | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2013 | English | , Retrospective database analysis | |
Adherence in tamoxifen therapy after conversion to a rebate pharmaceutical in breast cancer patients in Germany. | ||||
Kostev K1, May U2, Hog D2, Eisel J2, Kremmers T2, Kosteic M2, Waehlert L2, Hadji P3 | ||||
1 IMS Health, Frankfurt, Germany 2 Hochschule Fresenius, Idstein, Germany 3 Phillips-University of Marburg, Marburg, Germany | ||||
Int J Clin Pharmacol Ther., 2013, Dec;51(12):969-75 |
||||
, Article | ||||
, Germany | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/?term=Adherence+in+tamoxifen+therapy+after+conversion+to+a+rebate+pharmaceutical+in+breast+cancer+patients+in+Germany | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2013 | English | , Retrospective database analysis | |
(Analysis of the influence of the physician on the compliance of breast cancer patients) Analyse des Einflusses des Arztes auf die Compliance von Brustkrebs-Patientinnen. | ||||
Kostev K1, Oschmann L2, Schneider DM2, Gröger S2, Karsten T2, Waehlert L2 | ||||
1 IMS Health, Frankfurt, Germany 2 Fresenius University of Applied Sciences, Idstein, Germany | ||||
Monitor Versorgungsforschung, 2013, Mar. (01): 29-34. |
||||
, Article | ||||
, Germany | ||||
Abstract: http://www.monitor-versorgungsforschung.de/kurzfassungen/kurzfassungen-2013/Analyse_Einfluss_Arzt_auf_Compliance_Brustkrebs-Patientinnen | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2013 | German | , Compliance | |
(Significantly shortened survival time of patients with prostate cancer in the occurrence of bone metastases) Deutlich verkürzte Überlebenszeit von Patienten mit Prostatakarzinom beim Auftreten von Knochenmetastasen. | ||||
Haas G1, Kostev K1 | ||||
1 IMS Health, Frankfurt, Germany | ||||
Monitor Versorgungsforschung, 2013, May. (04): 27-31 |
||||
, Article | ||||
, Germany | ||||
Abstract: http://www.monitor-versorgungsforschung.de/kurzfassungen/kurzfassungen-2013/copy_of_Arzneimittelentwicklung-in-der-Onkologie | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2013 | German | , Burden of illness, Quality of life | |
Prevalence of renal impairment among cancer patients with bone metastases in the United States. | ||||
Shahinian V1, Chen K2, Hernandez R2, Quigley J3, Pirolli M3, Quach D3, Liede A2, Arellano J2 | ||||
1 Univ of Michigan Medical School, Ann Arbor, USA 2 Amgen, Inc, Thousand Oaks, USA 3 IMS Health, Plymouth Meeting, USA | ||||
American Society of Nephrology Kidney Week, 2013, November 5-10, Atlanta, USA (abstr TH-PO295, 171-A) |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2013 | English | , Retrospective database analysis | |
Prevalence of renal insufficiency (RI) in cancer (Ca) patients (pts) with bone metastases (BM). | ||||
Chen K1, Hernandez R1, Quigley J2, Pirolli M2, Quach D2, Liede A3, Arellano J3 | ||||
1 Amgen Inc., Thousand Oaks, USA 2 IMS Health, USA (Formerly SDI Health) 3 Amgen, Inc., South San Francisco, USA | ||||
2013 ASCO Annual Meeting; Citation: J Clin Oncol 31, 2013 (suppl; abstr e12508) |
||||
, Abstract | ||||
, USA | ||||
Abstract: http://meetinglibrary.asco.org/content/112069-132 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2013 | English | , Retrospective database analysis | |
Prevalence of hypercalcemia of malignancy in the United States. | ||||
Gastanaga V1, Jain R1, Pirolli M2, Quach D2, Quigley J2, Stryker S1, Liede A1 | ||||
1 Amgen, USA 2 IMS, Plymouth Meeting, USA | ||||
Thirty-Fifth Annual Meeting of the American Society for Bone and Mineral Research, 2013, October 4-7, Baltimore, USA (abstr MO0172, S384) |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2013 | English | , Retrospective database analysis | |
A pharmacoeconomic analysis of the use of single MMC instillation in low risk NMIBC in Italy. | ||||
Colombo R1, Pellucchi F1, Rocchini L1, Maccagnano C1, Katz P2, Pegoraro V2 | ||||
1 Department of Urology, University Vita-Salute, San Raffaele Hospital, Milan, Italy 2 CSD Medical Research S.r.l. Milan, Italy | ||||
farmeconomia Vol 14, No 1 (2013) > Colombo |
||||
, Article | ||||
, Italy | ||||
Abstract: http://journals.edizioniseed.it/index.php/FE/article/view/635 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2013 | English | , Economic evaluation | |
Identifying patients with undetected gastro-oesophageal cancer in primary care: External validation of QCancer® (Gastro-Oesophageal). | ||||
Collin GS, Altman DG | ||||
Eur J Cancer. 2013 Mar;49(5):1040-8. doi: 10.1016/j.ejca.2012.10.023. Epub 2012 Nov 15. |
||||
, Article | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/23159533 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2013 | English | ||
Identifying patients with undetected pancreatic cancer in primary care: an independent and external validation of QCancer(®) (Pancreas). | ||||
Collins GS & Altman DG | ||||
Br J Gen Pract. 2013 Sep;63(614):e636-42. doi: 10.3399/bjgp13X671623 |
||||
, Article | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/23998844 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2013 | English | ||
Identifying patients with undetected renal tract cancer in primary care: an independent and external validation of QCancer® (Renal) prediction model. | ||||
Collins GS & Altman DG | ||||
University of Oxford Centre for Statistics in Medicine | ||||
Cancer Epidemiol. 2013 Apr;37(2):115-20. doi: 10.1016/j.canep.2012.11.005. Epub 2012 Dec 29 |
||||
, Article | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/23280341 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2013 | English | , Retrospective database analysis | |
Identifying women with undetected ovarian cancer: independent and external validation of QCancer(®) (Ovarian) prediction model. | ||||
Collins GS & Altman DG | ||||
Eur J Cancer Care (Engl). 2013 Jul;22(4):423-9. doi: 10.1111/ecc.12015. Epub 2012 Nov 1 |
||||
, Article | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/23121234 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2013 | English | ||
Regional variations of basal cell carcinoma incidence in the U.K. using The Health Improvement Network database (2004-10). | ||||
Musah A, Gibson JE, Leonardi-Bee J, Cave MR, Ander EL & Bath-Hextall F. | ||||
University of Nottingham Division of Epidemiology and Public Health | ||||
Br J Dermatol. 2013 Nov;169(5):1093-9. doi: 10.1111/bjd.12446. |
||||
, Article | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/23701520 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2013 | English | , Epidemiological study, Retrospective database analysis | |
The association between smoking quantity and lung cancer in men and women. | ||||
Powell HA, Iyen-Omofoman B, Hubbard RB, Baldwin DR & Tata LJ. | ||||
University of Nottingham Nottingham Respiratory Research Unit | ||||
Chest. 2013 Jan;143(1):123-9. |
||||
, Article | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22797799 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2013 | English | , Retrospective database analysis | |
Type 2 diabetes mellitus and survival in pancreatic adenocarcinoma: a retrospective cohort study. | ||||
Hwang A, Narayan V & Yang YX | ||||
University of Pennsylvania Department of Gastroenterology | ||||
Cancer. 2013 Jan 15;119(2):404-10. doi: 10.1002/cncr.27731. Epub 2012 Aug 1. |
||||
, Article | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/23292900 | ||||
Condition | Year | Language | Analysis type | |
, Diabetes, Oncology | 2013 | English | , Retrospective database analysis | |
Utility and Willingness to Pay for Lung Cancer Treatments: Patient Versus General Population Values in Thailand. | ||||
Thongprasert S, Permsuwan U, Sakulbumrungsil R, Chaiyakunapruk N, Crawford B, Petcharapiruch S1, Leartsakulpanitch J. | ||||
1Outcomes Resarch, Medical Department, Pfizer (Thailand) Limited, Thailand | ||||
HTAi (June 17 – 19, 2013, Seoul Korea). |
||||
, Poster | ||||
, Thailand | ||||
Abstract: http://www.novelhealthstrategies.com/KoreaHTAiSchedule.pdf | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2013 | English | , Economic evaluation | |
Projection Methods Using Oncology Electronic Health Records to Produce Nationally Representative Estimates | ||||
Quach D1, Liede A2, Byekwaso S1, Eremina D1, Kossar B1, Zhou L1, Quigley J1, Kallich J2, Adams J3, Smith P1 | ||||
1 Oncology Marketing Analytics and Services, IMS Health, Plymouth Meeting, PA, United States 2 Center for Observational Research, Amgen Inc., Thousand Oaks, CA, United States 3 Kaiser Permanente, Pasadena, CA, United States | ||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2013 | English | , Review | |
Prevalence of Hypercalcemia of Malignancy in the United States | ||||
Gastanaga V1, Jain R1, Pirolli M2, Quach D2, Quigley J2, Stryker S1, Liede A1 | ||||
1 Amgen Inc., Thousand Oaks, CA 2 IMS Health, Plymouth Meeting, PA | ||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2013 | English | , Real World Data | |
Patterns of Treatment (tx) with Bone-Modifying Agents (BMA) in Patients with Bone Metastases (mets) | ||||
Quigley J1, Hernandez R2, Cetin K2, Pirolli M1, Quach D1, Liede A3 | ||||
1 IMS Health, Plymouth Meeting, USA 2 Amgen, Inc., Thousand Oaks, USA 3 Amgen, Inc., South San Francisco, USA | ||||
2013 ASCO Annual Meeting; Citation: J Clin Oncol 31, 2013 (suppl; abstr e20690) |
||||
, Abstract | ||||
, USA | ||||
Abstract: http://meetinglibrary.asco.org/content/115636-132 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2013 | English | , Retrospective database analysis | |
Prevalence of Renal Insufficiency (RI) in Cancer (Ca) Patients (pts) with Bone Metastases (BM) | ||||
Chen K1, Hernandez R1, Quigley J2, Pirolli M2, Quach D2, Liede A3, Arellano J3 | ||||
1 Amgen Inc., Thousand Oaks, USA 2 IMS Health, USA (Formerly SDI Health) 3 Amgen, Inc., South San Francisco, USA | ||||
2013 ASCO Annual Meeting; Citation: J Clin Oncol 31, 2013 (suppl; abstr e12508) |
||||
, Abstract | ||||
, USA | ||||
Abstract: http://meetinglibrary.asco.org/content/112069-132 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2013 | English | , Retrospective database analysis | |
Estimating Prevalence of Stage II-III Breast Cancer in the United States by Treatment and Biologic Subtypes Using Oncology Clinic Data | ||||
Quigley J1, Hernandez R2, Pirolli M1, Quach D1, Liede A3 | ||||
1 IMS Health, Plymouth Meeting, USA 2 Amgen, Inc., Thousand Oaks, USA 3 Amgen, Inc., South San Francisco, USA | ||||
San Antonio Breast Cancer Symposium, 2013, December 10-14, San Antonio, USA |
||||
, Abstract | ||||
, USA | ||||
Abstract: http://sabcs.org/ | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2013 | English | , Retrospective database analysis | |
Prevalence of Renal Impairment among Cancer Patients with Bone Metastases in the United States | ||||
Shahinian V1, Chen K2, Hernandez R2, Quigley J3, Pirolli M3, Quach D3, Liede A2, Arellano J2 | ||||
1 University of Michigan Medical School, Ann Arbor, USA 2 Amgen, Inc., Thousand Oaks, USA 3 IMS Health, Plymouth Meeting, USA | ||||
American Society of Nephrology Kidney Week, 2013, November 5-10, Atlanta, USA (abstr TH-PO295, 171-A) |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2013 | English | , Retrospective database analysis | |
Prevalence of Hypercalcemia of Malignancy in the United States | ||||
Gastanaga V1, Jain R1, Pirolli M2, Quach D2, Quigley J2, Stryker S1, Liede A1 | ||||
1 Amgen, USA 2 IMS, Plymouth Meeting, USA | ||||
Thirty-Fifth Annual Meeting of the American Society for Bone and Mineral Research, 2013, October 4-7, Baltimore, USA (abstr MO0172, S384) |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2013 | English | , Retrospective database analysis | |
Patterns of Treatment with Bone-Modifying Agents in Patients with Bone Metastases in the US | ||||
Quigley, J., Hernandez, R., Cetin, K., Pirolli, M., Quach, D., Arellano, J., Liede, A. | ||||
MASCC/ISOO International Symposium on Supportive Care in Cancer, 2013, June 27-29, Berlin, Germany |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2013 | English | , Retrospective database analysis | |
Projection Methods Using Oncology Electronic Health Records to Produce Nationally Representative Estimates | ||||
Quach, D., Liede, A., Byekwaso, S., Eremina, D., Kossar, B., Zhou, L., Quigley, J., Kallich, J., Adams, J., Smith, P. | ||||
International Conference on Pharmacoepidemiology & Therapeutic Risk Management, 2013. |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2013 | English | , Retrospective database analysis | |
Charateristics of Patients Included in the Myelofibrosis Real-World Practice-Based Network Research (ENRiCH) Data Platform | ||||
Hess, G1, Fonseca, E2, Lee, A3, Wang, H3, Dhawan, R3, Thompson, S4, Iqbal, S3, Redmond, S2 | ||||
1 Symphony Health Solutions, Horsham, PA 2 IMS Health, Plymouth Meeting, PA 3 Sanofi, Cambridge, MA 4 Sanofi, Bridgewater, NJ | ||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2013 | English | , Retrospective database analysis | |
Metformin and survival in pancreatic cancer: a retrospective cohort study | ||||
Hwang AL, Haynes K, Hwang WT, Yang YX | ||||
Pancreas. 2013 Oct;42(7):1054-9. doi: 10.1097/MPA.0b013e3182965a3c. |
||||
, Article | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3779343/ | ||||
Condition | Year | Language | Analysis type | |
, Diabetes, Oncology | 2013 | English | , Retrospective database analysis | |
Patients with bone metastases from solid tumors initiating treatment with a bone-targeted agent in 2011: a descriptive analysis using oncology clinic data in the US. | ||||
Hernandez RK1, Quigley J, Pirolli M, Quach D, Chen KS, Arellano J, Liede A. | ||||
1Center for Observational Research, Amgen, IMS Health, One IMS Drive, Global Health Economics, Amgen Inc | ||||
Support Care Cancer. 2014 Oct;22(10):2697-705 |
||||
, Article | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2013 | English | ||
Dietary intake of vitamin d and calcium and breast cancer risk in the European prospective investigation into cancer and nutrition | ||||
Abbas S, Linseisen J, Rohrmann S, Chang-Claude J, Peeters PH, Engel P et al | ||||
Nutr Cancer 2013; 65(2):178-87 |
||||
, Article | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2013 | English | , RWLPR (Real-World Late Phase Research-quintiles | |
Impact of oncology-related direct-to-consumer advertising | ||||
Abel GA, Chen K, Taback N, Hassett MJ, Schrag D, Weeks JC | ||||
1Division of Population Sciences, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA. gregory_abel@dfci.harvard.edu | ||||
Cancer 2013;119(5):1065-1072. |
||||
, Article | ||||
Abstract: http://onlinelibrary.wiley.com/doi/10.1002/cncr.27814/abstract;jsessionid=875CDEEE301260EAFDFA48F72D2B313F.f01t02 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2013 | English | , Real World Evidence | |
Management costs of the first five years after diagosis in Breast Cancer by Stage in France. | ||||
Atsou L, Bardoulat I, Colin X, Lemasson H, Ricarte C, Maurel F, Ajjouri R, Lancon F | ||||
1 IMS Health, La Defense, France, 2 French National Cancer Institute, Boulogne-Billancourt France Cedex, France | ||||
ISPOR Europe 2013 Annual meeting |
||||
, Poster | ||||
, France, Germany, Italy, Spain, UK | ||||
Abstract: http://www.valueinhealthjournal.com/article/S1098-3015(13)02369-3/abstract | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2013 | English | , Retrospective cohort analysis | |
Evaluation of treatment persistence with Tamoxifene or aromatase inhibitors in breast cancer patients in Germany. | ||||
Schmidt N, Haas G, Mergenthaler U, Kostev K, Hadji P | ||||
1 IMS Health, CES Oncology, Frankfurt, Germany, 2 IMS Health, CES Epidemiology, Frankfurt, Germany, 3 Department of Gynecology, Endocrinology and Oncology, Phillips-University of Marburg, Germany | ||||
ISPOR Europe 2013 Annual meeting |
||||
, Poster | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2013 | English | ||
Evolution of oral anticancer treatments use in France from 2004 to 2012: the Re-ACTOR Study. | ||||
Benjamin L, Maurel F, Bardoulat I, Ricarte C | ||||
1 Glaxosmithkline, 2 Health Economics and Outcomes Research, Marly le Rol, France, 3 IMS Health, La Defense, France | ||||
ISPOR Europe 2013 Annual meeting |
||||
, Poster | ||||
, China, France, Germany, Italy, Japan, Korea, Spain, Taiwan, UK | ||||
Abstract: http://www.valueinhealthjournal.com/article/S1098-3015(13)02489-3/fulltext | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2013 | English | , Retrospective database analysis | |
Current situation of oral anticancer treatments use in France: the ACTOR Study. | ||||
Benjamin L, Maurel F, Bardoulat I, Ricarte C | ||||
1 Glaxosmithkline, 2 Health Economics and Outcomes Research, Marly le Rol, France, 3 IMS Health, La Defense, France | ||||
ISPOR Europe 2013 Annual meeting |
||||
, Abstract | ||||
, China, France, Germany, Italy, Japan, Korea, Spain, Taiwan, UK | ||||
Abstract: http://www.valueinhealthjournal.com/article/S1098-3015(13)02492-3/fulltext | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2013 | English | ||
Evolution of Molecular Diagnostic test Usage in Solid tumours in EU5 (Analysis of Molecular Biomarker Tests in Oncology). | ||||
Ricarte C, Bruce A, Anger C | ||||
1 IMS Health, La Defense, France 2 IMS Health, London, United Kingdom | ||||
ISPOR Europe 2013 Annual meeting |
||||
, Poster | ||||
, France, Germany, Italy, Spain, UK | ||||
Abstract: http://www.valueinhealthjournal.com/article/S1098-3015(13)02310-3/pdf | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2013 | English | , Retrospective database analysis | |
Cost effectiveness analysis of bendamustine as first line treatment for chronic lymphocytic leukaemia in the Netherlands. | ||||
Vandekerckhove S1, Holtzer-Goor K2, Van Den Steen D1, van Megen Y3, Huijgens P4, Lamotte M1, Uyl- de Groot C5 | ||||
1 IMS Health, Vilvoorde, Belgium 2 iMTA, Rotterdam, Zuid Holland, Netherlands 3 Mundipharma Pharmaceuticals, Hoevelaken, Netherlands 4 VU University Medical Center, Amsterdam, Netherlands 5 Erasmus University, Rotterdam, Netherlands | ||||
15th ISPOR Annual European Congress, 2012, November 3-7, Berlin, Germany |
||||
, Abstract, Poster | ||||
, Netherlands | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2012 | English | , Cost effectiveness, Cost utility | |
Cost utility analysis of bortezomib in a biomarker positive subgroup of relapsed and refractory folicular lymphoma | ||||
Vandekerckhove S1, Lamotte M1, Iannazzo S2, Chirita O3 | ||||
1 IMS HEOR, Brussels, Belgium 2 IMS HEOR, Milan, Italy 3 Janssen-Cilag Ltd., Buckinghamshire, United Kingdom | ||||
15th ISPOR Annual European Congress, 2012, November 3-7, Berlin, Germany |
||||
, Abstract, Poster | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2012 | English | , Cost effectiveness, Cost utility | |
NICE Technology Appraisals and the uptake of breast cancer drugs in the UK | ||||
Bertwistle D1, Anderson P2, Jofre-Bonet M3 | ||||
1 IMS Health, London, UK 2 Swansea Centre for Health Economics, Swansea University, Wales, UK 3 City University, London, UK | ||||
ESMO (European Society for Medical Oncology) 2012 Value Health November 2012 Volume 15, Issue 7, Page A434 |
||||
, Abstract, Poster | ||||
, UK | ||||
Abstract: www.ispor.org/congresses/berlin1112 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2012 | English | , Economic evaluation | |
Blood component use and associated costs after standard dose chemotherapy-a prospective analysis of routine hospital care in lymphoproliferative disorders and NSCLC in Germany | ||||
Paessens B, Ihbe-Heffinger A, von Schilling C, Shlaen R2, Bernard R, Peschel C, Schramm W, Berger K | ||||
Krankenhausapotheke, Klinikum rechts der Isar (MRI) der Technischen Universität München, München, Germany, 2Health Economics and Outcomes Research, IMS Health GmbH & Co. OHG, Munich, Germany | ||||
Support Care Cancer, 2012, 20(5): 1011-1021 |
||||
, Article | ||||
, Germany | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/21562801 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2012 | English | , Prospective study | |
Antifungal management and resource use in patients with acute myeloid leukaemia after chemotherapy – retrospective analysis of changes over 3 yr in a German hospital | ||||
Boehme A1, Atta J1, Mousset S1, Ehlken B2, Shlaen M2, Bug G1, Serve H. 1, Hoelzer D. 1 | ||||
1 Department of Medicine, Hematology ⁄ Oncology, Goethe-University, Frankfurt ⁄ Main; 2 IMS Health, Munich, Germany | ||||
European Journal of Haematology, 2011, EPub Oct 13 European Journal of Haematology, 2012, 88(1): 68-77 |
||||
, Article | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2012 | English | , Retrospective cohort analysis | |
Major surgery in patients with metastatic colorectal cancer in western Europe. | ||||
Zhao Z1, Pelletier EM2, Barber B1, Bhosle M3, Wang S1, Klingman D3, Gao S1 | ||||
1Amgen Inc., Thousand Oaks, CA, USA, 2IMS Consulting, Watertown, MA, USA, 3IMS Consulting, Alexandria, VA, USA | ||||
J Gastrointest Cancer. 2012 Sep;43(3):456-61 |
||||
, Manuscript in preparation | ||||
, France, Germany, Italy, Spain, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22125088 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2012 | English | , Retrospective database analysis | |
Patterns of treatment with chemotherapy and monoclonal antibodies for metastatic colorectal cancer in Western Europe. | ||||
Zhao Z1, Pelletier EM2, Barber B1, Bhosle M3, Wang S1, Gao S1, Klingman D3 | ||||
Amgen Inc., Thousand Oaks, CA, USA1, IMS Consulting Group, Watertown, MA, USA2, IMS Consulting Group, Alexandria, VA, USA3 | ||||
Curr Med Res Opin 2012; 28(2):221-229; 2012 Jan 27 [Epub ahead of print] |
||||
, Abstract | ||||
, France, Germany, Italy, Spain, UK | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2012 | English | , Retrospective database analysis | |
Patient out-of-pocket payments for oral oncolytic therapies: results from a U.S. claims data analysis. | ||||
Raborn ML1, Pelletier EM2, Smith DB2, Reyes CM1 | ||||
1Genentech, Inc., South San Francisco, CA, USA, 2IMS Consulting Group, Watertown, MA, USA | ||||
Am J Manag Care 2012;18(2 Spec No.):SP57-SP64 |
||||
, Manuscript in preparation | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2012 | English | , Cost analysis, Retrospective database analysis | |
Risk of treatment failure after first-line sunitinib therapy in patients with metastatic renal cell carcinoma | ||||
Chen CC1, Hess GP1, Liu Z2, Gesme DH3, Agarwala SS4, Garay CA4, Hill JW1, Guo MA4 | ||||
1 IMS Health (formerly SDI), Plymouth Meeting, PA 2 Novartis Pharmaceuticals, East Hanover, NJ 3 Minnesota Hem Onc, Minneapolis, MN 4 St. Luke's Hospital and Health Network, Bethlehem, PA | ||||
Genitourinary Cancers Symposium 2012 |
||||
, Poster, Symposium | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Nephrology, Oncology | 2012 | English | , Retrospective database analysis | |
Economic burden of toxicities associated with metastatic colorectal cancer treatment regimens containing monoclonal antibodies. | ||||
Burudpakdee C1, Zhao Z2, Munakata J1, Gao S2, Trochlil K1, Barber B2 | ||||
1 IMS Health, Alexandria, VA, US 2 Amgen, Thousand Oaks, CA, US | ||||
J Med Econ, 2012, 15(2):371-7 |
||||
, Article | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2012 | English | , Cost analysis | |
Feasibility of Efficiency Frontier Analysis (EFA) In Metastatic Breast Cancer (MBC) treatments: A UK perspective (PCN94) | ||||
Burudpakdee C1, Bertwistle D2 | ||||
1IMS Health, Alexandria , VA, USA, 2IMS Health, London, UK | ||||
ISPOR 15th Annual European Congress, 3-7 November 2012, Berlin, Germany |
||||
, Poster | ||||
, UK | ||||
Abstract: http://www.ispor.org/congresses/Berlin1112/Posters3.aspx#top | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2012 | English | , Cost analysis | |
Assessing relative clinical value within three metastatic diseases | ||||
Karweit J1, Wolfe S1, Kotapati S2, Lees M3, Abernethy AP4 | ||||
1IMS Consulting Group, New York, NY, USA, 2Bristol-Myers Squibb Pharmaceuticals, Wallingford, CT, USA, 3Bristol-Myers Squibb, Rueil-Malmaison, France, 4Duke Clinical Research Institute and Duke Cancer Institute, Durham, NC, USA | ||||
ISPOR 15th Annual European Congress, 3-7 November 2012, Berlin, Germany |
||||
, Poster | ||||
Abstract: http://www.ispor.org/congresses/Berlin1112/Posters4.aspx | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2012 | English | , Cost analysis | |
Cost of Erythropoiesis-stimulating Agents (ESAs) in the treatment of Chemotherapy-related Anaemia in Spain | ||||
Duran A1, Spaepen E2, Lamotte M3, Brosa M4, Gutierrez L5, Restovic G6, Annemans L7 | ||||
1 IMS Health, London, UK 2 SBD Analytics BVBA/SPRL, Belgium 3 IMS Health, Vilvoorde, Belgium 4 Oblikue Consulting, Barcelona, Spain 5 Amgen S.A., Barcelona, Spain; 6 Independent Consultant, Barcelona, Spain 7 I-CHER Interuniversity Centre for Health Economics Research, Gent, Belgium | ||||
ISPOR 14th Annual European Congress, 5th - 8th November, Madrid, Spain |
||||
, Poster | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2012 | English | , Cost of illness | |
Preliminary validation of collect scale: a co-morbidity assessment tool for patients with Chronic Lymphocytic Leukaemia | ||||
Giraldo P1, Lopez A2, Rios E3, Gonzalez-Grande I4, Roset M5, Castro-Gomez A6, De La Serna J7, Carbonell F8 | ||||
1Hospital Universitario Miguel Servet, Zaragoza, Spain, 2Hospital Universitari Valle d'Hebron, Barcelona, Spain, 3Hospital Virgen de Valme, Sevilla, Spain, 4Roche Farma, S.A., Madrid, Spain, 5IMS Health, Barcelona, Spain, 6Roche, Madrid, Spain, 7Hospital Universitario 12 de Octubre, Madrid, Spain, 8Consorci Hospital General Universitari Valencia, Valencia, Spain | ||||
ISPOR 15th Annual European Congress, 3-7 November 2012, Berlin, Germany |
||||
, Poster | ||||
, Spain | ||||
Abstract: http://www.ispor.org/congresses/Berlin1112/Posters4.aspx | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2012 | English | ||
Cost-Effectiveness of Plerixafor plus GCSF for Mobilization of Peripheral blood Stem Cells in Patients with Myeloma and Lymphoma in Spain | ||||
Duarte RF1, Pérez-Simón JA2, Martín G3, de la Rubia J4, Marín P5, Álvarez MA6, Espinós B7, Roset M7 | ||||
1Institut Català D'Oncologia - Hospital Duran i Reynals, L'Hospitalet de Llobregat, Spain, 2Hospital Universitario Virgen del Rocío, Sevilla, Spain, 3Banc de Sang i Teixits, Barcelona, Spain, 4Hospital Universitario La Fe de Valencia, Valencia, Spain, 5Hospital Clínic, Barcelona, Spain, 6Hospital Reina Sofía, Córdoba, Spain, 7IMS Health, Barcelona, Spain | ||||
ISPOR 15th Annual European Congress, 3-7 November 2012, Berlin, Germany |
||||
, Poster | ||||
, Spain | ||||
Abstract: http://www.ispor.org/congresses/Berlin1112/Posters3.aspx | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2012 | English | , Cost effectiveness | |
Cost-Effectiveness Analysis of Erlotinib vs Plantinum based Chemotherapy as First-Line treatment of Non-Small Cell Lung Cancer EGFR Activating Mutations | ||||
Garrido P1, López-Vivanco G2, Rosell R3, Espinós B4, Castro-Gomez A5 | ||||
1Hospital Universitario Ramón y Cajal, Madrid, Spain, 2Hospital de Cruces, Barakaldo, Spain, 3Hospital Universitari Germans Trias i Pujol, Badalona, Spain, 4IMS Health, Barcelona, Spain, 5Roche, Madrid, Spain | ||||
ISPOR 15th Annual European Congress, 3-7 November 2012, Berlin, Germany |
||||
, Poster | ||||
Abstract: http://www.ispor.org/congresses/Berlin1112/Posters3.aspx | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2012 | English | , Cost effectiveness | |
Cancer Related Bisphosphonate Therapy In Different Treatment Facilities | ||||
Haas G1, Kostev K2 | ||||
1IMS Health, Frankfurt/Main, Germany, 2IMS Health, Frankfurt am Main, Germany | ||||
ISPOR 15th Annual European Congress, 3-7 November 2012, Berlin, Germany Value Health November 2012 Volume 15, Issue 7, Page A412 |
||||
, Abstract, Poster | ||||
Abstract: http://www.ispor.org/congresses/Berlin1112/Posters3.aspx | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2012 | English | , Observational study | |
Persistence in patients with breast cancer treated with Tamoxifen or Aromatase Inhibitors: Results of a Retrospective Cohort Study | ||||
Kostev K1, Haas G2, Hadji P3 | ||||
1IMS Health, Frankfurt am Main, Germany, 2IMS Health, Frankfurt/Main, Germany, 3Universityhospital of Giessen and Marburg GmbH, Marburg, Hessen, Germany | ||||
ISPOR 15th Annual European Congress, 3-7 November 2012, Berlin, Germany |
||||
, Poster | ||||
Abstract: http://www.ispor.org/congresses/Berlin1112/Posters3.aspx | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2012 | English | , Retrospective cohort analysis | |
Persistence in first line treatment of Metastatic Renal Cell Carcinoma in routine care in Germany | ||||
Mergenthaler U1, Morawski E2, Wendschlag A1 | ||||
1IMS Health, Frankfurt, Germany, 2Pfizer GmbH, Berlin, Germany | ||||
ISPOR 15th Annual European Congress, 3-7 November 2012, Berlin, Germany |
||||
, Poster | ||||
, Germany | ||||
Abstract: http://www.ispor.org/congresses/Berlin1112/Posters3.aspx | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2012 | English | , Burden of illness | |
Tumor hormone/HER2 receptor status and pharmacologic treatment of metastatic breast cancer in Western Europe | ||||
Gao S, Barber B, Schabert V, Ferrufino C. | ||||
1,2Amgen, Thousand Oaks, CA, USA, 3IMS Health, Woodland Hills, CA, USA, 4IMS Health, Alexandria, VA, USA | ||||
Curr Med Res Opin |
||||
, Manuscript in preparation | ||||
, Europe | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2012 | English | , Retrospective database analysis | |
Treatment cost of invasive fungal disease (lfd) in patients with acute myelogenous leukaemia (Aml) or myelodysplastic syndrome (Mds) in German hospitals. | ||||
Rieger CT1, Cornely OA2, Hoppe-Tichy T3, Kiehl M4, Knoth H5, Thalheimer M3, Schuler U, Ullmann AJ6, Ehlken B7, Ostermann H1 | ||||
1 Department of Hematology / Oncology, University Hospital of Munich, Munich 2 Germany Department I for Internal Medicine and ZKS Köln (BMBF 01KN0706), University of Cologne, Cologne 3 Germany Pharmacy Department, University Hospital of Heidelberg, Heidelberg 4 Germany Clinical Center Frankfurt/Oder 5 Germany University Hospital of Dresden, Dresden 6 Germany Department of Internal Medicine III, Johannes Gutenberg-University, Mainz, Germany 7 IMS Health, Munich, Germany | ||||
Mycoses, 2012, EPub April 3 |
||||
, Article | ||||
, Germany | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22471310 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2012 | English | , Cost analysis | |
Practice patterns in the management of prostate cancer in spain: results from a National Survey Among Radiation oncologists in 2009 | ||||
Zapatero A, López-Torrecilla J, Herruzco I, Calvo FA. | ||||
Department of Radiation Oncology, Health Research Institute IP, Hospital University of Princess, Madrid. | ||||
Clin Transl Oncol. 2013 Mar;15(3):226-32 |
||||
, Article | ||||
, Spain | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed?term=Practice%20patterns%20in%20the%20management%20of%20prostate%20cancer%20in%20spain%3A%20results%20from%20a%20National%20Survey%20Among%20Radiation%20oncologists%20in%202009 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2012 | Spanish | , Survey research | |
Analisi dei costi associati agli agenti stimolanti l’eritropoiesi nel trattamento dei pazienti con anemia indotta da chemioterapia in Italia (Costs analysis of erythropoiesis-stimulating agents in the treatment of chemotherapy- induced anemia) | ||||
Grabbi E1, Lucioni C2, Duran A1, Spaepen E3, Lamotte M4, Kutikova L5, Pujol B5, Gozzo M6, Iannazzo S7 | ||||
1 Health Economics and Outcomes Research, IMS Health, London, UK 2 Springer Healthcare Italia, Milan, Italy 3 SBD Analytics BVBA/SPRL, Belgium 4 Health Economics and Outcomes Research, IMS Health, Vilvoorde, Belgium 5 Amgen (Europe) GmbH, Zug, Switzerland 6 Amgen Dompé S.p.A., Milano, Italy 7 Health Economics and Outcomes Research, IMS Health, Milan, Italy | ||||
PharmacoEconomics Italian Research Articles, 2012; 14(2): 91-100 |
||||
, Article | ||||
, Italy | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2012 | English | , Cost analysis | |
Oncology growth drives new evidence needs | ||||
Berger K1 | ||||
1IMS Health, Munich, Germany | ||||
AccessPoint, Nov 2012; Vol 3(5); 11-15 |
||||
, Article | ||||
Abstract: http://www.imshealth.com/deployedfiles/imshealth/Global/Content/Services/Pharma%20Commercial%20Effectiveness/Health%20Economics%20_%20Outcomes%20Research/AccessPoint-5-281012%20F.pdf | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2012 | English | , Budget impact, Real World Evidence | |
Access to cancer screening in people with learning disabilities in the UK: cohort study in the health improvement network, a primary care research database. | ||||
Osborn DP, Horsfall L, Hassiotis A, Petersen I, Walters K & Nazareth I | ||||
Mental Health Sciences Unit | ||||
PLOS ONE 7(8):e43841 |
||||
, Article | ||||
, UK | ||||
Abstract: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0043841 | ||||
Condition | Year | Language | Analysis type | |
, Mental health, Oncology | 2012 | English | , Retrospective database analysis | |
Association Between Longer Therapy With Thiazolidinediones and Risk of Bladder Cancer: A Cohort Study. | ||||
Mamtani R, Haynes K, Bilker WB, Vaughn DJ, Strom BL, Glanz K & Lewis JD. | ||||
Sherwood Forest Hospitals Foundation Trust University of Pennsylvania Department of Medicine | ||||
J Natl Cancer Inst. 2012 Sep 19;104(18):1411-21. Epub 2012 Aug 9. |
||||
, Article | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3529598/pdf/djs328.pdf | ||||
Condition | Year | Language | Analysis type | |
, Diabetes, Oncology | 2012 | English | , Retrospective database analysis | |
First-line sunitinib in type I and II papillary renal cell carcinoma (PRCC): SUPAP, a phase II study of the French Genito-Urinary Group (GETUG) and the Group of Early Phase trials (GEP). | ||||
Ravaud A1, Oudard S2, De Fromont M3, Chevreau C4, Gravis G5, Zanetta S6, Theodore C7, Jimenez M8, Sevin E9, Laguerre B10, Rolland F11, Ouali M12, Culine S13, Escudier B14. | ||||
1Department of Medical Oncology, Bordeaux University Hospital, Bordeaux alain.ravaud@chu-bordeaux.fr. 2Department of Medical Oncology, Paris Rene Descartes University, Paris. 3Pathology Department, SCP Pathology, Marseille. 4Department of Medical Oncology, Institut Claudius Régaud/Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse. 5Department of Medical Oncology, Institut Paoli Calmettes, Marseille. 6Department of Medical Oncology, Centre Georges-François Leclerc, Dijon. 7Department of Medical Oncology, Hôpital Foch, Suresnes. 8Research and Development Department, Unicancer, Paris. 9Department of Medical Oncology, Centre François Baclesse, Caen. 10Department of Medical Oncology, Centre Eugène Marquis, Rennes. 11Department of Medical Oncology, Institut de Cancérologie de L'Ouest, Nantes. 12Department of Biostatistics, Institut Claudius Régaud/Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse. 13Medical Oncology, Hôpital Saint-Louis, Paris. 14Department of Medical Oncology, Gustave Roussy, Villejuif, France. | ||||
2009 ASCO Annual Meeting Abstract Number: 5146 |
||||
, Poster | ||||
, France | ||||
Abstract: http://meetinglibrary.asco.org/content/30779-65 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2012 | English | , Prospective study | |
How commonly is gastric cancer missed at endoscopy (a UK primary care based study) ? | ||||
Menon S, Dhar A, Hoare J, Trudgill N | ||||
Sandwell Hospital | ||||
Digestive Disease Week conference San Diego |
||||
, Abstract, Conference | ||||
, UK | ||||
Abstract: http://gut.bmj.com/content/61/Suppl_2/A43.1 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2012 | English | , Retrospective database analysis | |
Evaluation of the willingness-to-pay for cancer treatment in Korean metastatic breast cancer patients: a multicenter, cross-sectional study. | ||||
Do-Youn OH 1, Bruce CRAWFORD6, Sung-Bae KIM 2, Hyun-Cheol CHUNG 3, Jeffrey MCDONALD 6, Sang Yoon LEE 4, Su-Kyoung KO4 andJungsil RO 5 | ||||
1 Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine 2 Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine 3 Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Yonsei University Health System 4 Pfizer Korea, Seoul 5 Center for Breast Cancer, National Cancer Center, Goyang, Korea 6 Adelphi Values, Tokyo, Japa | ||||
Asia Pac J Clin Oncol. 2012 Sep;8(3):282-91. doi: 10.1111/j.1743-7563.2012.01546.x. Epub 2012 May 21. |
||||
, Article | ||||
, Korea | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22898238 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2012 | English | , Burden of illness, Survey research | |
Prevalence of Non-Metastatic Breast Cancer Patients Treated with Aromatase Inhibitors in the United States | ||||
Liede A1, Pirolli M2, Hernandez R1, Quigley J2, Quach D2 | ||||
1 Amgen, Inc., Thousand Oaks, USA 2 IMS Health, Plymouth Meeting, USA | ||||
San Antonio Breast Cancer Symposium, 2012, December 4-8, San Antonio, USA (abstr P2-13-03, 275s) |
||||
, Abstract | ||||
, USA | ||||
Abstract: http://www.sabcs.org/UserPortal/Documents/SABCS_2012_Abstract_Book.pdf | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2012 | English | , Retrospective database analysis | |
Castration Resistance and High-Risk Disease among Non-Metastatic (M0) Prostate Cancer (PC) Patients on Androgen Deprivation Therapy (ADT) | ||||
Pirolli M1, Hernandez R2, Cetin K2, Quigley J1, Grant-Huerta Y2, Stryker S2, Smith P1, Adams J3, Liede A2 | ||||
1 IMS Health, USA (Formerly SDI Health) 2 Amgen, Inc, Thousand Oaks, USA 3 RAND Corporation, Santa Monica, USA | ||||
J Clin Oncol., 30, 2012 (suppl; abstr 1581) |
||||
, Abstract | ||||
, USA | ||||
Abstract: http://meetinglibrary.asco.org/content/94833-114 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2012 | English | , Retrospective database analysis | |
FOLFIRINOX Treatment of Metastatic Pancreatic Cancer in an Electronic Health Records Warehouse in the US | ||||
Gastanaga, V., Lethen, J., Barlev, A., Wang, S., Kelsh, M. | ||||
Annals of Oncology, vol. 23 s4, p. iv63, 2012 |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2012 | English | , Retrospective database analysis | |
Risk of Significant Hemoglobin (Hb) Declination in Chemotherapy Patients Prior To and After Policy Changes Affecting Use of Erythropoiesis -Stimulating Agents (Esa's): 2006-2009 | ||||
Hill, J. W., Cong, Z., Hess, G. P., McGarvey, N., Nordyke, R. J. | ||||
International Journal of Medical Research |
||||
, Abstract | ||||
, USA | ||||
Abstract: http://www.medscape.com/medline/abstract/22971506 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2012 | English | , Retrospective database analysis | |
Diabetes and cancer (2): evaluating the impact of diabetes on mortality in patients with cancer | ||||
Renehan AG, Yeh HC, Johsnon JA, Wild SH, Gale EA, Moller H, Diabetes and Cancer Research Consortium | ||||
University of Manchester Department of Surgery, School of Cancer and Enabling Sciences | ||||
Diabetologia. 2012 Jun;55(6):1619-32. doi: 10.1007/s00125-012-2526-0. Epub 2012 Apr 4. |
||||
, Article | ||||
, UK | ||||
Abstract: http://link.springer.com/article/10.1007/s00125-012-2526-0/fulltext.html | ||||
Condition | Year | Language | Analysis type | |
, Diabetes, Oncology | 2012 | English | , Retrospective database analysis | |
Diabetes and cancer (1): evaluating the temporal relationship between type 2 diabetes and cancer incidence. | ||||
Johnson JA1, Carstensen B2 3, Witte D2, Bowker SL1, Lipscombe L4 & Renehan AG5 | ||||
1 School of Public Health, University of Alberta, 2 Steno Diabetes Center, 3 2 Department of Biostatistics, University of Copenhagen 4 Women’s College Hospital, University of Toronto, 5 School of Cancer and Enabling Sciences, University of Manchester | ||||
Diabetologia. 2012 Jun;55(6):1607-18. doi: 10.1007/s00125-012-2525-1. Epub 2012 Apr 4. |
||||
, Article | ||||
, Canada, UK | ||||
Abstract: http://link.springer.com/article/10.1007/s00125-012-2525-1/fulltext.html | ||||
Condition | Year | Language | Analysis type | |
, Diabetes, Oncology | 2012 | English | , Retrospective cohort analysis, Retrospective database analysis | |
The association between smoking quantity and lung cancer in men and women | ||||
Iyen-Omofoman B, Hubbard RB, Baldwin DR & Tata LJ | ||||
University of Nottingham Nottingham Respiratory Research Unit | ||||
Chest 10.1378/chest.12-1068. |
||||
, Article | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22797799 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2012 | English | , Retrospective database analysis | |
Patient-reported outcomes in patients with metastatic breast cancer form the VIRGO observational cohort study | ||||
Kaufman PA, Mayer M, Dreyer NA, Yim YM, Yu E, Su Z, Mun Y, Sloan JA, Cleeland CS | ||||
ASCO Breast Cancer Symposium, Sep 13 - 15, 2012, San Francisco, CA |
||||
, Symposium | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2012 | English | , RWLPR (Real-World Late Phase Research-quintiles | |
Observations of hepatocellular carcinoma (HCC) management patterns from the global HCC BRIDGE study: An interim analysis of the Asia-Pacific (AP) cohort | ||||
Chen PJ, Park JW, Chen M, Sherman M, Johnson P, Colombo M, Kudo M, Roberts L, Huang B, Wagner S | ||||
Asian Pacific Association for the Study of Liver. Feb 2012. Taipei, Taiwan |
||||
, Article | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2012 | English | , RWLPR (Real-World Late Phase Research-quintiles | |
Observations of hepatocellular carcinoma (HCC) management patterns from the global HCC BRIDGE study: First characterizations of the full study population | ||||
Park JW, Sherman M, Colombo M, Roberts L, Schwartz M, Degos F, Chen PJ, Chen M, Kudo M, Johnson P, Huang B, Orsini LS | ||||
ASCO. 2012. Chicago, IL |
||||
, Abstract | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2012 | English | , RWLPR (Real-World Late Phase Research-quintiles | |
Observations of hepatocellular carcinoma (HCC) management patterns from the global HCC BRIDGE study: Global comparison of outcomes by staging system | ||||
Sherman M, Colombo M, Roberts L, Schwartz M, Degos F, Chen PJ, Chen M, Park JW, Kudo M, Johnson P, Huang B, Wagner S, Orsini LS | ||||
American Society of Clinical Oncology. 2012. Chicago, IL |
||||
, Abstract | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2012 | English | , RWLPR (Real-World Late Phase Research-quintiles | |
Observed patterns of systemic therapy use in hepatocellular carcinoma (HCC) patients from the multinational HCC BRIDGE study: Results of a second interim analysis | ||||
Colombo M, Roberts L, Schwartz M, Degos F, Sherman M, Chen PJ, Chen M, Park JW, Kudo M, Johnson P, Huang B, Wagner S, Orsini LS | ||||
, Article | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2012 | English | , RWLPR (Real-World Late Phase Research-quintiles | |
Observations of hepatocellular carcinoma (HCC) management patterns from the global HCC BRIDGE study: Second interim analysis of the european (EU) cohort | ||||
Izzo F, Colombo M, Leroy V, Blanc JF, Johnson P, Fenwick S, Stal P, Assenat E, Matilla A, Bartolome SP, Bourcier V, Degos F, Huang B, Wagner S, Orsini LS | ||||
European Association for the Study of the Liver- International Liver Congress. 2012. Barcelona, Spain |
||||
, Article | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2012 | English | , RWLPR (Real-World Late Phase Research-quintiles | |
Incidence and predictors of venous thromboembolism (VTE) among ambulatory patients with lung cancer | ||||
Connolly GC, Dalal M, Lin J, Khorana AA | ||||
University of Rochester Medical Center, Rochester | ||||
Lung Cancer 2012;78(3):253-258. |
||||
, Abstract | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2012 | English | , Public Health | |
Treatment pattern by hormone receptors and HER2 status in patients with metastatic breast cancer in the United Kingdom, Germany, France, Spain, and Italy (EU-5): Results from a physician survey. | ||||
DeKoven M, Bonthapally V, Lee W, Pathak P, Jiao X, Ray S, Alexandria | ||||
IMS Health; Abbott Laboratories, Abbott Park, IL; IMS Health, Collegeville, PA | ||||
ASCO 2012; J Clin Oncol 30, 2012 (suppl; abstr 570) |
||||
, Abstract | ||||
, France, Germany, Italy, Spain, UK | ||||
Abstract: http://ascopubs.org/doi/abs/10.1200/jco.2012.30.15_suppl.570 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2012 | English | , Retrospective database analysis | |
Cost Analysis of Anaemia Treatment With Erythropoiesis-Stimulating Agents in Cancer Patients Receiving Chemotherapy | ||||
Duran A1, Spaepen E2, Lamotte M3, Walter E4, Kutikova L5, Pujol B5, Ribnicsek E6, Annemans L7 | ||||
1IMS Health, London, UK; 2SBD Analytics BVBA/SPRL, Belgium; 3IMS Health, Vilvoorde, Belgium; 4Institut für Pharmaökonomische Forschung, Vienna, Austria; 5Amgen (Europe) GmbH, Zug, Switzerland; 6Amgen, Vienna, Austria; 7I-CHER Interuniversity Centre for Health Economics Research, UGent, VUB, Belgium | ||||
16th Congress of the European Association of Hospital Pharmacists, 30 March - 1 April 2011. |
||||
, Poster | ||||
, Austria, Belgium | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2011 | English | , Cost analysis | |
Cost-effectiveness of cetuximab, bevacizumab, and panitumumab in first-line treatment of metastatic colorectal cancer (mCRC) for patients with KRAS wild-type (wt) tumors in the United Kingdom | ||||
Samyshkin Y1, Hertel N1, Griebsch I2 | ||||
1Health Economics and Outcomes Research, IMS Health, London, UK; 2Pricing & Health Economics, Merck KGaA, Darmstadt, Germany | ||||
The European Multidisciplinary Cancer Congress, Stockholm 23 – 27 September 2011 |
||||
, Poster | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2011 | English | , Cost effectiveness | |
Cost analysis of anemia treatment with erythropoieses-stimulating agents (ESAs) in patients with cancer receiving chemotherapy: a multi-country approach. | ||||
Duran A1, Spaepen E2, Lamotte M3, Walter E4, Lucioni C5, Pinheiro B6, Brosa M7, Kutikova L8, Pujol B8, Annemans L9 | ||||
1 IMS Health, London, United Kingdom 2 SBD Analytics, Belgium 3 IMS Health, Vilvoorde, Belgium 4 Institute for Parmacoeconomic Research, Vienna, Austria 5 Wolters Kluwer Health Italy, Milan, Italy 6 Centre de Investigaçao Sobre Economia Portuguesa, Lisboa, Portugal 7 Oblikue Consulting, Barcelona, Spain 8 Amgen (Europe), Zug, Switzerland 9 I-CHER Interuniversity Centre for Health Economics Research, Gent, Belgium | ||||
ISPOR 14th Annual European Congress 5-8 November 2011, Madrid, Spain |
||||
, Poster | ||||
, Austria, Italy, Portugal, Spain | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2011 | English | , Cost analysis | |
Management of febrile neutropenia - a german prospective hospital cost analysis in lymphoproliferative disorders, non-small cell lung cancer, and primary breast cancer | ||||
Ihbe-Heffinger A, Paessens BJ, von Schilling C, Shlaen M2, Gottschalk N, Berger K, Bernard R, Kiechle M, Peschel C, Jacobs VR | ||||
1Krankenhausapotheke, Klinikum rechts der Isar (MRI) der Technischen Universität München, München, Germany, 2Health Economics and Outcomes Research, IMS Health GmbH & Co. OHG, Munich, Germany | ||||
Onkologie 2011;34(5):241-6. Epub 2011 Apr 26 |
||||
, Article | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2011 | German | , Prospective study | |
Health resource consumption and costs attributable to chemotherapy-induced toxicity in German routine hospital care in lymphoproliferative disorder and NSCLC patients | ||||
Paessens BJ, von Schilling C, Berger K, Shlaen M2, Müller-Thomas C, Bernard R, Peschel C, Ihbe-Heffinger A. | ||||
Krankenhausapotheke, Klinikum rechts der Isar (MRI) der Technischen Universität München, München, Germany, 2Health Economics and Outcomes Research, IMS Health GmbH & Co. OHG, Munich, Germany | ||||
Ann Oncol, 2011, 22(10): 2310-2319 |
||||
, Article | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2011 | English | , Prospective study | |
A comparative effectiveness analysis of trastuzumab persistence between two adjuvant breast cancer treatment regimens among US health plan enrollees. | ||||
Lalla D1, Pelletier EM2, Goodman S2, Brammer M1, Schabert VF3 | ||||
1Genentech, Inc., South San Francisco, CA, USA, 2IMS Consulting Group, Watertown, MA, USA, 3IMS Consultin Group, Woodland Hills, CA, USA | ||||
34th Annual San Antonio Breast Cancer Symposium, December 2011, San Antonio, TX, USA |
||||
, Abstract, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2011 | English | , Retrospective cohort analysis, Retrospective database analysis | |
Are out-of-pocket payments for oral oncologic therapies too high? Updated results from a U.S. claims data analysis. | ||||
Raborn ML1, Pelletier EM2, Smith DB2, Reyes CM1 | ||||
1Genentech, Inc., South San Francisco, CA, USA, 2IMS Consulting Group, Watertown, MA, USA | ||||
International Society of Pharmacoeconomics and Outcomes Research (ISPOR) 14th Annual European Meeting, November 2011, Madrid, Spain |
||||
, Abstract, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2011 | English | , Cost analysis, Retrospective database analysis | |
Trastuzumab persistence between two adjuvant breast cancer treatment regimens among US health plan enrollees: a comparative effectiveness analysis. | ||||
Lalla D1, Pelletier EM2, Goodman S2, Brammer M1, Schabert VF3 | ||||
1Genentech, Inc., South San Francisco, CA, USA, 2IMS Consulting Group, Watertown, MA, USA, 3IMS Consulting Group, Woodland Hills, CA, USA | ||||
16th European Cancer Organisation (ECCO) – 36th European Society for Medical Oncology (ESMO) Multidisciplinary Cancer Congress, September 2011, Stockholm, Sweden |
||||
, Abstract, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2011 | English | , Retrospective cohort analysis, Retrospective database analysis | |
Extrapolation in Oncology Modelling: Novel Methods for Novel Compounds | ||||
Annemans L1, Asukai Y2, Barzey V2, Kotapati S3, Lees M4, Van Baardewijk M5, Wang Q4, Batty AJ6, Fisher D6 | ||||
1 Ghent University, Belgium, 2 IMS Health, London, UK, 3 Bristol-Myers Squibb Pharmaceuticals, Wallingford, CT, USA, 4 Bristol-Myers Squibb, Uxbridge, Middlesex, UK, 5 Bristol-Myers Squibb, Braine L'Alleud, Belgium, 6 BresMed Health Solutions, Sheffield, South Yorkshire, UK | ||||
ISPOR 14th Annual European Congress, 5th - 8th November, Madrid, Spain |
||||
Abstract: http://www.ispor.org/congresses/Spain1111/Podiums.asp#session3 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2011 | English | , Retrospective cohort analysis | |
Economic model of granulocyte-colony stimulating factor (G-CSF) in primary (PP) and secondary prophylaxis (SP) of febrile neutropenia (FN) in Non-Hodgkin's Lymphoma (NHL) patients undergoing chemotherapy in France. | ||||
Perrier L1, Sebban C1, Leon N2, Maurel F2, Cohen-Nizard S3, De Liège F3 | ||||
1 Cancer Centre Léon Bérard, Lyon, France 2 IMS Health, Puteaux, France 4 Amgen France SAS, Neuilly-sur-Seine, France | ||||
Abstract - Presentation PCN88 for the 14th European congress of Ispor 2011 |
||||
, Abstract | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2011 | English | , Cost effectiveness | |
Cost-effectiveness of ganulocyte colony stimulating factor (G-CSF) in primary (PP) and secondary prophylaxis (SP) of febrile neutropenia (FN) in patients with stages 2 and 3 breast cancer (BC) undergoing cytotoxic chemotherapy in France. | ||||
Perrier L1, Bachelot T2, Leon N3, Maurel F3, Cohen-Nizard S4, De Liège F4 | ||||
1 Cancer Centre Léon Bérard, Lyon, France 2 Centre Léon Bérard - Inserm U590, Lyon Cedex 08, France 3 IMS Health, Puteaux, France 4 Amgen France SAS, Neuilly-sur-Seine, France | ||||
Abstract - Presentation PCN77 for the 14th European Congress of ISPOR 2011 |
||||
, Abstract | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2011 | English | , Cost effectiveness | |
Correlation between quality of life and clinical outcomes in gastric cancer. | ||||
Goldberg E, DeKoven M, Su Y, Coyle K, Chapman R, Wagner S. | ||||
IMS Health, Bristol Myers Squibb | ||||
Annals of Oncology 2011; 22(Supplement 5): v34–v35. 13th World Congress on Gastrointestinal Cancer, Barcelona, Spain, June 22-25, 2011 |
||||
, Abstract | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2011 | English | , Literature Review | |
Cost-effectiveness of Cetuximab and Bevacizumab in the first-line treatment of metastatic colorectal cancer (MCRC) for patients with KRAS wild-type tumours in the United Kingdom | ||||
Samyshkin Y1, Hertel N1, Griebsch I2 | ||||
1IMS Health, London, UK, 2Merck KGaA, Darmstadt, Germany | ||||
ISPOR 14th Annual European Congress, 5th - 8th November, Madrid, Spain |
||||
, Poster | ||||
, UK | ||||
Abstract: http://www.ispor.org/congresses/Spain1111/Posters3.aspx PCN70 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2011 | English | , Cost effectiveness | |
Modeling Early Pricing And Strategic Assessments Of Oncology Agents | ||||
Lloyd A1, Munakata J2, Tencer T3 | ||||
1 IMS Health, London, UK 2 IMS Consulting Group, Redwood City, CA, USA 3 Eisai, Inc., Woodcliff Lake, NJ, USA | ||||
ISPOR 14th Annual European Congress, 5th - 8th November, Madrid, Spain |
||||
, Workshop | ||||
Abstract: http://www.ispor.org/congresses/spain1111/workshops.asp#sessioni W2 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2011 | English | , Cost effectiveness | |
Cost Analysis: Treatment of Chemotherapy-induced Anaemia with Erythropoiesis-Stimulating Agents (ESAS) in Spain | ||||
Duran A1, Spaepen E2, Lamotte M3, Brosa M4, Gutierrez L5, Restovic G5, Annemans L6 | ||||
1IMS Health, London, UK, 2SBD Analytics BVBA/SPRL, Bekkevoort, Belgium, 3IMS Consulting Group, Vilvoorde, Belgium, 4Oblikue Consulting, Barcelona, Spain, 5Amgen S.A., Barcelona, Spain, 6Ghent University, Ghent, Belgium | ||||
ISPOR 14th Annual European Congress, 5th - 8th November, Madrid, Spain |
||||
, Poster | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2011 | English | , Cost analysis | |
Cost analysis of anaemia treatment with erythropoiesis-stimulating agents (ESAs) in cancer patients receiving chemotherapy in Italy. | ||||
Duran A1, Spaepen E2, Lamotte M3, Lucioni C4, Kutikova L5, Pujol B5, Gozzo M6, Annemans L7 | ||||
1 IMS Health, London, UK 2 SBD Analytics BVBA/SPRL, Bekkevoort, Belgium 3 IMS Consulting Group, Vilvoorde, Belgium 4 Wolters Kluwer Health Italy Ltd., Milan, Italy 5 Amgen (Europe) GmbH, Zug, Switzerland 6 Amgen Dompe S.p.A., Milan, Italy 7 Ghent University, Ghent, Belgium | ||||
14th ISPOR Annual European Congress, 2011, November 5-8, Madrid, Spain |
||||
, Abstract, Poster | ||||
, Italy | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2011 | English | , Cost analysis | |
The cost effectiveness of Cetuximab (Erbitux) in the third line treatment of metastatic colorectal cancer in the UK | ||||
Perard R1, Samyshkin Y2, Guillermin ALG2 | ||||
1Merck Serono Limited, Feltham, UK, 2IMS Health, London, UK | ||||
ISPOR 14th Annual European Congress, 5th - 8th November, Madrid, Spain |
||||
, Poster | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2011 | English | , Cost effectiveness | |
An epidemiological evaluation of chemotherapy used in the treatment of metastatic prostate cancer. | ||||
Chevalier P1, Moeremans K1 | ||||
1 IMS Health, Vilvoorde, Belgium | ||||
14th ISPOR Annual European Congress, 2011, November 5-8, Madrid, Spain |
||||
, Abstract | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2011 | English | , Epidemiological study | |
Assessing relative clinical value across tumor types in metastatic disease | ||||
Karweit J1, Nanavati S1, Van Baardewijk M2, Wagner S3, Kotapati S4 | ||||
1IMS Consulting Group, New York, NY, USA, 2Bristol-Myers Squibb, Braine L'Alleud, Belgium, 3Bristol-Myers Squibb, Princeton, NJ, USA, 4Bristol-Myers Squibb, Wallingford, CT, USA | ||||
ISPOR 14th Annual European Congress, 5th - 8th November, Madrid, Spain |
||||
, Poster | ||||
Abstract: http://www.ispor.org/congresses/Spain1111/Posters3.aspx PRM60 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2011 | English | , Literature Review | |
Value of Progression-Free Survival (PFS) in refractory Non-Small Cell Lung Cancer (NSCLC): An exploratory modeling analysis | ||||
Ferrufino CP1, Foley D2, Trochlil K1, Munakata J3 | ||||
1IMS Consulting Group, Alexandria, VA, USA, 2Boehringer Ingelheim, Ridgefield, CT, USA, 3IMS Consulting Group, Redwood City, CA, USA | ||||
ISPOR 14th Annual European Congress, 5th - 8th November, Madrid, Spain |
||||
, Poster | ||||
Abstract: http://www.ispor.org/congresses/Spain1111/Posters3.aspx PCN88 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2011 | English | , Cost effectiveness | |
The impact of advanced or metastasic Non-Small Cell Lung Cancer (NSCLC) symptoms on patient daily living and health related quality of life: final results | ||||
Artal A1, Oramas J2, Cobo M3, Domine M4, Barneto I5, Rodríguez-Abreu D6, Menendez-Ureña M7, Andrade J8, Guillot M9, Perulero N10, Castro-Gomez AJ11 | ||||
1Hospital Universitario Miguel Servet, Zaragoza, Spain, 2Hospital Universitario de Canarias, La Laguna, Santa Cruz de Te, Spain, 3Hospital Regional Universitario Carlos Haya, Malaga, Spain, 4Fundación Jiménez-Díaz, Madrid, Spain, 5Hospital Universitario Reina Sofía, Córdoba, Andalucia, Spain, 6Hospital Universitario Insular de Gran Canaria, Las Palmas de Gran Canaria, Spain, 7Hospital Universitario de Móstoles, Mostoles, Madrid, Spain, 8Complejo Hospitalario de Toledo-Hospital Virgen de la Salud, Toledo, Castilla La Manc, Spain, 9Hospital Universitari Son Espases, Palma de Mallorca, Spain, 10IMS Health, Barcelona, Spain, 11Roche Farma S.A., Madrid, Spain | ||||
ISPOR 14th Annual European Congress, 5th - 8th November, Madrid, Spain |
||||
, Poster | ||||
Abstract: http://www.ispor.org/congresses/Spain1111/Posters3.aspx PCN138 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2011 | English | , Survey research | |
The incidence and outcome of febrile neutropenia in different chemotherapy regimens for cancer patients in Belgium. | ||||
Chevalier P1, Lamotte M1, Malfait M2, Marciniak A3 | ||||
1 IMS Health HEOR, Brussels, Belgium 2 Amgen nv, Brussels, Belgium 3 Amgen Ltd, Uxbridge, UK | ||||
The European Multidisciplinary Cancer Congress, 2011, September 23-27, Stockholm |
||||
, Poster | ||||
, Belgium | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2011 | English | ||
The incidence and outcome of febrile neutropenia in different chemotherapy regimens for cancer patients in Belgium. | ||||
Chevalier P1, Lamotte M1, Malfait M2, Marciniak A3 | ||||
1 IMS Health HEOR, Vilvoorde, Belgium 2 Amgen sa/nv, Brussels, Belgium 3 Amgen Ltd, Uxbridge, UK | ||||
14th ISPOR Annual European Congress, 2011, November 5-8, Madrid, Spain |
||||
, Abstract | ||||
, Belgium | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2011 | English | ||
Surgery in patients with metastatic colorectal cancer in western Europe. | ||||
Z. Zhao, E. M. Pelletier, B. Barber, M. Bhosle, S. Wang, D. Klingman, S. K. Gao; Amgen Inc., Thousand Oaks, CA; IMS Health, Inc., Watertown, MA; IMS Health, Inc., Falls Church, VA | ||||
1Amgen Inc., Thousand Oaks, CA, USA, 2IMS Consulting, Watertown, MA, USA, 3IMS Consulting, Alexandria, VA, USA | ||||
2011 American Society of Clinical Oncology (ASCO) Annual Meeting, June 2011, Chicago, IL, USA |
||||
, Abstract | ||||
, France, Germany, Italy, Spain, UK | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2011 | English | , Retrospective database analysis | |
Metastatic renal cell carcinoma: patient characteristics, treatment patterns, and schedule compliance in clinical practice | ||||
Hess GP1, Chen CC1, Hill JW1, Liu Z2, Gesme DH3, Agarwala SS4 | ||||
1 IMS Health (formerly SDI), Plymouth Meeting, PA; SDI, 2 Novartis Pharmaceuticals, East Hanover, NJ 3 Minnesota Hem Onc, Minneapolis, MN 4 St. Luke's Hospital and Health Network, Bethlehem, PA | ||||
Kidney Cancer Journal 2011; 9(3) |
||||
, Article | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2011 | English | , Retrospective database analysis | |
Clinical burden of illness in patients with neuroendocrine tumors | ||||
Hess GP1, Chen CC1, Liu Z2, Yao JC3, Phan AT3, Hill JW1. | ||||
1 IMS Health (formerly SDI), Plymouth Meeting, US 2 Novartis Pharmaceuticals, East Hanover, NJ 3 Department of GI Medical Oncology, University of Texas M. D. Anderson Cancer Center, Houston, TX | ||||
Pancreas. 2012 Apr 17 In press |
||||
, Article | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2011 | English | , Burden of illness | |
Metastatic renal cell carcinoma: patient characteristics and recent treatment patterns in real-world practice. | ||||
Hess GP1, Chen CC1, Liu Z2, Gesme DH3, Agarwala SS4 | ||||
1 IMS Health (formerly SDI), Plymouth Meeting, PA, USA 2 Novartis Pharmaceuticals, East Hanover, NJ, USA 3 Minnesota Hem Onc, Minneapolis, MN, USA 4 St. Luke's Hospital and Health Network, Bethlehem, PA, USA | ||||
JMCP April 2011;17(3):232-272 (suppl: abstract) |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2011 | English | , Retrospective database analysis | |
Patient compliance with metastatic renal cell carcinoma treatments. | ||||
Hess GP1, Chen CC1, Liu Z2, Gesme DH3, Agarwala SS4 | ||||
1 IMS Health (formerly SDI), Plymouth Meeting, PA, USA 2 Novartis Pharmaceuticals, East Hanover, NJ, USA 3 Minnesota Hem Onc, Minneapolis, MN, USA 4 St. Luke's Hospital and Health Network, Bethlehem, PA, USA | ||||
JMCP April 2011;17(3):232-272 (suppl: abstract) |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2011 | English | , Retrospective database analysis | |
Risk of treatment failure after first-line tyrosine kinase inhibitors (TKI) therapy in patients with metastatic renal cell carcinoma | ||||
Hess GP1, Chen CC1, Liu Z2, Gesme DH3, Agarwala SS4, Hill JW1 | ||||
1 IMS Health (formerly SDI), Plymouth Meeting, PA, USA 2 Novartis Pharmaceuticals, East Hanover, NJ, USA 3 Minnesota Hem Onc, Minneapolis, MN, USA 4 St. Luke's Hospital and Health Network, Bethlehem, PA, USA | ||||
J Clin Oncol 29: 2011 (suppl; abstr e15114) |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2011 | English | , Retrospective database analysis | |
Patient Compliance with Metastatic Renal Cell Carcinoma Treatments | ||||
Hess GP, Chen C, Liu Z, Gesme DH, Agarwala SS | ||||
IMS Health (formerly SDI Health),Plymouth Meeting, PA,USA | ||||
AMCP's 23rd Annual Meeting April 27-29, 2011. |
||||
, Abstract | ||||
, USA | ||||
Abstract: http://www.amcp.org/WorkArea/DownloadAsset.aspx?id=8975 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2011 | English | , Retrospective database analysis | |
Metastatic Renal Cell Carcinoma: Patient Characteristics and Recent Treatment Patterns in Real-World Practice | ||||
Hess GP, Chen C, Liu Z, Gesme DH, Agarwala SS | ||||
IMS Health (formerly SDI Health), Plymouth Meeting, PA, USA | ||||
AMCP's 23rd Annual Meeting April 27-29, 2011 |
||||
, Abstract | ||||
, USA | ||||
Abstract: http://www.amcp.org/WorkArea/DownloadAsset.aspx?id=8975 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2011 | English | , Retrospective database analysis | |
Health resource utilization and costs associated with gastric cancer: results from a US claims database. | ||||
Knopf K1, Smith D2, Doan J3, Munakata J4 | ||||
1 California Pacific Medical Center, San Francisco, CA, US 2 IMS Consulting Group, Watertown, MA, US 3 Genentech Inc., South San Francisco, CA, US 4 IMS Consulting Group, Redwood City, US | ||||
The European Multidisciplinary Cancer Congress, 2011, September 23-27, Stockholm |
||||
, Poster | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2011 | English | , Retrospective database analysis | |
Estimating the economic burden of gastric cancer. | ||||
Knopf KB1, Smith DB2, Doan JF3, Munakata J4 | ||||
1 California Pacific Medical Center, San Francisco, CA, US 2 IMS Consulting Group, Watertown, MA, US 3 Genentech Inc., South San Francisco, CA, US 4 IMS Consulting Group, Redwood City, CA, US | ||||
J Clini Oncol, 2011, 29:(suppl; abstr e16589) |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2011 | English | , Retrospective database analysis | |
An epidemiological evaluation of chemotherapy used in the treatment of metastatic prostate cancer. | ||||
Chevalier P1, Moeremans K1 | ||||
1 IMS Consulting Group, Vilvoorde, Belgium | ||||
14th ISPOR Annual European Congress, 2011, November 5-8, Madrid, Spain |
||||
, Abstract, Poster | ||||
, Belgium | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2011 | English | ||
Iron deficiency anaemia and delayed diagnosis of colorectal cancer: a retrospective cohort study. | ||||
Damery S, Ryan R, Wilson S, Ismail T, Hobbs R. | ||||
Colorectal Dis. 2011 Apr;13(4):e53-60. doi: 10.1111/j.1463-1318.2010.02488.x. |
||||
, Article | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/21054747 | ||||
Condition | Year | Language | Analysis type | |
, Hematology, Oncology | 2011 | English | ||
Linking cancer registry records to THIN - a UK general practice database. | ||||
Marshall T, Dattani H, Thompson M, Bourke A, Pinder L & Blak BT | ||||
Cegedim | ||||
27th International conference on pharmacoepidemiology & therapeutic risk management (ICPE) Chicago, USA |
||||
, Poster | ||||
, UK | ||||
Abstract: http://csdmruk.cegedim.com/THINBibliography.pdf | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2011 | English | , Retrospective database analysis | |
The distribution of lung cancer across sectors of society in the United Kingdom: a study using national primary care data. | ||||
2Iyen OB, Hubbard RB, Smith CJ, Sparks E, Bradley E, 1Bourke A & Tata LJ | ||||
1Cegedim 2Division of Epidemiology and Public health, University of Nottingham, Clinical Sciences Building, City Hospital, Nottingham, NG5 1PB, UK | ||||
BMC Public Health 2011, 11:857 |
||||
, Article | ||||
, UK | ||||
Abstract: http://www.biomedcentral.com/1471-2458/11/857 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2011 | English | , Retrospective database analysis | |
The Use of Large GPs Longitudinal Database in the Reasearch of Causal Associations Among Pathologies: The Case of Diabetes and Cancer Incidence. | ||||
Katz P, Ripellino C., Heiman F., Chatenoud F. | ||||
Value in Health. 11/2011; 14(7). DOI: 10.1016/j.jval.2011.08.1293 |
||||
, Article | ||||
Abstract: http://www.researchgate.net/publication/238509387_PCN194_The_Use_of_Large_GPs_Longitudinal_Database_in_the_Reasearch_of_Causal_Associations_Among_Pathologies_The_Case_of_Diabetes_and_Cancer_Incidence | ||||
Condition | Year | Language | Analysis type | |
, Diabetes, Oncology | 2011 | English | ||
Chemotherapy Relative Dose Intensity Among Older (>65) and Younger (<65) Patients with Non-Hodgkin Lymphoma Recieving CHOP+R | ||||
Whittaker, S., Abella, S., Schwartzberg, L., Saleh, M. | ||||
Blood, 2011 |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2011 | English | , Retrospective database analysis | |
The Problem of Missing Data: Using Imputation Methods to Facilitate Oncology Outcomes Research | ||||
Lau, E.C., Legg, J.C., Watson, H.N., Steffey, D.L., Mowat, F.S., Kelsh, M.A. | ||||
ICPE, 2011 |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2011 | English | , Retrospective database analysis | |
Assessing the Comparability of EMR Information to Patient Registry and Health Claims Data | ||||
Mowat, F.S., Lau, E.C., Kelsh, M.A., Legg, J.C., Engel-Nitz, N.M., Watson, H.N., Collins, H.L., Nordyke, R.J., Whyte, J.L. | ||||
ICPE, 2011 |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2011 | English | , Retrospective database analysis | |
A Validation Study of Algorithms for Identifying Metastatic Breast, Lung, or Colorectal Cancer in Administrative Claims Data | ||||
Whyte, J.L., Engel-Nitz, N., Teitelbaum, A., Gomez-Rey, G., Kallich, J. | ||||
Value in Health, 14(3):A6, 2011 |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2011 | English | , Retrospective database analysis | |
Use of Electronic Medical Records (EMR) for Oncology Outcomes Research: Assessing the Comparability of EMR Information to Patient Registry and Health Claims Data | ||||
Lau, E. L., Mowat, F. S., Kelsh, M. A., Legg, J., Enge-Nitz, N. M., Watson, H. N., Collins, H., Nordyke, R. J., Whyte, J. L. | ||||
Clinical Epidemiology |
||||
, Abstract | ||||
, USA | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3224632/ | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2011 | English | , Retrospective database analysis | |
Hemoglobin Trends and Anemia Treatment Due To Concomitant Chemotherapy in Community Oncology Clinics | ||||
Feinberg, B., Gilmore, A., Haislip, S., Gilmore, J., Jain, G., Whyte, J. | ||||
Journal of Oncology Practice |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2011 | English | , Retrospective database analysis | |
Chemotherapy Relative Dose Intensity Among Older (>65) and Younger (<65) Patients with Non-Hodgkin Lymphoma Receiving CHOP+/-R | ||||
Whittaker, S., Abella, S., Schwartzberg, L., Saleh, M. | ||||
Blood |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2011 | English | , Retrospective database analysis | |
Rate of Hemoglobin Decline in Patients Receiving Chemotherapy Without an Erythropoiesis-Stimulating Agent in the United States Community Setting | ||||
Pirolli, M., Collins, H., Quigley, J., Hulnick, S. | ||||
European Journal of Cancer |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2011 | English | , Retrospective database analysis | |
The Problem of Missing Data: Using Imputation Methods to Facilitate Oncology Outcomes Research | ||||
Lau, E. C., Legg, J. C., Watson, H. N., Steffey, D. L., Mowat, F. S., Kelsh, M. A. | ||||
ICPE |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2011 | English | , Retrospective database analysis | |
Assessing the Comparability of EMR Information to Patient Registry and Health Claims Data | ||||
Mowat, F. S., Lau, E. C., Kelsh, M. A., Legg, J. C., Engel-Nitz, N. M., Watson, H. N., Collins, H. L., Nordyke, R. J., Whyte, J. L. | ||||
ICPE |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2011 | English | , Retrospective database analysis | |
Rate of Hemoglobin Decline from <10 G/Dl to <9 G/Dl by Electronic Medical-Record (EMR) Evaluation in Community Oncology Patients Receiving Chemotherapy in the Absence of ESA Treatment | ||||
Pirolli, M., Collins, H., Quigley, J., Hulnick, S. | ||||
ASCO |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2011 | English | , Retrospective database analysis | |
Synchronization of Administrations of Chemotherapy and Erythropoiesis-Stimulating Agents and Frequency of Associated Health Care Visits | ||||
Hill, J., Shreay, S., McGarvey, N., De, A. P., Hess, G., Corey-Lisle, P. | ||||
Value in Health, 14(3):A75 |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2011 | English | , Retrospective database analysis | |
Use of Electronic Medical Records (EMR) for Oncology Outcomes Research: Assessing the Comparability of EMR Information to Patient Registry and Health Claims Data | ||||
Lau, E. L., Mowat, F. S., Kelsh, M. A., Legg, J., Engel-Nitz, N. M., Watson, H. N., Collins, H., Nordyke, R. J., Whyte, J. L. | ||||
Value in Health, 14(3):A178 |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2011 | English | , Retrospective database analysis | |
A Validation Study of Algorithms for Identifying Metastatic Breast, Lung, or Colorectal Cancer in Administrative Claims Data | ||||
Whyte, J. L., Engel-Nitz, N., Teitelbaum, A., Gomez-Rey, G., Kallich, J. | ||||
Value in Health, 14(3):A6 |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2011 | English | , Retrospective database analysis | |
Development of Algorithms to Identify Metastatic Cancer in Claims Data, Using Oncology EMR Data | ||||
Nordstrom, B., Whyte, J., Kallich, J. | ||||
AHRQ Symposium on Research Methods for Comparative Effectiveness and Patient-Centered Outcomes Research |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2011 | English | , Retrospective database analysis | |
Analisi di budget impact sull’utilizzo di pegfilgrastim nella profilassi della neutropenia febbrile in Italia. | ||||
Rosti G1, Lebboroni M1, Cerchiari A2, Katz P3. | ||||
1 Oncologia Medica, Ospedale Regionale, Azienda Unità Locale Socio Sanitaria n°9 di Treviso, 2 Amgen Dompè SpA, Italia, 3 CSD Medical Research Srl, Italia | ||||
Farmeconomia e percorsi terapeutici. 12(3). 119-127. |
||||
, Article | ||||
, Italy | ||||
Condition | Year | Language | Analysis type | |
, Health economics, Oncology | 2011 | Italian | , Budget impact | |
The use of large GPs longitudinal database in the research of causal associations among pathologies : the case of diabetes and cancer incidence | ||||
Katz P 1, Ripellino C 1, Heiman F 1, Chatenoud L. 2 | ||||
1 CSD Medical Research srl, Milan, Italy, 2 Istituto di Ricerche Farmacologiche, Milan, Italy | ||||
ISPOR Annual European Congress, Madrid, 2011 |
||||
, Poster | ||||
, Italy | ||||
Condition | Year | Language | Analysis type | |
, Diabetes, Oncology | 2011 | English | , Retrospective database analysis | |
Observations of hepatocellular carcinoma (HCC) management patterns from the multinational HCC BRIDGE study: First overall analysis of the North American cohort | ||||
Roberts L, Sherman M, Castel H, Schwartz M, Therneau T, Huang B, Orsini LS | ||||
American Association for Study of Liver Diseases. Nov 2011. San Francisco, CA |
||||
, Abstract | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2011 | English | , RWLPR (Real-World Late Phase Research-quintiles | |
Observed patterns of systemic therapy use in hepatocellular carcinoma (HCC) patients from the multinational HCC BRIDGE study: An initial analysis | ||||
Roberts L, Colombo M, Schwartz M, Degos F, Sherman M, Chen PJ, Chen M, Park JW, Kudo M, Johnson O, Therneau T, Huang B, Orsini, LS | ||||
International Liver Cancer Association. Sept 2011. Hong Kong |
||||
, Abstract | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2011 | English | , RWLPR (Real-World Late Phase Research-quintiles | |
Observations of hepatocellular carcinoma (HCC) management patterns from the multinational HCC BRIDGE study: An interim analysis | ||||
Sherman M, Colombo M, Roberts L, Schwartz M, Degos F, Chen PJ, Chen M, Park JW, Kudo M, Johnson P, Therneau T, Huang B, Orsini LS | ||||
International Liver Cancer Association. Sept 2011. Hong Kong |
||||
, Abstract | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2011 | English | , RWLPR (Real-World Late Phase Research-quintiles | |
Advancing performance measurement in oncology: quality oncology practice initiative participation and quality outcomes | ||||
Campion FX, Larson LR, Kadlubek PJ, Earle CC, Neuss MN | ||||
J Oncol Pract 2011; 7(3s):31s-35s |
||||
, Article | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2011 | English | , RWLPR (Real-World Late Phase Research-quintiles | |
Design and rationale of the HCC BRIDGE study in China: a longitudinal, multicenter cohort trial in hepatocellular carcinoma. | ||||
Chen M1, Therneau T, Orsini LS, Qiao YL. | ||||
Department of Hepatobiliary Surgery, Sun Yat-Sen University Cancer Center, Guangdong Province, China | ||||
BMC Gastroenterol. 2011 May 12;11:53 |
||||
, Article | ||||
, China | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3115904/ | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2011 | English | , Clinical setting: hospital, Retrospective cohort analysis | |
Oncology Market Research Provides a Feasible Index for Standardization of Colorectal Cancer Chemotherapy. | ||||
Inoue Y, Toiyama Y, Tanaka K, Uchida K, Mohri Y, Kusunoki M | ||||
1 Department of Gastrointestinal and Pediatric surgery,2 Division of reparative medicine, 3 Institute of Life Sciences,4Mie University Graduate school of Medicine, Mie, Japan, 4 IMS Health Oncology, Fairfield, CT, USA | ||||
Japanese journal of clinical oncology, 2011, 41(10):1203-1208 |
||||
, Book chapter | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2011 | English | , Cost effectiveness, Database Study, Retrospective database analysis | |
Metagenes Associated with Survival in Non-Small Cell Lung Cancer | ||||
Urgard E, Vooder T,Võsa U, Välk K, Liu M,Luo C, Hoti F, Roosipuu R, Annilo T, Laine J, Frenz CM, Zhang L, Metspalu A | ||||
Department of Information and Computer Science, Aalto University School of Science, Otakaari 1, FI-02150 Espoo, Finland | ||||
Stat Med |
||||
, Article | ||||
, Estonia | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3118451/ | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2011 | English | ||
Cost-effectiveness analysis of pemetrexed versus docetaxel in the second-line treatment of non-small cell lung cancer in Spain: results for the non-squamous histology population. | ||||
Asukai Y1, Valladares A2, Camps C3, Wood E1, Taipale K4, Arellano J4, Cassinello A2, Sacristan JA2, Dilla T2. | ||||
1 IMS Health, London, UK 2 Eli Lilly SA, Madrid, Spain 3 Hospital General Universitario, Valencia, Spain 4 Eli Lilly, Windlesham, Surrey, UK | ||||
BMC Cancer. 2010 Jan 29;10:26 |
||||
, Article | ||||
, Spain | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/20113499 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2010 | English | , Cost effectiveness | |
Cost effectiveness of cetuximab in 1st-line treatment of metastatic colorectal cancer in the UK | ||||
Griebsch I1, Eggington S2, Garrell D3, Samyshkin Y2 | ||||
1 Merck KGaA, Darmstadt, Germany; 2 IMS Health, London, UK; 3 Merck Serono UK, Middlesex, UK | ||||
ASCO Gastrointestinal symposium, Orlando, Florida 22-24 January 2010 |
||||
, Poster | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2010 | English | , Cost effectiveness | |
[Pegfilgrastim vs filgrastim in primary prophylaxis of febrile neutropenia in patients with breast cancer after chemotherapy: a cost-effectiveness analysis for Germany] | ||||
Sehouli J1, Goertz A1, Steinle T1, Dubois R1, Plesnila-Frank C2, Lalla A1, von Minckwitz G1 | ||||
1 Charité/Campus Virchow-Klinikum, Klinik für Gynäkologie, Universitätsmedizin Berlin, Berlin, Germany 2 IMS Health GmbH & Co. OHG, Munich, Germany | ||||
Deutsche medizinische Wochenschrift 2010 Mar, 135(9): 385-9 |
||||
, Article | ||||
, Germany | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/20180162 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2010 | German | , Cost effectiveness | |
Krebsinzidenz bei insulinpflichtigen Diabetikern in Deutschland – eine Analyse der Publikation von Hemkens et al. anhand der STROBE-Qualitätskriterien [Cancer incidence for insulin-dependent diabetics in Germany - an analysis of the publication of Hemkens et al. based on the STROBE criteria] | ||||
Fuchs S1, Fricke F-U1,2, Pirk O1 | ||||
1 IMS Health GmbH & Co. OHG, Nuremberg, Germany 2 Georg Simon Ohm University, Nuremberg, Germany | ||||
Perfusion 2010; 23: 4-10 |
||||
, Article | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Diabetes, Oncology | 2010 | German | , Literature Review | |
Cost effectiveness of cetuximab in 1st-line treatment of metastatic colorectal cancer in the UK: A summary of the submission to NICE | ||||
Griebsch I1, Samyshkin Y2, Eggington S2, Garrell D3 | ||||
1 Merck Serono, Germany 2 IMS Health HEOR, London UK 3 Merck Serono, UK | ||||
12th World Congress on Gastrointestinal Cancer, Barcelona 30 June - 3 July 2010 |
||||
, Poster | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2010 | English | , Cost effectiveness | |
Cost-utility analysis of Dasatinib as a second-line treatment in the chronic phase of Chronic Myeloid Leukaemia in Russia | ||||
Kuznetzov SV1, Mungapen L2, Samyshkin Y2, Jakouloff D3, Sbarigia U4, van Baardewijk M4 | ||||
1 Haematology Research Centre, Russian Academy of Medical Sciences (RAMN), Moscow, Russia 2 IMS Health, London, UK 3 BMS Russia, Moscow, Russia 4 BMS Europe, Belgium | ||||
ISPOR 13th Annual European Congress, 6-9 November 2010, Prague, Czech Republic |
||||
, Poster | ||||
, Russian Federation | ||||
Abstract: http://www.ispor.org/Events/Index.aspx?eventId=33 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2010 | English | , Cost utility | |
Outcomes and costs of Nanoparticle Albumin-bound(NAB) Paclitaxel compared to Docetaxel in women with pretreated metastatic breast cancer. | ||||
Donatti CM1, McLeod E1, Lloyd A1, Prunièras FJ2 | ||||
1 Health Economics & Outcomes Research, IMS Health, London, UK 2 Pricing and Reimbursement, Abraxis Bioscience, Paris, France | ||||
International Society for Quality of Life Research, 17th Annual Conference, October 27-30, 2010, Hilton Metropole, London, England |
||||
, Poster | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2010 | English | , Cost benefit | |
Indirect comparison and UK cost-effectiveness analysis of paclitaxel albumin vs docetaxel for pretreated metastatic breast cancer | ||||
Prunieras F1, McLeod E2, Lloyd A2, Canney P3 | ||||
1Abraxis Bioscience, Paris, France 2 IMS Health, London, UK, 3 Glasgow, UK | ||||
35th ESMO Congress, 8-12 October 2010, Milan, Italy |
||||
, Poster | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2010 | English | , Cost effectiveness | |
A UK Cost-Utility Analysis of Paclitaxel Albumin compared to solvent-based Paclitaxel Monotherapy and Docetaxel Monotherapy for pretreated Metastatic Breast Cancer (Mbc) | ||||
McLeod EJ1, Lloyd A1, Samyshkin Y1, Prunièras F2, Canney P3 | ||||
1IMS Health, London, UK, 2Abraxis Bioscience, Paris, France, 3Beatson West of Scotland Cancer Centre, Glasgow, UK | ||||
ISPOR 13th Annual European Congress, 6-9 November 2010, Prague, Czech Republic |
||||
, Poster | ||||
, UK | ||||
Abstract: http://www.ispor.org/congresses/Prague1110/posters1.aspx | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2010 | English | , Cost utility | |
Quality of life, outcomes and costs in the Belgian population receiving 90Y-Zevalin for non-hodgkin lymphoma: a study for reimbursement revision. | ||||
Caekelbergh K, Moeremans K | ||||
IMS Health Consulting, Brussels, Belgium | ||||
ISPOR 13th Annual European Congress, 2010, November 6-9, Prague, Czech Republic |
||||
, Abstract | ||||
, Belgium | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2010 | English | , Quality of life | |
Change of antifungal tretment patterns and associated costs in patients with acute myelogenous leukemia (AML) after chemotherapy in a german hospital from 2004 to 2006 | ||||
Boehme A1, Atta J1, Mousset S1, Steffen B1, Serve H1, Hoelzer D1, Shlaen R2, Ehlken B2, Bug G1 | ||||
1 Med Clinic II, J.W. Goethe-University, Frankfurt, Germany, 2 IMS Health GmbH & Co. OHG, Munich, Germany | ||||
ISPOR 13th Annual European Congress, 6-9 Nov., 2010, Prague, Czech Republic |
||||
, Abstract | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2010 | English | , Retrospective cohort analysis | |
Cost-utility analysis of dasatinib as a second line treatment in the chronic phase of chronic myeloid leukaemia in Russia | ||||
Kuznetzov S1, Mungapen L2, Samyshkin Y2, Jakouloff D3, Sbarigia U4, van Baardewijk M4 | ||||
1 Haematology Research Centre, Moscow, Russia, 2 IMS Health, London, UK, 3 BMS, Moscow, Russia, 4 BMS, Braine L’Alleud, Belgium | ||||
ISPOR 13th Annual European Congress, 6-9 November 2010, Prague Congress Centre, Prague, Czech Republic. |
||||
, Poster | ||||
, Russian Federation | ||||
Condition | Year | Language | Analysis type | |
, Hematology, Oncology | 2010 | English | , Cost utility | |
Real-Life Cost Analysis of Anemia Treatment with Erythropoiesis Stimulating Agents In Cancer Patients Receiving Chemotherapy | ||||
Duran A1, Spaepen E2, Lamotte M3, Walter E4, Kutikova L5, Pujol B5, Annemans L6 | ||||
1 IMS Health, London, UK; 2 SBD Analytics BVBA/SPRL, Belgium; 3 IMS Health, Brussels, Belgium; 4 Institut fuer Pharmacoekonomische Forschung, Vienna, Austria; 5 Amgen (Europe) GmbH, Zug, Switzerland; 6 I-CHER Interuniversity Centre for Health Economics Research, Gent, Belgium | ||||
American Society of Hematology. December 4-7, 2010 Orlando, FL. USA |
||||
, Poster | ||||
, Austria | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2010 | English | , Cost analysis | |
The use of chemotherapy regimens carrying a moderate or high risk of febrile neutropenia and the corresponding management of febrile neutropenia: an expert survey in breast cancer and non-Hodgkin's lymphoma. | ||||
Gerlier L1, Lamotte M1, Awada A2, Bosly A3, Bries G4, Cocquyt V5, Focan C6, Henry S7,8, Lalami Y2, Machiels JP9, Mebis J10, Straetmans N11, Verhoeven D12, Somers L13 | ||||
1 IMS Health Consulting, Vilvoorde Belgium 2 Jules Bordet Institute, Brussels, Belgium 3 University Hospital of Mont-Godinne, Yvoir, Belgium 4 Virga Jesse Hospital, Hasselt, Belgium 5 University Hospital Ghent, Gent, Belgium 6 CHC-Saint-Joseph Clinic, Liège, Belgium 7 University Hospital of Mont-Godinne, Yvoir, Belgium 8 Sainte-Elisabeth Clinic, Namur, Belgium 9 UCL Saint-Luc University Hospital, Brussels, Belgium 10 Virga Jesse Hospital, Hasselt, Belgium 11 Jolimont Hospital, Haine-Saint-Paul, Belgium 12 AZ Klina, Brasschaat, Belgium 13 OncoLogX, Wuustwezel, Belgium | ||||
BMC Cancer, 2010, 10:642 |
||||
, Article | ||||
, Belgium | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2010 | English | , Survey research | |
Cost Evaluation study of oral treatment with Xeloda and Tarceva compared to intravenous chemotheraphy from the perspective of a Spanish private insurance company | ||||
Benito A1, Caballo B2, Gomez J2, Moyano N3, Gimenez E4, Prior M4. | ||||
1 Mapfre Familiar, 2 H. U.Madrid Sanchinarro, 3Hospital QuirónMadrid, 4 IMS Health, barcelona, Spain | ||||
Revista Española Economía de la Salud 2010;9(1):28-36 |
||||
, Article | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2010 | Spanish | , Economic evaluation | |
Clinical and economic burden of toxicities associated with monoclonal antibodies for metastatic colorectal cancer (MCRC). | ||||
Burudpakdee C, Zhao Z, Trochlil K, Gao S, Munakata J, Barber B | ||||
The 35th ESMO Congress, 2010, October 8-12, Milan |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2010 | English | , Cost analysis | |
Systematic Therapy for Metastatic Colorectal Cancer: Patterns of Chemotherapy and Biologic Therapy Use in US Medical Oncology Practice | ||||
Hess, G. P., Wang, P. F., Quach, D., Barber, B., Zhao, Z. | ||||
Journal of Oncology Practice, 6(6):301-307 |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2010 | English | , Retrospective database analysis | |
Real-World Use of Granulocyte Colony-Stimulating Factor Support with CHOP+/-R Therapy for Non-Hodgkin's Lymphoma | ||||
Campomayor, C., Jurss, L. | ||||
The Journal of Supportive Oncology, 8(5):A12 |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2010 | English | , Retrospective database analysis | |
Clinical Practice Use of Absolute Neutrophil Count Monitoring with Chemotherapy | ||||
Barron, R. L., Pirolli, M., Hess, G., Quach, D., Quigley, J. M., Hill, J. | ||||
JMCP |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2010 | English | , Retrospective database analysis | |
Hemoglobin Trends Among Patients with Anemia with Concomitant Chemotherapy in the Community Oncology Clinic Setting | ||||
Feinberg, B., Gilmore, A., Haislip, S., Gilmore, J., Jain, G., Whyte, J. | ||||
Supportive Care in Cancer, 18:S138 |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2010 | English | , Retrospective database analysis | |
Trends in Erythropoiesis-Stimulating Agents (ESAs) Utilization and Hemoglobin (Hb) Levels Among Cancer Patients Undergoing Chemotherapy (2006-2008) | ||||
Hill, J., Cong, Z., Hess, G., Nordyke, R. | ||||
Supportive Care in Cancer, 18:S138-9 |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2010 | English | , Retrospective database analysis | |
Incidence of cancer in the general population and in patients with or without atopic dermatitis in the U.K. | ||||
Arana A, Wentworth CE, Ferna´ndez-Vidaurre C, Schlienger RG, Conde E & Arellano F | ||||
Risk Management Resources, Pharmacovigilance Services SL, Spain | ||||
Br J Dermatol. 2010 Nov;163(5):1036-43. doi: 10.1111/j.1365-2133.2010.09887.x. |
||||
, Abstract | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/20545690 | ||||
Condition | Year | Language | Analysis type | |
, Dermatology, Oncology | 2010 | English | , Retrospective database analysis | |
Incidence rates of edema in solid tumor cancer patients in the THIN Database. | ||||
Gastanaga V, Wenstowrth C, Ganesh V, Hughes G, Xue F, Verma M, Dimery I & Zhao S | ||||
Amgen | ||||
Pharmacoepidemiol Drug Saf. 2010 Aug;19:S1-S347 |
||||
, Abstract, Poster | ||||
, UK | ||||
Abstract: https://www.sd.imshealth.com/SiteCollectionDocuments/Medical%20Research%20Scientific%20Publications/CSDScientificPublications_2014.pdf? | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease, Oncology | 2010 | English | , Retrospective database analysis | |
Incidence rates of retinal artery thrombosis in solid tumor cancer patients in the THIN Database | ||||
Gastanaga V, Wentworth C, Hughes G, Xue F, Ganesh V, Verma M, Dimery I & Zhao S | ||||
Amgen | ||||
Pharmacoepidemiol Drug Saf. 2010 Aug;19:S1-S347. |
||||
, Abstract, Poster | ||||
, UK | ||||
Abstract: https://www.sd.imshealth.com/SiteCollectionDocuments/Medical%20Research%20Scientific%20Publications/CSDScientificPublications_2014.pdf? | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease, Oncology, Ophthalmology | 2010 | English | , Retrospective database analysis | |
Lymphoma among patients with atopic dermatitis treated with topical corticosteroids and/or topical calcineurin inhibitors | ||||
Arana A, Wentworth CW, Rivero E, Plana E & Conde E | ||||
Risk MR Pharmacovigilance Services, Zaragoza, Spain | ||||
Journal of American academy of dermatology 2010 |
||||
, Abstract | ||||
, UK | ||||
Abstract: http://www.jaad.org/article/S0190-9622(10)01118-7/abstract | ||||
Condition | Year | Language | Analysis type | |
, Dermatology, Oncology | 2010 | English | , Retrospective database analysis | |
Explorative analysis about the potential of a large GPs longitudinal database on searching causal associations among pathologies | ||||
Katz P, Heiman F. | ||||
CSD Medical Research srl | ||||
ISPOR Annual European Congress, Prague, 2010 |
||||
, Poster | ||||
, Italy | ||||
Condition | Year | Language | Analysis type | |
, Diabetes, Oncology | 2010 | English | , Retrospective database analysis | |
Capturing breast cancer patients experience beyond disease progression: Implementation of a patient-reported outcome (PRO) substudy in the VIRGO metastatic breast cancer observational cohort study | ||||
Kaufman PA, Dreyer NA, Mayer M, Sloan JA, Chung CY, Sing A, Yim YM, Yu E, Mathias SD, Cleeland CS | ||||
ASCO. June, 2010 |
||||
, Abstract | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2010 | English | , RWLPR (Real-World Late Phase Research-quintiles | |
NICE implementation uptake report: The diagnosis and treatment of lung cancer. | ||||
IMS | ||||
NICE Guidance |
||||
, Article | ||||
, UK | ||||
Abstract: http://www.nice.org.uk/media/8E2/8C/UptakeReportLungCancerFinal.pdf | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2010 | English | , Retrospective database analysis | |
Reasons for discontinuation of hormonal therapy in breast cancer patients across five european countries. | ||||
Petrilla AA, Ferrufino | ||||
CPIMS Health, Falls Church, VA, USA | ||||
ISPOR 13th Annual European Congress |
||||
, Poster | ||||
Abstract: http://www.ispor.org/research_pdfs/36/pdffiles/PCN157.pdf | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2010 | English | , Retrospective database analysis | |
Incidence of cancer and statin usage—record linkage study | ||||
Haukka J, Sankila R, Klaukka T, Lonnqvist J, Niskanen L, Tanskanen A, Wahlbeck K, Tiihonen J | ||||
Data Analysis and Interpretation Group, International Agency for Research on Cancer, Helsinki, Finland | ||||
International Journal of Cancer (2010); 126(1):279-84 |
||||
, Article | ||||
, Finland | ||||
Abstract: https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.24536 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2010 | English | , Epidemiological study, Population Based Study, Retrospective cohort analysis | |
Incidence of cancer and antidepressant medication: Record linkage study | ||||
Haukka J, Sankila R, Klaukka T, Lonnqvist J, Niskanen L, Tanskanen A, Wahlbeck K, Tiihonen J | ||||
Data Analysis and Interpretation Group, International Agency for Research on Cancer, Helsinki, Finland | ||||
International Journal of Cancer (2010);126(1):285-96 |
||||
, Article | ||||
, Finland | ||||
Abstract: https://onlinelibrary.wiley.com/doi/full/10.1002/ijc.24537 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2010 | English | , Epidemiological study, Population Based Study, Retrospective database analysis | |
Epidemiologic study to assess patients' involvement with adjuvant chemotherapy in breast cancer (PROSA study). | ||||
Tusquets I1, Espinosa Arranz E2, Méndez M3, JM Gil4, Guayar JL5, Perulero N6. | ||||
1 Servicio de Oncología, Hospital de Mar, Barcelona, Spain 2 Servicio de Oncología, Hospital de la Paz, Madrid, Spain 3 Servicio de Oncología, Hospital de Móstoles, Madrid, Spain 4 Institut Català de Oncologa- hospital Duran i Reynals, L’Hospitalet, Spain 5 Sanofi-Aventis, Barcelona, Spain 6 IMS Health, HEOR Barcelona, Spain | ||||
Clin Transl Oncol. 2009;11(4):221-7. |
||||
, Article | ||||
, Spain | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/19380299 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2009 | English | , Epidemiological study | |
Cost-effectiveness of Rituximab combined with Fludarabine and Cyclophosphamide in previously untreated patients with Chronic Lymphocytic Leukemia in France | ||||
Roussel M1, Troussard X2, Delmer A3, Poinso M4, Miadi-Fargier H5 | ||||
1 Roche, Neuilly-sur-Seine, France 2 Clémenceau Hospital, Haematology department, Caen, France 3 Robert Debré Hospital, Haematology department, Reims, France 4 IMS Health HEOR, Puteaux, France | ||||
ISPOR 12th Annual European Congress, Paris, France, 24-27 October 2009 |
||||
, Poster | ||||
, France | ||||
Abstract: http://www.ispor.org/congresses/paris1009/Posters1.aspx | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2009 | English | , Cost effectiveness | |
Mobilization with chemotherapy compared to G-CSF alone: an analysis of resource use and cost in autologous stem cell transplant patients. | ||||
Pelletier EM1, Smith PJ1, Dembek CJ2. | ||||
1IMS Health, Watertown, MA, USA, 2Genzyme Corporation, Cambridge, MA, USA | ||||
BMT Tandem Meeting, 2009, February 11-15, Tampa, FL, US |
||||
, Abstract, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2009 | English | , Cost analysis | |
Cost effectiveness of Cetuximab in first line treatment of metastatic colorectal cancer: description of a NICE submission | ||||
Eggington SG1, Garrell D2, Griebsch I3, Samyshkin Y1 | ||||
1IMS Health, London, UK, 2Merck Serono UK, Feltham, UK, 3Merck KGaA, Darmstadt, Germany | ||||
ISPOR 12th Annual European Congress, Paris France, 24-27 October 2009 |
||||
, Poster | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2009 | English | , Cost effectiveness | |
Cost-effectiveness analysis of Pemetrexed/Cisplatin in the first-line treatment of non-small cell lung cancer in Italy: results for the Adenocarcinoma histology sub-population | ||||
Guidi L1, Malik S2, Valle D1, Asukai Y2, Taipale K3 | ||||
1Eli Lilly Italia S.p.A., Firenze, Italy, 2IMS Health, London, UK, 3Eli Lilly and Company, Lilly Research Centre, Windlesham, UK | ||||
ISPOR 12th Annual European Congress, 24th – 27th October 2009, Paris, France |
||||
, Poster | ||||
, Italy | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2009 | English | , Cost effectiveness | |
Cost utility analysis of 90y-Ibritumomab Tiuxetan following first-line chemotherapy compared to no follow-up in patients with stage III or IV follicular lymphoma in Spain | ||||
Eggington S1, Piñol C2, Musi E3, Valderrama A4 | ||||
1IMS Health, London, Camden, UK, 2Bayer HealthCare, Barcelona, Spain, 3Bayer HealthCare, Sant Joan Despí (Barcelona), Catalonia, Spain, 4Bayer Healthcare Pharmaceuticals Inc, Pine Brook, NJ, USA | ||||
ISPOR 12th Annual European Congress, 24th – 27th October 2009, Paris, France |
||||
, Poster | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2009 | English | , Cost utility | |
The bone metastases quality of life questionnaire (BOMET-QoL. In: Preedy VR and Watson RR. Handbook of Disease Burdens and Quality of Life Measures. | ||||
Badia X, Vieta A, Gilabert M. | ||||
Badia X1, Vieta A1, Gilabert M2. 1 IMS Health HEOR Spain 2 Novartis Oncology, Spain | ||||
New York: Springer 2009;Part 1:195-207 |
||||
, Book chapter | ||||
Abstract: http://www.springerlink.com/content/r23j12761mm36354/ | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2009 | English | , , Burden of illness, Quality of life | |
Cost-effectiveness analysis of Pemetrexed in the first-line treatment of non-small cell lung cancer in Italy: Results for the adenocarcinoma histology sub-population | ||||
Guidi L1, Malik S2, Valle D1, Asukai Y2, Taipale K3 | ||||
1Eli Lilly Italia S.p.A., 2IMS Health, London, UK, 3Eli Lilly and Company, Lilly Research Centre, UK | ||||
ISPOR 12th Annual European Congress, 24th - 27th October 2009, Paris, France |
||||
, Poster | ||||
, Italy | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2009 | English | , Cost effectiveness | |
Custo do tratamento do cancro em Portugal. [Cost of cancer care in Portugal]. | ||||
Araújo A1, Barata F2, Barroso S3, Cortes P4, Damasceno M5, Parreira A6, Espírito Santo J7, Teixeira E8, Pereira R9. | ||||
1 Serviço de Oncologia. Instituto Português de Oncologia. Porto 2 Serviço de Pneumologia. Centro Hospitalar de Coimbra. Coimbra 3 Serviço de Oncologia. Hospital do Espírito Santo. Évora 4 Serviço de Oncologia. Hospital de Santa Maria. Lisboa 5 Serviço de Oncologia. Hospital de São João. Porto 6 Departamento de Hematologia. Instituto Português de Oncologia. Lisboa 7 Serviço de Oncologia. Hospital de Nossa Senhora do Rosário. Barreiro 8 Serviço de Pneumologia, Hospital de Santa Maria. Lisboa 9 IMS Health Portugal, HEOR | ||||
Acta Med Port 2009; 22: 525-536. |
||||
, Article, Manuscript in preparation | ||||
, Portugal | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2009 | Spanish | , | |
Retrospective cost analysis of management of febrile neutropenia in cancer patients in Spain. | ||||
Mayordomo JI, López A, Viñolas N, Castellanos J, Pernas S, Domingo Alonso J, Frau A, Layola M, Antonio Gasquet J, Sánchez J; ENIA Study Group. | ||||
1 Clínico Lozano Blesa, Zaragoza, Spain 2 Vall d’Hebron, Barcelona, Spain 3 Clínic i Provincial, Barcelona, Spain 4 Xeral-Cíes, Vigo, Spain 5 Institut Català d’Oncologia, L’Hospitalet-Barcelona, Spain 6 Virgen de la Arrixaca, Murcia, Spain 7 Provincial de Castellón, Castellón, Spain 8 Health Economics and Outcomes Research, IMS Health, Barcelona, Spain 9 Amgen S.A., Barcelona, Spain | ||||
Curr Med Res Opin. 2009 Oct;25(10): 2533-42. |
||||
, Article | ||||
, Spain | ||||
Abstract: http://informahealthcare.com/doi/abs/10.1185/03007990903209563 | ||||
Condition | Year | Language | Analysis type | |
, Hematology, Oncology | 2009 | English | , | |
Patient out-of-pocket payments for second-line non-small-cell lung cancer oncologic therapies: results from a U.S. claims data analysis. | ||||
Pelletier EM1, Tierce J2, Reyes CM3 | ||||
1IMS Health, Watertown, MA, USA, 2IMS Health, Falls Church, VA, USA, 3Genentech Inc., South San Francisco, CA, USA | ||||
International Association for the Study of Lung Cancer (IASLC) 13th World Conference on Lung Cancer (WCLC), 2009, August, San Francisco, CA, USA |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2009 | English | , Cost of illness | |
Patient characteristics and patterns of therapy use among newly diagnosed patients with early breast cancer: results from a U.S. claims data analysis. | ||||
Pelletier EM1, Smith DB1, Kaura S2, Zelt S2, Battleman DS3 | ||||
1IMS Health, Watertown, MA, USA, 2Novartis Pharmaceuticals, East Hanover, NJ, USA, 3IMS Health, Falls Church, VA, USA | ||||
32nd Annual San Antonio Breast Cancer Symposium, 2009, December, San Antonio, TX, USA |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2009 | English | , Retrospective database analysis | |
Patient out-of-pocket payments for oral oncologic therapies: updated results from a U.S. claims data analysis. | ||||
Pelletier EM1, Tierce J2, Yim YM3, Reyes C3 | ||||
1IMS Health, Watertown, MA, USA, 2IMS Health, Falls Church, VA, USA, 3Genentech Inc., South San Francisco, CA, USA | ||||
American Society of Clinical Oncology (ASCO) 45th Annual Meeting, 2009, May, Orlando, FL, USA |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2009 | English | , Cost analysis | |
Health economic review of non-small cell lung cancer (NSCLC) treatment in the United States. | ||||
Munakata J1, Trochlil K1, Battleman D1, Foley D2 | ||||
1IMS Health, Falls Church, VA, USA, 2Boehringer Ingelheim Ltd, Ridgefield, CT, USA | ||||
ISPOR 12th Annual Europena Congress, Paris, France 24-27 October 2009 PCN145 |
||||
, Poster | ||||
, USA | ||||
Abstract: http://www.ispor.org/congresses/paris1009/posters1.aspx | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2009 | English | , Literature Review | |
The Importance of Clinical Variables in Comparative Analyses Using Propensity Score Matching: the Case of ESA Costs for the Treatment for Chemotherapy-Induced Anemia | ||||
Polsky, D., Eremina, D., Hess, G., Hill, J., Hulnick, S., Roumm, A., Whyte, J. L., Kallich, J. | ||||
Pharmacoeconomics, 27(9):755-765 |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2009 | English | , Retrospective database analysis | |
Review: Use of Electronic Medical Records for Health Outcomes Research: A Literature Review | ||||
Dean, B. B., Lam, J., Natoli, J. L., Butler, Q., Aguilar, D., Nordyke, R. J. | ||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2009 | English | , Retrospective database analysis | |
Erythropoiesis Stimulating Agent (ESA) Administration at Hb<10 G/Dl for Chemotherapy-Induced Anemia (CIA) Following the National Coverage Decision (NCD) | ||||
Hulnick, S. A., Hess, G., Hill, J., Viswanathan, H. N., Nordyke, R. J. | ||||
Journal of Clinical Oncology, 27(suppl; abstract e20627): Pub only abstract for ASCO |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2009 | English | , Retrospective database analysis | |
Trajectory of Hemoglobin (Hb) in Patients Receiving Erythropoiesis-Stimulating Agents (ESAs) for Anemia Due to Concomitantly Administered Myelosuppressive Chemotherapy (CIA) (2006~2008) | ||||
Hill, J., Cong, Z., Hess, G. P., Nordyke, R. | ||||
Blood |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2009 | English | , Retrospective database analysis | |
NSAID use and risk of leukaemia: a population-based case-control study | ||||
Bhayat F, Das-Gupta E, Smith C & Hubbard R | ||||
Division of Epidemiology and Public Health, University of Nottingham | ||||
Pharmacoepidemiol Drug Saf. 2009 Sep;18(9):833-6. doi: 10.1002/pds.1789. |
||||
, Abstract | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/19551758 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2009 | English | , Retrospective database analysis | |
The incidence of and mortality from leukaemias in the UK: a general population-based study | ||||
Bhayat F, Das-Gupta E, Smith C, McKeever T & Hubbard R | ||||
Division of Epidemiology and Public Health, University of Nottingham | ||||
BMC Cancer 2009, 9:252 |
||||
, Abstract | ||||
, UK | ||||
Abstract: http://www.biomedcentral.com/1471-2407/9/252 | ||||
Condition | Year | Language | Analysis type | |
, Hematology, Oncology | 2009 | English | , Retrospective database analysis | |
Cancer incidence in The Health Improvement Network | ||||
Haynes K, Forde KA, Schinnar R, Wong P, Strom BL & Lewis JD | ||||
Department of Biostatistics and Epidemiology, University of Pennsylvania School of Medic | ||||
Pharmacoepidemiol Drug Saf. 2009 Aug;18(8):730-6. doi: 10.1002/pds.1774. |
||||
, Abstract | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/19479713 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2009 | English | , Retrospective database analysis | |
Lymphoma among patients with atopic dermatitis and/or treated with topical immunosuppressants in the United Kingdom. | ||||
Arellano FM, Arana A, Wentworth CE, Fernández-Vidaurre C, Schlienger RG & Conde E | ||||
Risk MR, LLC, Bridgewater, NJ, USA | ||||
J Allergy Clin Immunol. 2009 May;123(5):1111-6, 116.e1-13. doi: 10.1016/j.jaci.2009.02.028. Epub 2009 Apr 10. |
||||
, Abstract | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/19361841 | ||||
Condition | Year | Language | Analysis type | |
, Dermatology, Hematology, Oncology | 2009 | English | , Retrospective database analysis | |
The risk of colorectal cancer with symptoms at different ages and between the sexes: a case-control study | ||||
Hamilton W, Lancashire R, Sharp D, Peters TJ, Cheng K & Marshall T | ||||
Academic Unit of Primary Health Care, Department of Community Based Medicine, University of Bristol | ||||
BMC Medicine 2009, 7:17 |
||||
, Article | ||||
, UK | ||||
Abstract: http://www.biomedcentral.com/1741-7015/7/17 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2009 | English | , Retrospective database analysis | |
A Model to Demonstrate the Comparative Costs Between Panitumumab and Cetuximab for Third-line Metastatic Colorectal Cancer Patients in Italy | ||||
Bracco A1 Farrimond BJ2 Fitzgibbon JW2 Eggington SG2 Lavelle RJB2 Lamarque H1 | ||||
1Amgen, Zug, Switzerland; 2IMS Consulting, Cambridge, United Kingdom | ||||
ISPOR 11th Annual European Congress, 8 - 11November 2008, Athens, Greece |
||||
, Poster | ||||
, Italy | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2008 | English | , Economic evaluation | |
Cost-Effectiveness of Pemetrexed Plus Cisplatin: Malignant Pleural Mesothelioma Treatment in UK Clinical Practice | ||||
Cordony A, Le Reun C, Smala A, Symanowski JT, Watkins J | ||||
Value in Health 11 (1), 4–12. |
||||
, Manuscript in preparation | ||||
, UK | ||||
Abstract: http://www.mesothelioma-line.com/articles/2008/02/02/cost-effectiveness-of-pemetrexed-plus-cisplatin-malignant-pleural-mesothelioma-treatment-in-uk-clinical-practice/trackback/ | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2008 | English | , Cost effectiveness | |
Impact of brain metastases on health care costs associated with the management of patients with metastatic breast cancer in France and Germany. | ||||
S Cottrell1, M Walker2, H Scheijbeler1, L Christova1, N Hertel3, B Hass3, M Behrens4, E Roux5, M Amonkar6, Aristides M1 | ||||
1 IMS HEOR, London, UK 2 GlaxoSmithKline, Greenford, UK 3 IMS HEOR, Nuremberg, Germany 4 GlaxoSmithKline, Munich, Germany 5 GlaxoSmithKline, Paris, France 6 GlaxoSmithKline, Philadelphia, USA | ||||
6th European Breast Cancer Conference (EBCC-6), 15-19 April 2008, Berlin, Germany |
||||
, Oral presentation | ||||
, France, Germany | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2008 | English | , Budget impact | |
Can the Spanish care system assume the new costs of medications against cancer? | ||||
Camps C, Caballero C, Sirera R, Blasco A, Cayuela D, Gil M, Badia X | ||||
Clin Transl Oncol 2008;10(2):96-101 |
||||
, Article | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2008 | English | , Cost consequence | |
Endoscopic ultrasound guided fine-needle aspiration for the staging of non-small cell lung cancer and the diagnosis of mediastinal masses | ||||
Medical Services Advisory Committee (assessors Pricing and Market Access, Sydney Australia) | ||||
Commonwealth of Australia |
||||
, Review | ||||
, Australia | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/17296659?dopt=Abstract | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2008 | English | , Review | |
Economic Burdern of Toxicities Associated with Salvage Treatment in Advanced and Metastic Breast Cancer. | ||||
Kowal-Podmore S1, Munakata J1, Tencer T, Smith TW1 | ||||
1 IMS Health, Falls Church, VA, US | ||||
ISPOR 11th Annual European Congress, 2008, Athens, Greece; November 8-11, 2008. |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2008 | English | , Cost analysis | |
Five-Year Routine Cervical Cancer Screening Rates and Intervals in a United States Health Plan | ||||
Schabert VF, Ye X, Insinga RP, Singhal PK, Riedel AA | ||||
Current Medical Research and Opinion 2008; 24(9):2429-2435. |
||||
, Manuscript in preparation | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2008 | English | , Observational study | |
Development of a questionnaire on the effects of hot flashes on the quality of life of patients with advanced prostatic cancer. ESCAPA study | ||||
Carballido Rodríguez JA, Tisaire JL, Perulero N | ||||
Medicina Clínica 2008;130(15):561-567 |
||||
, Article | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2008 | Spanish | , Quality of life | |
Cost-effectiveness analysis of darbepoetin alfa every three week versus its weekly administration in the treatment of chemotherapy-induced anemia | ||||
Riera M, Pérez F, Vieta A, Arocho R | ||||
Pharmacoeconomics Spanish Research Articles 2008;5(1):1-10 |
||||
, Article | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2008 | Spanish | , Cost effectiveness | |
Cost Utility Analysis of Alemtuzumab compared to chlorambucil in untreated patients with high-risk (17p-) Chronic Lymphocytic Leukemia in the United Kingdom. | ||||
Lloyd AC1,Valderrama A2,Ferguson J3, Gilmour L3, Ravndal F1 | ||||
1 IMS, London, United Kingdom, 2 Bayer Healthcare Pharmaceuticals Inc, Pine Brook, NJ, USA, 3 Bayer Healthcare Pharmaceuticals Inc, Newbury, Berkshire, United Kingdom | ||||
ISPOR 11th Annual European Congress, 2008, Athens, Greece; November 8-11, 2008. |
||||
, Poster | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2008 | English | , Cost utility | |
Cost Effectiveness of Cetuximab in first line treatment of Metastatic Colorectal Cancer: A Modelling Approach for the UK | ||||
Garrell D1, Griebsch I2, Samyshkin Y3 | ||||
1Merck Serono UK, Feltham, United Kingdom, 2Merck KGaA, Darmstadt, Germany, 3IMS Health, London, United Kingdom | ||||
ISPOR 11th Annual European Congress, 2008, Athens, Greece; November 8-11, |
||||
, Poster | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2008 | English | , Cost effectiveness | |
Cost-effectiveness and development of new drugs in oncology | ||||
Badia X1 | ||||
1Health Economics and Outcomes Research, IMS Health, Barcelona, Spain, | ||||
2nd Symposium New Paradigms of quality of oncological assistance 2008 June 20. Valencia, Spain |
||||
, Invited speaker | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2008 | Spanish | , Cost effectiveness | |
Cost-utility analysis in a Spanish setting of adjuvant therapy with trastuzumab (Herceptin®) in patients with her-2 positive breast cancer | ||||
Polanco C, Carulla M, Badia X, Ramirez-Arellano A | ||||
ISPOR 11th Annual European Congress 2008 November 8-11, Athens, Greece |
||||
, Poster | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2008 | English | , Cost utility | |
Health economic evaluation of treating anemia in cancer patients receiving chemotherapy: a study in Belgian hospitals. | ||||
Spaepen E, Demarteau N, Van Belle S, Annemans L | ||||
The Oncologist, 2008, 13: 596-607 |
||||
, Article | ||||
, Belgium | ||||
Abstract: http://theoncologist.alphamedpress.org/cgi/content/full/13/5/596 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2008 | English | , Cost analysis | |
Economic burden associated with the management of cervical cancer, cervical dysplasia and genital warts in Belgium. | ||||
Annemans L, Rémy V, Lamure E, Spaepen E, Lamotte M, Muchada JP, Largeron N | ||||
Journal of Medical Economics, 2008, 11: 135-150 |
||||
, Article | ||||
, Belgium | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2008 | English | , Economic evaluation | |
Trastuzumab treatment of early stage breast cancer is cost-effective from the perspective of the Belgian health care authorities. | ||||
Van Vlaenderen I1, Canon JL, Cocquyt V, Jerusalem G, Machiels JP, Neven P, Nechelput M, Delabaye I, Gyldmark M, Annemans L1 | ||||
1 IMS Health, Brussels, Belgium | ||||
Acta Clin Belg. 2009 Mar-Apr;64(2):100-12. |
||||
, Article | ||||
, Belgium | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2008 | English | , Cost utility | |
Deriving utility values from the general population for induction chemotherapy administered before concurrent chemotherapy-radiation therapy in the treatment of head and neck cancer | ||||
Cordony A, Yuen C, Kovacs G, Guarnieri C, Adams J | ||||
ISPOR 11th Annual European Congress 8–11 November 2008 Athens Greece ISPOR 11th Annual European Congress, Athens Greece, November 2008 |
||||
, Oral presentation, Poster | ||||
, Australia | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2008 | English | , Utility analysis | |
Erlotinib bei nichtkleinzelligem Lungenkarzinom in Deutschland - eine kostensparende Option [Erlotinib in Non-Smal Cell Lung Cancer (NSCLC) - A cost-saving second-line treatment option] | ||||
Gatzemeier U1,Kotowa W2, Pirk O2, Gabriel A2, Heigener D1 | ||||
1 Zentrum für Pneumologie und Thoraxchirurgie Krankenhaus Großhansdorf, Großhansdorf, Germany 2 IMS Health, Nuremberg, Germany | ||||
Tumordiagn u Ther 2008; 29: 211-217 |
||||
, Article | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2008 | German | , Cost minimization | |
Economic evaluation of use of pegfilgrastim versus filgrastim in primary profilaxis in patients with breast cancer with febril neutropenia risk in Spain | ||||
Mayordomo Cámara JI, López Pousa A, Giménez García E, Badia Llach X, Lara Surinyach N, Sorio Vilela F, Liu Z, Arocho R | ||||
Pharmacoeconomics Spanish Research Articles 2008;5(3):71-81 |
||||
, Article | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2008 | Spanish | , Economic evaluation | |
Payer costs of autologous stem cell transplant: results for a U.S. claims data analysis. | ||||
Pelletier EM1, Smith PJ1, Dembek CJ2 | ||||
1IMS Health, Watertown, MA, USA, 2Genzyme Corporation, Cambridge, MA, USA | ||||
American Society of Hematology (ASH) 50th Annual Meeting, 2008, December 6-9, San Francisco, CA, USA |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2008 | English | , Cost analysis | |
Patient out-of-pocket payments for oral oncologic therapies: results from a U.S. claims data analysis. | ||||
Pelletier EM1, Tierce J2, Reyes CM3 | ||||
1IMS Health, Watertown, MA, USA, 2IMS Health, Falls Church, VA, USA, 3Genetech Inc., South San Francisco, CA, USA | ||||
International Association for the Study of Lung Cancer (IASLC) Multidisciplinary Symposium in Thoracic Oncology, 2008, November 13-15, Chicago, IL, USA |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2008 | English | , Cost analysis | |
Epidemiology and economic burden of brain metastases among patients with primary breast cancer: results from a U.S. claims data analysis. | ||||
Pelletier EM1, Shim B1, Goodman S1, Amonkar MM2 | ||||
1IMS Health, Watertown, MA, USA, 2GlaxoSmithKline, Collegeville, PA, USA | ||||
Breast Cancer Research and Treatment, 2008, 108(2): 297-305 (epub 2007 Jun 19) |
||||
, Manuscript in preparation | ||||
, USA | ||||
Abstract: http://epidemiology.researchtoday.net/archive/4/2/1532.htm | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2008 | English | , Burden of illness, Cost analysis | |
Utility of bortezomib retreatment in relapsed or refractory multiple myeloma patients: a multicenter case series | ||||
Wolf J, Richardson PG, Schuster M, LeBlanc A, Walters IB, Battleman DS1 | ||||
1 IMS Health, Falls Church, VA, US | ||||
Clin Adv Hematol Oncol. Oct;6(10):755-60. 2008 |
||||
, Manuscript in preparation | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2008 | English | , Cost utility | |
Adherence to Guidelines for Use of Erythropoieses-Stimulating Agents in Patients with Chemotherapy-Induced Anemia: Results of a Retrospective Study of an Electronic Medical-Records Database in the United States, 2002-2006 | ||||
Luo, W., Nordstrom, B. L., Fraeman, K., Nordyke, R., Ranganathan, G., Linz, H. E., Winterkorn, A., Stokes, M., Ross, S. D., Knopf, K. | ||||
Clinical Therapeutics, 30(12):2423-35 |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2008 | English | , Retrospective database analysis | |
Use of Erythropoiesis-Stimulating Agents Among Chemotherapy Patients with Hemoglobin Exceeding 12 Grams Per Deciliter | ||||
Nordstrom, B. L., Luo, W., Fraeman, K. H., Whyte, J. L., Nordyke, R. J. | ||||
Journal of Managed Care Pharmacy, 14(9):858-69 |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2008 | English | , Retrospective database analysis | |
Utilization of Darbepoetin Alfa in Relation to Cancer Patients' Hemoblogin Levels | ||||
Hess, G., Hill, J., Clough, J., Hulnick, S., Nordyke, R. J. | ||||
Current Medical Research Opinion, 24(3):815-19 |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2008 | English | , Retrospective database analysis | |
The Importance of Clinical Variables for Propensity Score Matching When Comparing Costs: the Case of ESA Treatments for Chemotherapy Induced Anemia | ||||
Polsky, D., Eremina, D., Hess, G., Hill, J., Hulnick, S., Roumm, A., Whyte, J. L., Kallich, J. | ||||
Blood, 112(11):4695 |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2008 | English | , Retrospective database analysis | |
Effect of Changes in Labeling and Reimbursement on Use of ESAs and Transfusions | ||||
Hess, G., Nordyke, R. J., Pirolli, M., Hulnick, S., Curry, A., Gesme, D. | ||||
Journal of Clinical Oncology, 26:A20589) |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2008 | English | , Retrospective database analysis | |
Red Blood Cell Transfusions Among Cancer Patients on Chemotherapy: A Descriptive Epidemiologic Study | ||||
Nordstrom, B. L., Fraeman, K. H., Luo, W., Collins, J. M., O'Malley, C. D., Nordyke, R. J. | ||||
Journal of Clinical Oncology, 26:A20623) |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2008 | English | , Retrospective database analysis | |
Synchronization of Treatment with Erythropoiesis Stimulating Agents and Chemotherapy | ||||
Nordstrom, B. L., Fraeman, K. H., Collins, J. M., Luo, W., O'Malley, C. D., Whyte, J. L., Nordyke, R. | ||||
Journal of Managed Care Pharmacy, 14(7):694 |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2008 | English | , Retrospective database analysis | |
Red Blood Cell Transfusions Among Cancer Patients in Chemotherapy: A Descriptive Epidemiologic Study | ||||
Nordstrom, B., Fraeman, K., Luo, W., Collins, J., O'Malley, C. | ||||
Supportive Care in Cancer Journal, A41 |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2008 | English | , Retrospective database analysis | |
The Importance of Clinical Variables for Propensity Score Matching When Comparing Costs: the Case of EMA Treatments for Chemotherapy Induced Anemia | ||||
Polsky, D., Eremina, D., Hess, G., Hill, J., Hulnick, S., Roumm, A., Whyte, J., L., Kallich, J. | ||||
Blood, 112(11):4695 |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2008 | English | , Retrospective database analysis | |
Effect of Changes in Labeling and Reimbursement on Use of ESAs and Transfusions | ||||
Hess, G., Nordyke, R. J., Pirolli, M., Hulnick, S., Curry, A., Gesme, D. | ||||
Journal of Clinical Oncology, 26:A20589) |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2008 | English | , Retrospective database analysis | |
Red Blood Cell Transfusions Among Cancer Patients on Chemotherapy: A Descriptive Epidemiologic Study | ||||
Nordstrom, B. L., Fraeman, K. H., Luo, W., Collins, J. M., O'Malley, C. D., Nordyke, R. J. | ||||
Journal of Clinical Oncology, 26:A20623 |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2008 | English | , Retrospective database analysis | |
Synchronization of Treatment with Erythropoiesis-Stimulating Agents and Chemotherapy | ||||
Nordstrom, B. L., Fraeman, K. H., Collins, J. M., Luo, W., O'Malley, C. D., Whyte, J. L., Nordyke, R. | ||||
Journal of Managed Care Pharmacy, 14(7):694 |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2008 | English | , Retrospective database analysis | |
Red Blood Cell Transfusions Among Cancer Patients in Chemotherapy: A Descriptive Epidemiologic Study | ||||
Nordstrom, B., Fraeman, K., Luo, W., Collins, J., O'Malley, C. | ||||
Supportive Care in Cancer Journal, A41 |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2008 | English | , Retrospective database analysis | |
Validation of the CAPER score for diagnosis for colorectal cancer and comparison with NICE guidance | ||||
Hamilton WT, Lancashire R, Sharp D, Peters TJ, Cheng K & Marshall T | ||||
University of Birmingham | ||||
The Society For Academic Primary Care, 37th Annual Scientific Meeting |
||||
, Abstract, Poster | ||||
, UK | ||||
Abstract: https://www.sd.imshealth.com/SiteCollectionDocuments/Medical%20Research%20Scientific%20Publications/CSDScientificPublications_2014.pdf | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2008 | English | , Retrospective database analysis | |
Antibiotic use and the risk of lung cancer. | ||||
Zhang H, García Rodríguez LA & Hernández-Díaz S. | ||||
Department Epidemiology, Harvard School of Public Health | ||||
Cancer Epidemiol Biomarkers Prev. 2008 Jun;17(6):1308-15. doi: 10.1158/1055-9965.EPI-07-2817. Epub 2008 Jun 10. |
||||
, Abstract, Article | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/18544646 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2008 | English | , Retrospective database analysis | |
Recording of pancreatic, colorectal, and lung cancer incidence in the Health Improvement Network (THIN) | ||||
Haynes K, Schinnar R, Wong P, Strom B & Lewis J | ||||
Healthcore Inc | ||||
Pharmacoepidemiology and Drug Safety 17(S38) Pharmacoepidemiology and drug safety 2008 |
||||
, Abstract | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Miscellaneous, Oncology | 2008 | English | , Retrospective database analysis | |
Validation of THIN data for non-melanoma skin cancer. | ||||
Meal A1, Leonardi-Bee J, Smith C, Hubbard R, Bath-Hextall F. | ||||
School of Nursing, University of Nottingham | ||||
Qual Prim Care. 2008;16(1):49-52. |
||||
, Abstract, Article | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/18700078 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2008 | English | , Retrospective database analysis | |
Validation of cases of lymphoma in THIN | ||||
Arellano F, Conde E, Wentworth C, Schlienger R, Fernandez-Vidauure C & Arana A | ||||
GSK | ||||
24th International Conference on Pharmacoepidemiology. January 2008 Pharmacoepidemiology and Drug Safety 17(S87-S88) |
||||
, Abstract, Poster | ||||
, UK | ||||
Abstract: https://www.rtihs.org/publications/validation-cases-lymphoma-thin | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination, Oncology | 2008 | English | , Retrospective database analysis | |
The importance of anaemia in diagnosing colorectal cancer: a case-control study using electronic primary care records. | ||||
Hamilton W, Lancashire R, Sharp D, Peters T J, Cheng K & Marshall T | ||||
Academic Unit of Primary Health Care, Department of Community Based Medicine, University of Bristol | ||||
Br J Cancer. 2008 Jan 29;98(2):323-7. doi: 10.1038/sj.bjc.6604165. Epub 2008 Jan 22. |
||||
, Abstract | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/18219289 | ||||
Condition | Year | Language | Analysis type | |
, Hematology, Oncology | 2008 | English | , Retrospective database analysis | |
The risk of colorectal cancer with symptoms at different ages and between the sexes: a case-control study | ||||
Hamilton W, Lancashire R, Sharp D, Peters TJ, Cheng K & Marshall T | ||||
Academic Unit of Primary Health Care, Department of Community Based Medicine, University of Bristol | ||||
BMC Medicine 17;7:17. doi: 10.1186/1741-7015-7-17 |
||||
, Article | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/19374736 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2008 | English | , Retrospective database analysis | |
Bendamustine | ||||
Keating M, Bach C, Yashothan U, Kirkpatrick P | ||||
IMS Health, London | ||||
Nature Reviews Drug Discovery, 2008, 7:473-474 |
||||
, Article | ||||
, UK | ||||
Abstract: http://www.nature.com/nrd/journal/v7/n6/box/nrd2596_BX1.html | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2008 | English | ||
Topotecan NICE submission: response document. | ||||
QuintilesIMS | ||||
NICE Guidance |
||||
, Manuscript in preparation | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2008 | English | ||
Cost of initial prostate cancer treatment following diagnosis per patient by stage: estimates from the UK, France, Germany, Italy and Spain. | ||||
Benedict A, Black L, Stokes M, Dorval | ||||
1 United BioSource Corporation, Budapest, Hungary 2 GlaxoSmithKline, Research Triangle Park, NC, USA 3 United BioSource Corporation, Dorval, QC, Canada | ||||
ISPOR 11th Annual European Congress |
||||
, Abstract | ||||
, France, Germany, Italy, Spain, UK | ||||
Abstract: http://www.valueinhealthjournal.com/article/S1098-3015(10)66210-9/pdf | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2008 | English | , Cost effectiveness | |
Resource use and time savings in Spain linked with new chemotherapy presentations: the case of oxaliplatin | ||||
Betegón L, Echevarria A, Soler F, Quer N | ||||
, Poster | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2007 | English | , Burden of illness | |
Economic burden of brain metastases in breast cancer patients in a U.S. managed-care population. | ||||
Amonkar MM1, Pelletier EM2, Shim B2 | ||||
1GlaxoSmithKline, Collegeville, PA, USA, 2IMS Health, Watertown, MA, USA | ||||
American Society of Clinical Oncology (ASCO) 43rd Annual Meeting, 2007, June, Chicago, IL, USA Journal of Clinical Oncology, 2007, Part I. Vol 25, No 18S (June 20 Supplement): 17069 |
||||
, Poster | ||||
, USA | ||||
Abstract: http://www.asco.org/ASCO/Abstracts+%26+Virtual+Meeting/Abstracts?&vmview=abst_detail_view&confID=47&abstractID=33687 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2007 | English | , Cost analysis | |
A cost-consequence analysis of darbepoetin alfa administered every 3 weeks (q3w_da) compared to weekly epoetin alfa (qw_ea) or epoetin beta (qw_eb) in patients with chemotherapy-induced anemia (cia): the Italian case | ||||
Esposito G, Lamotte M, Annemans L, Bracco A | ||||
ISPOR 2007 10th Annual European Congress |
||||
, Italy | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2007 | English | , Cost consequence | |
A cost-consequence analysis of darbepoetin alfa administered every 3 weeks (q3w_da) compared to weekly epoetin alfa (qw_ea) or epoetin beta (qw_eb) in patients with chemotherapy-induced anemia (cia): the German case. | ||||
Van Bellinghen LA, Esposito G, Lamotte M, Bracco A, Goertz A, Annemans L | ||||
ISPOR 10th Annual European Congress Value in Health 10(6):A328 ISPOR 10th Annual European Congress, 2007, October 20-23, Dublin, Ireland |
||||
, Oral presentation | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2007 | English | , Cost consequence | |
Cost-effectiveness of pemetrexed plus cisplatin: malignant pleural mesothelioma treatment in UK clinical practice. | ||||
Cordony A, Le Reun C, Smala A, Symanowski JT, Watkins J | ||||
Value in Health. In press |
||||
, Manuscript in preparation | ||||
, UK | ||||
Abstract: http://www.mesothelioma-line.com/articles/2008/02/02/cost-effectiveness-of-pemetrexed-plus-cisplatin-malignant-pleural-mesothelioma-treatment-in-uk-clinical-practice/trackback/ | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2007 | English | , Cost effectiveness | |
Health outcomes and cost-effectiveness of aprepitant in outpatients receiving antiemetic prophylaxis for highly emetogenic chemotherapy in Germany. | ||||
Lordick F, Ehlken B, Ihbe-Heffinger A, Berger K, Krobot KJ, Pellissier J, Davies G, Deuson R. | ||||
Eur J Cancer 2007; 43(2): 299-307 |
||||
, Manuscript in preparation | ||||
, Germany | ||||
Abstract: http://www.druglib.com/abstract/lo/lordick-f_eur-j-cancer_20070100.html | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2007 | English | , Cost effectiveness | |
Cost-effectiveness and cost-utility of rituximab maintenance therapy for patients with relapsed/refractory follicular lymphoma in French setting. | ||||
Pacull A, Coudray-Omnes C, Brice P, Deconinck E, Le Pen C, Miadi-Fargier H | ||||
ISPOR 2007 10th Annual European Congress |
||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2007 | English | , Cost effectiveness | |
Estimating the cost effectiveness of prophylactic cervical cancer vaccination in ireland using a mathematical model | ||||
S. Redmond N Demarteau | ||||
ISPOR 2007 10th Annual European Congress |
||||
Condition | Year | Language | Analysis type | |
, Oncology | 2007 | English | , Cost effectiveness | |
Evaluating the clinical effects and the cost-effectiveness of prophylactic cervical cancer vaccination within an organised population-based screening setting ? case Finland | ||||
Saku Torvinen, Pekka Nieminen, Nadia Demarteau, Susanne Bergius, Jarmo Hahl | ||||
ISPOR 2007 10th Annual European Congress |
||||
, Finland, Nordic | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2007 | English | , Cost effectiveness | |
Adjuvant trastuzumab treatment in early stage breast cancer: cost-effectiveness in the Belgian healthcare setting | ||||
Van Vlaenderen I, Canon JL, Cocquyt V, Jerusalem G, Machiels JP, Neven P, Nechelput M, Delabaye I, Gyldmark M, Annemans L | ||||
ISPOR 2007 10th Annual European Congress |
||||
, Belgium | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2007 | English | , Cost effectiveness | |
Incidence and prevalence of brain metastases among patients with advanced breast cancer in a U.S. managed-care population | ||||
Pelletier EM1, Amonkar MM2, Shim B1 | ||||
1IMS Health, Watertown, MA, USA, 2GlaxoSmithKline, Collegeville, PA, USA | ||||
American Society of Clinical Oncology (ASCO) 43rd Annual Meeting, 2007, June, Chicago, IL, USA |
||||
, Poster | ||||
, USA | ||||
Abstract: http://www.asco.org/ASCO/Abstracts+%26+Virtual+Meeting/Abstracts?&vmview=abst_detail_view&confID=47&abstractID=33687 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2007 | English | , Epidemiological study | |
Final development and validation of the BOMET-QoL questionnaire for assessing quality of life in patients with malignant bone disease due to neoplasia. | ||||
Sureda A, Isla D, Cózar JM, Ruiz M, Domine M, Margelí M, Adrover E, Ramos M, Pastor M, Martín A, Llombart A, Massuti B, Muñoz M, Barnadas A, Fernández J, colomer R, Allepuz C, Gilabert M, Badia X | ||||
J Medical Econ 2007;10:27-39 |
||||
, Article | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2007 | English | , Quality of life | |
Behandlungsmuster und Kosten bei der Neueinstellung von onkologischen Patienten mit mäßig starken bis starken, nicht akuten Schmerzen auf transdermale Opioidanalgetika. | ||||
Paessens B, Lippert B, Ehlken B, Berger K, Amann S, Bernard R, Ihbe-Heffinger A. | ||||
Krankenhauspharmazie 2007; 28 (2): 47-53 |
||||
, Manuscript in preparation | ||||
Abstract: http://www.adka.de/daten/any/Opioidanalgetika.pdf | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2007 | German | ||
A health economic evaluation of hexvix as adjunct to standard white light cystoscopy in the management of superficial bladder cancer | ||||
Demarteau N, Braeckman J, Michielsen D, Sweet A, Zyczynski T, Lamotte M | ||||
ISPOR 2007 10th Annual European Congress |
||||
, Belgium | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2007 | English | ||
Treatment patterns for patients with glioblastoma multiforme (GBM) in Germany | ||||
Jenkins A, Aristides M, Liepa AM, Relf C, Feilding B. | ||||
ISPOR 2007 10th Annual European Congress |
||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2007 | English | ||
Adaptation of a health economic model of the natural history of HPV infection and cervical cancer in a well functioning population-based screening system ? a model calibration to Finland | ||||
Saku Torvinen, Pekka Nieminen, Nadia Demarteau, Susanne Bergius, Jarmo Hahl | ||||
ISPOR 2007 10th Annual European Congress |
||||
, Finland, Nordic | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2007 | English | ||
Impact of the allowable gap on persistence in the bisphosphonate market | ||||
Scott C. Henderson, Heather von Allmen, Thomas W. Weiss | ||||
ISPOR 2007 10th Annual European Congress |
||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2007 | English | ||
Cost of management of metastatic soft tissue sarcoma. | ||||
Judson I1, Al-Muderis O1, Scott D2, Lloyd A2, Garcia B3. | ||||
1 The Institute of Cancer Research, Royal Marsden Hospital, London, UK 2 Fourth Hurdle Consulting Ltd., London, UK 3 PharmaMar, Madrid, Spain | ||||
NCRI Cancer Conference, Birmingham, UK, 2007. |
||||
, Poster | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2007 | English | , Cost of illness | |
on the individual: a discrete-event simulation model of HPV infection, progression and control. | ||||
Thompson WA1, Kretzschmar M2 | ||||
1 IMS Health, London, UK, 2 University of Bielefeld, Germany | ||||
IV Annual Meeting Health Technology Assessment International, 17th-20th June, Barcelona, Spain. |
||||
, Poster | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2007 | English | ||
Second-line treatment of non-small lung cancer (NSCLC) with erlotinib is potentially cost-saving for the German healthcare system | ||||
Gatzemeier U1, Pirk O2, Kotowa W2, Erhardt W3, Gabriel A2 | ||||
1 Center for Pneumology and Thoracic Surgery, Hospital Grosshansdorf, Grosshansdorf, Germany 2 IMS Health, Nuremberg, Germany 3 F. Hoffmann-La Roche AG, Basel, Switzerland | ||||
12th World Conference on Lung Cancer, Sep. 2-6, 2007, Seoul |
||||
, Abstract | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2007 | English | , Cost minimization | |
A comparison of the estimated cost of erlotinib, docetaxel and pemetrexed for the second-lne treatment of non-small cell lung cancer from the German healthcare perspective | ||||
Kotowa W1 , Gatzemeier U2, Pirk O1, Gabriel A1 , Heigener D2 | ||||
1 Center for Pneumology and Thoracic Surgery, Hospital Grosshansdorf, Grosshansdorf, Germany 2 IMS Health, Nuremberg, Germany 3 F. Hoffmann-La Roche AG, Basel, Switzerland | ||||
12th World Conference on Lung Cancer, Sep. 2-6, 2007, Seoul Journal of Medical Economics; 10:255-271 |
||||
, Article, Oral presentation | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2007 | English | , Cost minimization | |
Endoscopic ultrasound for evaluating pancreatic, gastric, oesophageal and hepatobiliary neoplasms | ||||
Medical Services Advisory Committee (assessors Pricing and Market Access Sydney Australia) | ||||
Commonwealth of Australia |
||||
, Review | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2007 | English | , Review | |
Questionnaire of treatment preferences in patients with advanced non-small cell lung cancer | ||||
Garcia R, Juan O, Vázquez S, Barneto I, Cardenal F, Varela C, Perulero N | ||||
ISPOR 11th Annual European Congress 2008 November 8-11, Athens, Greece |
||||
, Poster | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2007 | English | , Quality of life | |
Factores económicos de los avances en oncología [Economic factors of advances in oncology] | ||||
Faull I1 | ||||
1Health Economics and Outcomes Research, IMS Health, Barcelona, Spain, | ||||
Congreso anual de la SEFH (Sociedad Española de Farmacia Hospitalaria)2007 Septembre 27. Tenerife, Spain |
||||
, Oral presentation | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2007 | Spanish | ||
Treatment patterns and costs at the point of initiation of oncology patients with moderate to severe pain, not urgent transdermal Opioidanalgetika [Neueinstellung onkologischer Patienten auf transdermale Opioid-Analgetika - Behandlungsmuster und Kosten] | ||||
Paessens B 1, Lippert B 2, Ehlken B 2, Berger K 2, Amann S 1, Bernard R 1, Ihbe-Heffinger A 1. | ||||
1 Klinikum rechts der Isar der Technischen Universität München, Apotheke, Munich, Germany 2 IMS Health, Munich, Germany | ||||
Krankenhauspharmazie 2007; 28 (2): 47-53. |
||||
, Article | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2007 | German | , Prospective study | |
Risk of Renal Failure Associated with IV Bisphosphonate Use in Patients with Multiple Myeloma | ||||
Joyce A, Harrison D, Jun S, Feliu A, Anthony M | ||||
American Society of Clinical Oncology Annual Meeting, 2007, June 1-5, Chicago, USA |
||||
, Oral presentation | ||||
, USA | ||||
Abstract: http://www.asco.org/ASCO/Abstracts+%26+Virtual+Meeting/Abstracts?&vmview=abst_category_abstracts_view&confID=47&subCatID=44 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2007 | English | , Retrospective database analysis | |
Differences in alpha blocker usage among enlarged prostate patients receiving combination therapy with 5 ARIs. | ||||
Naslund M, Black L, Eaddy M, Batiste L | ||||
Am J Manag Care. 2007; 13 Suppl 1:S17-22 |
||||
, Article | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2007 | English | , Retrospective database analysis | |
Finasteride versus dutasteride: a real-world economic evaluation. | ||||
Fenter T, Runken M, Black L, Eaddy M | ||||
Am J Manag Care., 2007, 13 Suppl 1:S23-8 |
||||
, Article | ||||
, USA | ||||
Abstract: http://www.druglib.com/abstract/fe/fenter-tc_am-j-manag-care_20070200.html | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2007 | English | , Retrospective database analysis | |
The Utilization of Darbepoetin Alfa (DA) in Relation to Cancer Patients' Hemoglobin Levels | ||||
Hess, G., Hill, J., Hulnick, S., Nordyke, R. | ||||
Blood, 110(11):3756 |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2007 | English | , Retrospective database analysis | |
Adherence to Guidelines for Use of Erythropoiesis Stimulating Proteins in Patients with Chemotherapy-Induced Anemia: Trends from Electronic Medical Records | ||||
Luo, W., Nordstrom, B., Ranganathan, G., Fraeman, K., Linz, H., Stokes, M., Knopf, K., Ross, S. | ||||
Supportive Care in Cancer, 15(6):757 |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2007 | English | , Retrospective database analysis | |
Use Patterns of Erythropoiesis Stimulating Agent in Electronic Medical Records of Cancer Patients | ||||
Hess, G. P., Hulnick, S. A., Kallich, J. D., Whyte, J. L. | ||||
Supportive Care in Cancer, 15(6):758 |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2007 | English | , Retrospective database analysis | |
The Utilization of Darbepoetin Alfa (DA) in Relation to Cancer Patients' Hemoglobin Levels | ||||
Hess, G., Hill, J., Hulnick, S., Nordyke, R. | ||||
Blood, 110(11):3756 |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2007 | English | , Retrospective database analysis | |
Adherence to Guidelines for Use of Erythropoiesis Stimulating Proteins in Patients with Chemotherapy-Induced Anemia: Trends from Electronic Medical Records | ||||
Luo, W., Nordstrom, B., Ranganathan, G., Fraeman, K., Linz, H., Stokes, M., Knopf, K., Ross, S. | ||||
Supportive Care in Cancer, 15(6):757 |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2007 | English | , Retrospective database analysis | |
Use Patterns of Erythropoiesis Stimulating Agent in Electronic Medical Records of Cancer Patients | ||||
Hess, G. P., Hulnick, S. A., Kallich, J. D., Whyte, J. L. | ||||
Supportive Care in Cancer, 15(6):758 |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2007 | English | , Retrospective database analysis | |
The incidence of cancer in patients with idiopathic pulmonary fibrosis and sarcoidosis in the UK. | ||||
Le Jeune I, Gribbin J, West J, Smith C, Cullinan P & Hubbard R | ||||
Division of Epidemiology and Public Health, University of Nottingham | ||||
Respir Med. 2007 Dec;101(12):2534-40. Epub 2007 Sep 17. |
||||
, Abstract | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/17870458 | ||||
Condition | Year | Language | Analysis type | |
, Oncology, Respiratory disease | 2007 | English | , Retrospective database analysis | |
Use of antidepressants and risk of lung cancer. | ||||
Toh S, García Rodríguez LA & Hernández-Díaz S | ||||
Department of Epidemiology, Harvard School of Public Health, Boston | ||||
Cancer Causes Control. 2007 Dec;18(10):1055-64. Epub 2007 Aug 8. |
||||
, Abstract, Article | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/17682831 | ||||
Condition | Year | Language | Analysis type | |
, Mental health, Oncology | 2007 | English | , Retrospective database analysis | |
Use of antidepressants and risk of lung cancer. | ||||
Toh S, García Rodríguez LA & Hernández-Díaz S | ||||
Cancer Causes Control. 2007 Dec;18(10):1055-64. Epub 2007 Aug 8. |
||||
, Abstract | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/17682831 | ||||
Condition | Year | Language | Analysis type | |
, Mental health, Oncology | 2007 | English | ||
Non-steroidal anti-inflammatory drugs and risk of lung cancer | ||||
Hernandez-Diaz S & Garcia Rodriguez LA | ||||
Department of Epidemiology, Harvard School of Public Health, Boston | ||||
Int J Cancer. 2007 Apr 1;120(7):1565-72. |
||||
, Abstract, Article | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/17205530 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2007 | English | , Retrospective database analysis | |
Risk factors for the development of oesophageal cancer in Barrett’s oesophagus: a primary care cohort study | ||||
Cooper SC, Graham P & Trudgill NJ | ||||
Department of Gastroenterology, Sandwell and West Birmingham Hospitals NHS Trust | ||||
Gastroenterology 132(4) Suppl 2: A420 |
||||
, Abstract | ||||
, UK | ||||
Abstract: http://ueg.sagepub.com/content/2/2/91.full | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2007 | English | , Retrospective database analysis | |
Trends in incidence of skin basal cell carcinom: Additional evidence from a UK primary care database study | ||||
Bath-Hextall F , Leonardi-Bee J, Smith C, Meal A & Hubbard R | ||||
Centre for Evidence-Based Dermatology, School of Nursing, University of Nottingham | ||||
International Journal of Cancer 121(9):2105-8 |
||||
, Article | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2007 | English | , Retrospective database analysis | |
The effect of cancer drug vintage on cancer survival and mortality. | ||||
IMS Health | ||||
2007 European Society of Medical Oncology |
||||
, Article | ||||
, France, Germany, Italy, Spain, UK | ||||
Abstract: https://academic.oup.com/annonc/article/18/suppl_3/iii67/214317/The-effect-of-cancer-drug-vintage-on-cancer | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2007 | English | ||
A comparative budget impact (BI) analysis of Aranesp® (darbepoetin alfa) 500µG Q3W versus other erythropoiesis stimulating proteins (ESP) in chemotherapy-induced anemia (CIA) in Spain | ||||
Pérez Alcàntara F, Badia X, Arocho R | ||||
1Health Outcomes Research, Barcelona, Barcelona, Spain, 2 Health Outcomes Research Europe, IMS Health, Barcelona, Spain, 3Amgen SA, Barcelona, Barcelona, Spain | ||||
ISPOR 9th Annual European Congress, 28-31 October 2006, Copenhagen, Denmark |
||||
, Poster | ||||
, Spain | ||||
Abstract: http://www.ispor.org/congresses/denmark1006/posters2.asp#Cancer | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2006 | English | , Budget impact | |
Treatment of actinic keratosis (AK) and basal cell carcinoma (BCC) with Metvix® (MAL-PDT) in real life practice: a cost of illness and model validation study. | ||||
Caekelbergh K1, Annemans L1 | ||||
1 IMS Health, Brussels, Belgium | ||||
ISPOR 9th Annual European Congress, 2006, October 29-31, Copenhagen, Denmark |
||||
, Poster | ||||
, Belgium | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2006 | English | , Cost of illness | |
Cost analysis of febrile neutropenia management of breast cancer patients in clinical practice in Spain. | ||||
Mayordomo JI, Castellanos J, Pernas S, Ruiz-Borrego M, Velasco A, Frau A, Lamas MJ, Lara N. | ||||
31st European Society of Medical Oncology congress (ESMO), Estambul (Tukey) 29 Septiember-03 October |
||||
, Poster | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2006 | English | , Burden of illness | |
Cost of febrile neutropenia management in cancer patients in Spain. | ||||
Mayordomo JI, Lopez A, Viñolas N, Castellanos J, Pernas S, Alonso JD, Frau A, Layola M, Gasquet JA, Sanchez JA, on behalf of the ENIA Study Group. | ||||
American Society of Clinical Oncology (ASCO) Annual Meeting 2006, Atlanta (GA, US) 2-6 June |
||||
, Poster | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2006 | English | , Burden of illness | |
A cost-consequence analysis of darbepoetin alfa administered every 3 weeks (Q3W_DA) compared to weekly epoetin alfa (QW_EA) or epoetin beta (WQ_EB) in patients with chemotherapy-induced anemia (CIA): A retrospective study. | ||||
Van Bellinghen LA, Demarteau N, Annemans, Bracco A | ||||
ISPOR 9th Annual European Congress, 2006, October 29-31, Copenhagen, Denmark |
||||
, Poster | ||||
, Belgium | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2006 | English | , Cost consequence | |
Cost effectiveness of cetuximab in combination with radiotherapy versus radiotherapy alone in the treatment of locally advanced head and neck cancer in Spain | ||||
Brosa M, Robinson P Brown B | ||||
Max Brosa, , Director1, Paul Robinson, BSc, MSc, Senior Economist2, Ben Brown, MSc, Economist21Oblikue Consulting, Barcelona, SC, Spain; 2 IMS Health Economics & Outcomes Research, London, United Kingdom | ||||
ISPOR Ninth Annual European Congress Copenhagen, Denmark October, 2006 |
||||
, Poster | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2006 | English | , Cost effectiveness | |
Cost-effectiveness of cetuximab (Erbitux®) in combination with radiotherapy versus radiotherapy alone in the treatment of locally advanced head and neck cancer in France | ||||
Brown B, Roninson P, Launois R, Griebsch I | ||||
, Poster | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2006 | English | , Cost effectiveness | |
Cost-effectiveness analysis of adjuvant therapy with trastuzumab (Herceptin) for the treatment of breast cancer in inicial stages. | ||||
Polanco Sánchez C, Rodríguez Sánchez C, Sánchez-Rovira P, Barnadas Molins A, Sabater Torres FJ, Álvarez Sanz C. | ||||
VII Scientific Meeting of the Asociación Española de Evaluación de Tecnologías Sanitarias (Spanish Association of Health Technology Evaluation), Sevilla (Spain) 16-17 November |
||||
, Poster | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2006 | English | , Cost effectiveness | |
Cost-effectiveness of pemetrexed plus cisplatin versus cisplatin alone in the treatment of malignant pleural mesothelioma | ||||
Davey P, Cordony A, Rajan N, Arora B, Pavlakis N. | ||||
ISPOR 2nd Asia-Pacific conference ISPOR 2nd Asia-Pacific conference, Worldfield Convention Hotel, Shanghai, China |
||||
, Poster | ||||
Condition | Year | Language | Analysis type | |
, Oncology, Respiratory disease | 2006 | English | , Cost effectiveness | |
Cost-effectiveness of pemetrexedplus cisplatin versus cisplatin alone in the treatment of malignant pleuralmesothelioma. | ||||
Davey P, Cordony a, Rajan N, Arora B, Pavlakis | ||||
ISPOR 2nd Asia-Pacific Congress,Shanghai, China |
||||
, Poster | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2006 | English | , Cost effectiveness | |
Economic evaluation of treatments for non-microcytic lung cancer | ||||
Alberola V, Antón A, Carrato A, Cortés-Funes H, Guillem V, Le Lay K, et al. | ||||
Rev Esp Econ Salud 2007;6(4):242-9 |
||||
, Manuscript in preparation | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2006 | Spanish | , Economic evaluation | |
Toxicity and health-related quality of life in breast cancer patients receiving adjuvant docetaxel, doxorubicin, cyclophosphamide (TAC) or 5-fluorouracil, doxorubicin and cyclophosphamide (FAC). | ||||
Martin M, Lluch A, Segui MA, Ruiz A, Ramos M, Adrover E, et al. | ||||
Ann Oncol 2006;17(8):1205-12 |
||||
, Manuscript in preparation | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2006 | English | , Quality of life | |
European organisation for research and treatment of cancer. European guidelines for the management of chemotherapy-induced anaemia and health economic aspects of treatment. | ||||
Repetto L, Moeremans K, Annemans L | ||||
Cancer Treat Rev., 2006, 32(Suppl 2): S5-9 |
||||
, Manuscript in preparation | ||||
, Europe | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2006 | English | , Quality of life | |
Economic evaluation of surgical treatment vs. Imiquimod 5% cream in patients with Superficial Basal Cell Carcinoma | ||||
Vanaclocha F, Badia X, Guillén V, Sánchez J, Sáinz de los Terreros M, Llorens MA. | ||||
Br J Dermatol. 2007 Apr;156(4):769-71. |
||||
, Article | ||||
, Spain | ||||
Abstract: http://www3.interscience.wiley.com/journal/117983521/abstract?CRETRY=1&SRETRY=0 | ||||
Condition | Year | Language | Analysis type | |
, Health economics, Oncology | 2006 | English | ||
An update: Health economics of managing multiple myeloma | ||||
K Moeremans, L Annemans. | ||||
European Journal of Cancer, 2006; 42(11):1684-96 |
||||
, Manuscript in preparation | ||||
, Belgium | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2006 | English | ||
High energy transurethral microwave thermotherapy for benign prostatic hyperplasia. Assessment report. | ||||
Medicare Services Advisory Committee (MSAC). | ||||
Department of Health and Ageing, Commonwealth of Australia. Canberra. |
||||
, Manuscript in preparation | ||||
, Australia | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2006 | English | ||
Long term clinical effect of an HPV-vaccine for the prevention of cervical cancer in France in relation to age of vaccination: Results from a markov model | ||||
Demarteau N, Detournay B, El Hansnaoui A Standaert B, Annemans L | ||||
, Poster | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2006 | English | ||
Erlotinib in non-small cell lung cancer (NSCLC) in Germany - A cost-saving second-line treatment option? | ||||
Gabriel A1, Pirk O1, Kotowa W1 | ||||
1 IMS Health, Nuremberg, Germany | ||||
Value in Health 2006, 9(6): A278 |
||||
, Abstract, Oral presentation | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2006 | English | , Cost minimization | |
Costs of chemotherapy for indolent follicular nonHodgkin’s lymphoma in the UK: an observational study. | ||||
Hutchinson J1, Lloyd A1, Gray A2, Gale R3, Hancock B4. | ||||
1 Fourth Hurdle Consulting, London, UK 2 Health Economics Research Centre, Oxford University, Oxford UK 3 Schering Health Care, West Sussex, UK 4 School of Medicine and Biomedical Sciences, University of Sheffield, Sheffield, UK | ||||
Acta Haematol. 2006;115(1-2):28-34. |
||||
, Manuscript in preparation | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2006 | English | , Cost of illness | |
Patient preference and willingnesss-to-pay for pemetrexed versus docetaxel in the Patient preference and willingnesss-to-pay for pemetrexed versus docetaxel in the second-line treatment of advanced non-small cell lung cancer: a discrete choice conjoint analysis | ||||
Brown A, Aristides M, FitzGerald P, Liepa A, Boyer M, Clarke S | ||||
ISPOR 2nd Asia-Pacific conference |
||||
, Poster | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2006 | English | , Willingness to pay | |
Validity of tests for initial diagnosis and its concordance with final diagnosis in patients with suspected benign prostatic hyperplasia | ||||
Carballido J, Badia X, Gimeno A, Regadera L, Dal-Ré L, Guilera M | ||||
Actas Urol Esp 2006;30(7):667-4 |
||||
, Article | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2006 | Spanish | , Quality of life | |
Adjuvant trastuzumab treatment in early stage breast cancer: cost-effectiveness in the Belgian healthcare setting. | ||||
Van Vlaenderen I, Canon JL, Cocquyt V, Jerusalem G, Machiels JP, Neven P, Nechelput M, Delabaye I, Gyldmark M, Annemans L | ||||
Value in Health, 10(6): A336 |
||||
, Oral presentation | ||||
, Belgium | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2006 | English | , Cost utility | |
Health outcomes and cost-effectiveness of aprepitant in outpatients receiving antiemetic prophylaxis for highly emetogenic chemotherapy in Germany. | ||||
Lordick F 1, Ehlken B 2, Ihbe-Heffinger A 3, Berger K 2, Krobot KJ 4, Pellissier J 5, Davies G 5, Deuson R 6. | ||||
1 Third Medical Department, Klinikum rechts der Isar, Technische Universität München, Munich, Germany 2 IMS Health, Munich, Germany 3 Dept. of Pharmacy, Klinikum rechts der Isar, Technische Universität München, Munich, Germany 4 Outcomes Research, MSD Sharp & Dohme GmbH, Haar, Germany 5 Health Economic Statistics, Merck & Co. Inc., 10 Sentry Pkwy, Blue Bell, USA 6 Outcomes Research, Merck & Co. Inc., One Merck Drive, Whitehouse Station, NJ, USA | ||||
Eur J Cancer 2007; 43(2): 299-307 |
||||
, Article | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2006 | English | , Cost effectiveness | |
Nelarabine | ||||
Gandhi V, Keating M, Bate G, Kirkpatrick P | ||||
IMS Consulting and Services, IMS Health, London | ||||
Nature Reviews Drug Discovery, 2006, 5:17-18 |
||||
, Article | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2006 | English | ||
NICE implementation uptake report: Capecitabine and oxaliplatin for colon cancer. | ||||
IMS Oncology Analyzer (IMS OA), QuintilesIMS | ||||
NICE Guidance |
||||
, Article | ||||
, UK | ||||
Abstract: http://www.nice.org.uk/media/543/99/UptakeReportTA100CapecitabineOxaliplatin.pdf | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2006 | English | , Cost effectiveness | |